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CHAPTER 1 
Overview of Glycosylation Reactions, Automated Oligosaccharide 
Synthesis, and Fluorous-Tag Based Microarray Formation 
Sahana K. Nagappayya and Nicola L. B. Pohl 
Dissertation organization  
This dissertation consists of six chapters. Chapter 1 is an overview of the automated 
solution phase synthesis of oligosaccharides and an introduction to carbohydrate 
microarrays. Some portions of the microarray preparations have been published in a 
chapter titled ‘Production of fluorous-based microarrays with uncharged carbohydrates’ 
in Carbohydrate Microarrays: Methods and Protocols1. Chapter 2 describes an approach 
to synthesizing anomerically-pure α or β−linkages in rhamnopyranosides using a 
protecting group strategy to direct the glycosylation. Various electron-withdrawing 
protecting groups are strategically placed at the O-3 and O-4 of L-rhamnose and the 
glycosylation of such building blocks with a standard fluorous-tag containing L-rhamnose 
is performed. Chapter 3 discusses the first automated solution-phase synthesis of 
fragments of the plant polysaccharide homogalacturonan (HG). The galacturonic acid 
residues required for the backbone synthesis are derived from galactose; a hexasaccharide 
of α-linked galacturonic acid is synthesized using the automated solution-phase platform. 
Chapter 4 describes the development of methods for the synthesis of the plant 
polysaccharide rhamnogalacturonan – I (RG-I) backbone on the automated platform. α-
Linked D-galacturonic acid was glycosylated with a fluorous-tag containing L-rhamnose 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Nagappayya, S. K.; Pohl, N. L. B. Methods in Molecular Biology, Humana Press 2012, 
88, 149-155 
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building block to synthesize the backbone of RG-I. These plant polysaccharide 
backbones constructed on the automated solution-phase synthesis platform are the first 
reports of the automated synthesis of both HG and RG-I fragments. Chapter 5 describes 
the development of a hexyl fluorous tag, which was used for the microarraying of sugars 
and also describes a comparative study of this hexyl fluorous di-tag with the traditional 
mono-octylfluorous tag. Parts of this chapter are published in a report in Chemical 
Communications 2. Chapter 6 is the conclusion of this dissertation and also discusses the 
future direction of the studies and experiments described thus far.  
Glycosylation reactions of carbohydrates 
Since the first synthesis of monosaccharides in the late 1800s by Emil Fischer (Fischer, 
1902) carbohydrate synthesis methods and their structure/function studies have not 
developed as quickly as those of proteins and nucleic acids. It is now commonly known 
that carbohydrates play a crucial role in the development, growth, function, and survival 
of living cells, and also in cell-cell interactions, especially between a pathogen and its 
host cells (Varki, 1993). As more information is now being found on the importance of 
carbohydrates, interest in obtaining pure oligosaccharides is increasing. The task of 
synthesizing even a fully protected monosaccharide requires several chemical 
transformations as compared to a nucleic acid or protein building block. There are two 
important challenges in obtaining pure well-characterized oligosaccharides. First, the 
hydroxyl functional groups on a monosaccharide display similar reactivities and therefore 
the synthesis of a building block ready for glycosylation requires a number of functional 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2 Edwards, H. D.; Nagappayya, S. K.; Pohl, N. L. B. Chem. Comm. 2012, 48, 510-512 	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group transformations and protection/deprotection strategies. The other challenge in 
making oligosaccharides is the stereochemistry at the anomeric center. Synthesizing a 
pure 1,2-cis or 1,2-trans-linkage is non-trivial and a number of factors have to be taken 
into account, including protecting groups, solvent conditions, promoters, thermodynamic 
and kinetic factors and the leaving groups (Davis, 2000).              
A typical sugar molecule in its pyranose or furanose form contains multiple hydroxyl 
groups and to design a monosaccharide building block and chemically synthesize an 
anomerically-pure carbohydrate linkage, various protecting group transformations have 
to be performed. A glycoside bond is formed between a glycosyl donor, generally an 
electrophile, and a glycosyl acceptor, generally a nucleophile that contains a free 
hydroxyl group (Fig. 1-1). As shown in the figure, the glycosyl donor contains a leaving 
group or a group that can be converted into a leaving group under the reaction conditions, 
and upon activation by a promoter, a glycosidic bond is formed between the donor and 
the acceptor. Even after strategically designing the building blocks to obtain pure α or β 
linkages at the anomeric position, there is often still some undesired anomeric product 
obtained. With certain oligosaccharides, some anomeric linkages are extremely 
challenging to synthesize due to the anomeric effect and the resulting thermodynamic 
stability of one linkage over the other.  A glycosylation reaction is a particularly sensitive 
reaction. Over time, many researchers have developed a variety of methods for high-
yielding and strereochemically-pure glycosylations with various building blocks, 
protection group schemes, solvents, and promoters (Schmidt, 1986; Zhu et al, 2008). In 
addition to challenges in the synthesis of oligosaccharides, the purification and 
characterization of an oligosaccharide with multiple sugars and various anomeric 
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linkages is also very challenging. The synthetic challenges of carbohydrate chemistry, 
especially building block synthesis and the rapid assembly of these building blocks, are a 
major limitation of this field.  
                       
Figure 1-1. Glycosidic bond formation 
 
One of the most popular methods of glycosylation is the use of trichloroacetimidate 
donors (Schmidt, 1986). This method was first developed by Schmidt and Michel and 
therefore is also called the Schmidt glycosylation method (Schmidt et al, 1980). The 
anomeric hydroxyl of a sugar is reacted with trichloroacetonitrile under basic conditions 
to obtain the trichloroacetimidate donor of the carbohydrate. This donor is reacted with 
an acceptor in the presence of an appropriate promoter under acidic conditions to obtain 
the glycosidic bond. The streochemical outcome at the anomeric center is guided by a 
number of factors like the stereochemistry at the anomeric center of the 
trichloroacetimidate, neighboring group participation primarily by the protecting group at 
C-2 position, solvents, thermodynamic and kinetic effects (Schmidt, 1986).  
 
In this dissertation, all the glycosylation reactions discussed have been carried out using a 
tricholoroacetimidate donor given its broad utility. Chapter 2 discusses the 
stereochemical outcome of the glycosylation reaction of L-rhamnose to investigate the 
effect of electron-withdrawing groups farther away from the anomeric center on the α/β 
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ratio of the glycosylated product. In Chapter 3 and 4, glycosylations with 
trichloroacetimidate donors are demonstrated on an automated solution-phase synthesis 
platform. 
Automated solution-phase oligosaccharide synthesis 
As noted above, the chemical synthesis of oligosaccharides is challenging due to the 
stereochemical outcome at the anomeric center that can affect the reactivity as well as the 
bioactivity of the synthesized oligosaccharides (Zhang et al, 2008).  Many of these 
challenges can be tackled by choosing a protecting group that can direct the linkage 
between two sugars by neighboring group participation; also the choice of the glycosyl 
donor can sometimes decide the stereochemical outcome of the glycosylation reaction 
(Schmidt et al, 1980). The synthesis of building blocks is one of the challenges in 
oligosaccharide synthesis. Once fully-protected glycosyl donor and acceptors are 
synthesized, the difficulty in the glycosylation reaction and building up the 
oligosaccharide chain are also many and this process can be lengthy and require up to 
months to construct an oligosaccharide chain, depending on the number of monomer 
units.  
To ease this problem of the synthesis of polysaccharide chains, there is much interest in 
the development of synthesis platforms that can automate the assembly of 
oligosaccharide chains as proposed by Bruce Merrifield in his Nobel address (Merrifield, 
1985). Seeberger and co-workers reported the first example of an automated solid-phase 
oligosaccharide synthesis platform, which was comparable to automated nucleic acid and 
peptide synthesis (Plante et al, 2001). This platform is a modified peptide synthesizer that 
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delivers suitable reagents to the reactor vial where the oligosaccharide chain is built up on 
a solid resin. Once all the sugars have been added in a stepwise manner and the reaction 
is complete; the final oligosaccharide is cleaved from the resin. Although the method 
should in theory simplify the assembly of sugar chains, in practice it has a number of 
disadvantages including the use of large excesses of building blocks (~5 to 20 
equivalents) for each coupling cycle. Furthermore, there is no simple way of monitoring 
the reaction and identifying mistakes during the coupling cycle (Seeberger, 2008).  
To overcome some of these issues with oligosaccharide synthesis and to find a more 
efficient method of carbohydrate synthesis, an automated solution-phase oligosaccharide 
synthesizer was developed (Pohl, 2008b). The advantages of the solution-phase 
oligosaccharide synthesis method are that lower numbers of equivalents of donors can be 
used (1.5 to 3.5 equivalents) and that the reaction can be monitored at each step of the 
synthesis. A small amount of sample can be withdrawn by the robotic arm and transferred 
to a vial after each coupling and deprotection reaction and this aliquot can be monitored 
by thin layer chromatography (TLC) or mass spectrometry (MS), ensuring that the 
reaction proceeds correctly at each step. This new automated solution-phase 
oligosaccharide synthesis strategy is based on fluorous-tag affinity purification steps. The 
lengthening oligosaccharide chain is built upon a fluorous handle and can be easily 
purified in each step using Fluorous Solid-Phase Extraction (FSPE) (Curran, 2001). The 
fluorous tag can be attached to the anomeric or other position of a carbohydrate and the 
chain can be grown from that sugar, as shown in Fig. 1-2. The tag is designed to be 
orthogonal to the protection and deprotection strategies used for oligosaccharide 
synthesis and to be stable under the automation cycles. After the desired length of 
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oligosaccharide is achieved, the fluorous tag can be easily cleaved from the chain or kept 
for use in fluorous-based microarray formation of the synthesized oligosaccharide as 
described in the next section. 
                                  
 
Figure 1-2. Schematic of automated solution phase synthesis using FSPE. 
Fluorous-based carbohydrate microarrays  
Carbohydrate microarrays are a facile method to qualitatively and quantitatively study 
carbohydrate binding with various binding partners like proteins and antibodies (Pohl, 
2008a). Given the difficulty in obtaining large amounts of pure oligosaccharides from 
either synthesis or isolation from natural sources, microarray platforms are a particularly 
good method to study the interaction of these saccharides with other molecules, as only a 
milligram of sugar can be used to form dozens of microarray spots. 
Whereas most microarray platforms require covalent attachment of the analyte to the 
slide, an alternate non-covalent approach relies on the hydrophobic or “fluorophilic” 
interactions of a fluorocarbon- tagged compound with a perfluoroalkylsilane-coated glass 
slide surface. Such fluorous-based microarrays have seen use for probing carbohydrates 
as well as non-carbohydrate molecules (Nicholson et al, 2007; Vegas et al, 2008). In the 
case of carbohydrates, a fluorous-tagged carbohydrate obtained through the direct 
O
O
Glycosylation
FSPE
OFtag
O
NH
CCl3
O
O
O
OFtag
Deprotection
O
O
NH
CCl3
(i) Glycosylation
(ii) FSPE
(iii) Deprotection
	  	  	  
8	  
reaction of the reducing end of an unmodified sugar with a tag (Chen et al, 2007) or 
through synthesis in which the fluorous tag aids the purification steps throughout (Jaipuri 
et al, 2008) is spotted onto the fluorous glass slide using a standard robot used for DNA 
arraying (Fig. 1-3). The fluorous tail of the carbohydrate aligns itself onto the glass in a 
humidified chamber and then the slide is incubated with a protein of interest, for example 
the jack bean lectin concanavalin A (ConA) labeled with fluorescein isothiocyanate 
(FITC) (Jaipuri et al, 2008; Ko et al, 2005). After the slide is washed to remove 
nonbinding proteins, the binding of FITC- ConA with -mannose is then observed under a 
standard fluorescence slide scanner (Jaipuri et al, 2008; Ko et al, 2005). 
          
Figure 1-3. Schematic of the work flow for fluorous-based carbohydrate microarray 
production and screening. 
 
The fluorous-tag containing oligosaccharide obtained after the automated solution-phase 
synthesis, can be deprotected and the resulting carbohydrate can be used for 
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microarraying on a fluorous coated glass slide to test the recognition of these sugars with 
plant lectins or other proteins of interest. The fully deprotected fluorous-tagged 
oligosaccharide is immobilized on the fluorous-coated glass slide as shown in Fig. 1-4. 
The spots can then be incubated with the protein of interest, washed and visualized. 
Useful information about carbohydrate-protein interaction can thus be obtained using 
fluorous-based microarray. Since minimum amounts of oligosaccharide are required for 
microarray formation, the multi-milligram-scale synthesis on the automated platform 
yields sufficient material for a number of arrays. C8F17 - containing oligosaccharides are 
shown to be efficient for immobilization on the fluorous-coated glass slides for good 
microarray formation (Jaipuri et al, 2008). More recently, a tag containing two C6F13 
moieties has been developed that could be applied to the automated solution-phase 
synthesis of longer oligosaccharide chains. Microarrays could be performed with these 
di-C6F13-tagged sugars to obtain information about carbohydrate-protein binding. The 
development of this di-C6F13-tag is discussed more in Chapter 5.  
 
 
Figure 1-4. Automated synthesis of carbohydrates and direct microarray formation of the 
fluorous-tagged carbohydrate on the flurous coated glass slide for screening.	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CHAPTER 2 
Effect of Electron-Withdrawing Groups at O-3 and O-4 Positions of L-
Rhamnose Trichloroacetimidate Donors for Rhamnopyranosylation 
Sahana K. Nagappayya and Nicola L. B. Pohl* 
Portions of this chapter will be submitted to Journal of American Chemical Society 
Abstract 
A study of the effect of the α/β- directing ability of various electron-withdrawing groups 
on the glycosylation of L-rhamnose trichloroacetimidate donors with a fluorous-taggged 
rhamnose acceptor is reported.  The effect of the electron-withdrawing groups at O-3 and 
O-4 positions of L-rhamnose is studied to get insight into the mechanism of glycosylation 
under standard conditions with trichloroacetimidate (TCA) donors for the deoxy sugar L-
rhamnose. Both participating and non-participating electron-withdrawing groups are used 
in this study and a plausible mechanism is proposed.  
Introduction 
Carbohydrates play important roles in many biological processes in both plants and 
animals including growth, development and recognition of the cells (Varki, 1993). 
Development of carbohydrate-based synthetic drug (Petitou et al, 2004) has stimulated 
more interest in glycoconjugates. Research on carbohydrate-based therapeutics has 
accelerated in the recent past with carbohydrate inspired drugs like Tamiflu (Weizman, 
2003) and heparin, to name a few. The array of glycans found on the cell surface in the 
form of glycolipids and glycoproteins, modulate cell functions like transcriptional 
regulation, proliferation and cell migration (Seeberger et al, 2005). Carbohydrates also 
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play an important role in the development and function of the nervous system (Murrey et 
al, 2008). Carbohydrate-based vaccines are slowly and steadily gaining importance and 
the advances in the synthesis of carbohydrate units have helped in such developments 
(Hakomori, 2001). Glycochemistry and glycoconjugate research are increasingly gaining 
more and more importance, especially in medicinal chemistry.   
 
To chemically synthesize a carbohydrate-based therapeutic, one of the most important 
aspects to take into account is the formation of stereoselective glycosidic linkages. Many 
attempts have been carried out to synthesize stereospecific glycosidic linkages using 
various strategies like synthesis of reactive donors or acceptors, use of various promoters 
and activators and changing glycosylation conditions (Boons, 1996).  
 
Rhamnose is one of the very few naturally available deoxy-sugars. It is also unique as it 
is one of the very few sugars naturally occurring in L- form.	  Chemically, L-rhamnose is 
6-deoxy-L-mannose (Fig. 2-1). It is found on the lipopolysaccharides of Gram-negative 
bacteria (Lindberg et al, 1972), and also is a component of many plant sugars	   including 
pectin rhamnogalacturonans (Willats et al, 2001) and muricatin A, which has anti- 
bacterial activity (Khanna et al, 1967). LL-rhamnose also occurs in many other natural 
products like buckthorn (Seebeck et al, 1946). Rhamnose containing oligosaccharides are 
widely present in immunogenic glycans and lipopolysaccharides and are often the 
immune-determinant group of the immunogen (Zhang et al, 2001). Recently, high levels 
of antibodies against L-rhamnose have been discovered in human cells. Due to the 
ubiquitous presence of L-rhamnose in nature and the discovery of anti-rhamnose 
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antibodies in humans, L-rhamnose could act as a potential replacement for the α-
galactose epitope in cancer therapeutics (Chen et al, 2011).  
 
 
Figure 2-1. Structures of L-rhamnose and D-mannose 
 
Although the α-L-rhamnosidic linkage is more common, β-rhamnosidic linkage is also 
found in nature (Perry et al, 1990). The antigen with β-rhamnosidic linkage was found to 
be a more efficient inhibitor for the binding of serum to Salmonella serogroup 
lipopolysaccharide than the antigen containing α-rhamnosidic linkage (Chernyak et al, 
1993). The 1, 2-cis (β) and 1, 2-trans (α) linkages in L-rhamnose are shown in Fig 2-2. 
The importance and abundance of L-rhamnose in the biological systems probe the 
importance of the study of the chemistry of rhamnose. The stereochemical outcome of 
glycosylation reactions is very important for the application of these saccharides in any 
biological systems. Chemical methods to provide exclusive α or β linkages can to be 
great tools for the synthesis of oligosaccharides important for glycobiological studies as 
well as for the study of the chemistry of rhamnose.  
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Figure 2-2. 1, 2-cis (β) and 1, 2-trans (α) linkages in L-rhamnose 
 
The formation of 1, 2- cis- glycosidic linkages in L-rhamnose a very challenging problem 
and is similar to the problem of forming β-D-mannopyranosides (Paulsen, 1982).  The 
traditional method of obtaining a β-linkage is by employing a neighboring participating 
acyl group at the C-2 position. But neighboring group participation predominantly yields 
α- product in the case of L-rhamnose and D-mannose (Fig. 2-3). 
 
 
Figure 2-3. Neighboring group participation and formation of α-anomeric linkage in L-
rhamnose 
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Also, the anomeric effect in L-rhamnose and D-mannose guides these sugars to adopt an 
axial orientation at the anomeric center. The α- anomers are both thermodynamically and 
kinetically stable in the case of mannose and deoxy-mannose. The 1, 2- cis (β) linkage in 
O-rhamnopyranosylation and O-mannopyranosylation is particularly difficult to 
synthesize as rhamnosyl and mannosyl donors have a higher selectivity of 1, 2- trans (α) 
linkage due to the steric hindrance by the axial 2-O substituent and also the 
stereoelectronc effect (Gridley et al, 2000; Ashry et al, 2008). 
 
A closer inspection of the mechanism of glycosylation might have a clue to the synthesis 
of exclusive 1, 2- cis or 1, 2- trans glycosidic linkage or a way to increase the ratio of β 
over α. The glyosidic bond formation reaction as shown in the Fig. 2-4 is a SN2 type 
reaction where the glycosyl acceptor (a nucleophile) attacks the glycosyl donor to form 
the product. During the reaction, an oxocarbenium ion can be generated when the 
anomeric leaving group forms an intimate ion-pair (Fig. 2-4A). If the acceptor alcohol 
reacts at this stage, a β-linkage is likely to be formed. When the nucleophile reacts at the 
solvent separated ion-pair stage (Fig. 2-4B), more α-linkage is likely to be formed due to 
the anomeric effect. And when the free oxocarbenium ion is formed, the α-glycosidic 
linkage predominates. So, by shifting the equilibrium shown in fig. 2-4, it is potentially 
possible to obtain exclusive 1, 2- cis or 1, 2- trans glycosidic linkage. This can be 
achieved by utilizing the electronic properties of glycosyl acceptors. In the case of L-
rhamnose where the formation of β-linkage is highly challenging, if the equilibrium of 
the glycosylation reaction is moved more to the left by destabilizing the oxocarbenium 
ion, a potential excess of β-linkage would be obtained.  
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Figure 2-4.  Mechanism of glycosylation 
 
One of the recent successful attempts at synthesizing β-D-mannopyranoside was 
undertaken by Crich and co-workers where they used a 4, 6- O- benzylidene sulfoxide 
donor of mannose (Crich et al, 1996). In this attempt, the glycosyl donor was activated 
using triflic anhydride, 2, 6-di-tert-butyl-4-methylpyrimidine (DTBMP) at -78 oC (Fig. 2-
5). High β-selectivity of the glycosylation was observed with simple alcohols as well as 
hindered carbohydrate acceptors. In case of 4, 6-O-benzylidene –protected D-mannose 
donors, the above equilibrium is shifted greatly toward the covalent glycosyl donor and 
the intimate ion-pair. This is because the mannopyranoside ring becomes rigid in the 
presence of the benzylidene and thus, the oxocarbenium ion is difficult to form. In such a 
case, the β-D-manopyranoside predominates. But since this kind of protecting-group 
influence is not possible in L-rhamnose due to the lack of 6-hydroxyl function, the 
formation of the β-linkage in L-rhamnose becomes more challenging.  
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Figure 2-5. β-D-mannopyranoside synthesis using 4, 6-O-benzylidene- protected donor 
(Crich et al, 1996).  
 
In order to achieve β−L-rhamnopyranosides, the previously attempted methods have 
utilized 2, 3-O carbonate (Backinowsky et al, 1980) and 2, 3-O alkylidine-protected 
(Iversen et al, 1980) glycosyl bromides activated by silver-based promoters. 2,3-O-
cyclohexylidene derivative of L-rhamnose was converted into its bromide and then 
reacted under standard Koenigs-Knorr conditions with silver carbonate as the promoter to 
yield β-L-rhamnopyranoside with simple alcohol acceptors like methanol and also with 
protected sugar molecules, in moderate to high yield (Fig. 2-6A). 2,3-O cyclic carbonate 
protecting group has also been used to synthesize rhamnosyl donors to obtain β-
glycosidic linkage under standard Koenigs-Knorr condition in the presence of an 
insoluble silver salt like silver oxide (Fig. 2-6B). If the reaction proceeds in a 
homogeneous solution with the silver promoter, high α-selectivity was observed (Crich et 
al, 2003) 
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Figure 2-6. Glycosylation with 2, 3-O-benzylidene protected and 2, 3-O-carbonate L-
rhamnosyl donor to give β-rhamnosylation (A. Backinowsky et al, 1980; B Iversen et al, 
1980). 
 
A recent attempt at synthesizing β-L-rhamnopyranoside utilized 2-O-sulfonate protecting 
group of β-L-thiorhamnosides (Crich et al, 2003). The glycosylation method carried out 
in this work involved the activation of the β-thiorhamnoside with 1-benzenesulfinyl 
piperidine (BSP) and triflic anhydride in the presence of 2, 4, 6-tri-tert-butylpyrimidine 
(TTBP) (Fig. 2-7). The 2-O-benzene sulfonate groups carried functional groups to make 
this protecting group electron-rich or electron-deficient.  Highest β-selectivity of the 
glycosyl bond was achieved when the reaction was carried out with 3β-cholestanol as 
acceptor and p-trifluoromethylbenzene sulfonate at the 2-O position. Attempts to form 
the β-rhamnopyranoside linkage with other simple carbohydrate acceptors like glucose 4-
OH acceptor, resulted in a 1:1 mixture of α and β linkages. However, this work is a good 
example of the use of the electronic properties of the protecting group on L-rhamnose 
donor to direct the stereoelectronic outcome of glycosylation.   
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Figure 2-7.  β-rhamnosylation with 2-O sulfonate protected rhamnose (Crich et al, 2003). 
 
So far, the majority of attempts to synthesize the β−glycosidic linkage of L-rhamnose, 
have been using thiorhamnoside donors (Crich et al, 2003) or using the Koenigs-Knorr 
method (Backinowsky et al, 1980; Iversen et al, 1980). But a widely used method for 
glycosylation is the Schmidt glycosylation developed by Schmidt and Michel (Schmidt et 
al, 1980) In this method, trichloroacetonitrile is used to prepare the trichloroacetimidate 
(TCA) donor at the anomeric center of the sugar under basic conditions, which is reacted 
with a glycosyl acceptor under mild acidic condition with a promoter, usually TMSOTf 
(Figure 2-8). This is a very popular method of glycosylation as the trichloroacetimidates 
are introduced under mild conditions and are formed in excellent yields. They react to 
form the glycosidic linkage readily to give good yield of the product and in many cases 
very good α/β selectivity. This method is also orthogonal to a wide range of protecting 
groups (Schmidt, 1986). 
 
 
Figure 2-8. Schmidt’s trichloroacetonitrile method for glycosylation (Schmidt et al, 
1980). 
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An elegant work using TCA donors of D-mannose with electron-withdrawing groups at 
the O-3, O-4 and O-6 positions was carried out by Kim and co-workers (Baek et al, 
2009). In this study, both participating and non-participating electron withdrawing groups 
containing D-mannose trichloroacetimidate donors were synthesized and their 
glycosylation with a number of acceptors was carried out. The electron withdrawing 
effect and remote participating effect would have opposite effects in the stereochemical 
outcome of glycosylation reaction. This study is an ingenious example of the use of the 
electronic property of the protecting groups to guide the stereochemical output of the 
glycosylation reaction, and in turn, gain knowledge of the mechanism of glycosylation of 
D-mannose.  
 
 
Figure 2-9. Glycosylation with various D-mannose TCA donors containing electron-
withdrawing groups (Baek et al, 2005). 
  
The protecting group at the O-2 position of D-mannose was kept constant and those at O-
3, O-4 and O-6 were sequentially changed. Both participating and non-participating 
electron-withdrawing groups were used. Glycosylation with TCA donors were carried out 
at -78 oC for 2h with various acceptors (summarized in Fig. 2-9). The authors observed 
OBnO
RO
BnO OBn
O CCl3
NH ORO
BnO
BnO OBn
O CCl3
NH OBnO
BnO
RO OBn
O CCl3
NH
R = Electron withdrawing groups
A B C
A or B or C
ROH
TMSOTf
CH2Cl2 
-78 oC, 2h
OPO
PO
PO OBn
O CCl3
NH OPO
PO
PO OBn
OR
	  	  	  
20	  
that both participating and non-participating electron withdrawing groups at O-4 position 
of D-mannose donor predominantly formed the β-glycosidic linkage.  Non-participating 
groups at O-3 yielded high β-selectivity of mannosylation whereas participating groups 
like acyl groups were α-directing when placed at position 3. At the O-6 position only the 
acetyl group showed α-directing tendency, all other electron-withdrawing groups yielded 
β-mannopyranoside.  
 
This methodical and effective study throws some light on the mechanism of the 
glycosylation of mannose TCA donors. The resulting stereochemical outcome with the 
various electron-withdrawing group can help in designing a logical building block for 
stereo-directed glycosylations using the electronic property nature of the protecting 
groups to D-mannose.  
 
However, such a systematic study has yet not been undertaken in case of L-rhamnose 
TCA donors. In this chapter, an attempt at such a study on L-rhamnose is described. 
Firstly, L-rhamnose TCA donors containing both participating and non-participating 
electron withdrawing groups at the O-3 and O-4 positions are designed and synthesized 
and then rhamnopyranosylation is carried out to determine the α/β ratio of the product 
formed. The mechanism of glycosylation with L-rhamnose and also the effect of the 
electron-withdrawing properties of the various protecting groups are probed in this study.   
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Results and discussion 
 
Figure 2-10. Glycosylation strategy for this study 
 
In the work presented in this chapter, trichloroacetimidate donors of L-rhamnose 
containing different electron withdrawing groups at the O-3 and O-4 positions are 
synthesized and their glycosylation is carried out with fluorous tag containing L-
rhamnose acceptor (Fig. 2-10). The electron withdrawing groups used in this study are 
participating groups like acetyl, benzoyl and p-nitrobenzoyl, and non-participating 
sulfonylbenzyl at the O-3 and O-4 positions of L-rhamnsoe (Fig. 2-11). The choice of 
these electron withdrawing groups is inspired by the studies performed on mannose by 
Kim and co-workers (Baek et al, 2009). The L-rhamnose TCA donors with electron 
withdrawing groups at position O-4 are labeled type A and those with electron 
withdrawing groups at position O-3 are labeled type B. The positions not protected by 
electron withdrawing groups were converted into benzyl ethers.   
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Figure 2-11.  Building blocks and the electron-withdrawing protecting groups used for 
this study. 
 
For the synthesis of the L-rhamnose TCA donors, the first reaction sequence was to find a 
suitable anomeric protecting group which would be robust under the various reaction 
conditions of protection and deprotection strategies and can itself be protected and 
deprotected under mild conditions. The anomeric position was protected as the allyl 
ether, methyl ether and p-methoxyphenyl (-OMp) ether (Table 2-1). Although the yields 
of the reaction were all comparable, the removal condition of the methoxy group was 
very harsh; and for the removal of the allyl group, two steps were involved which 
required the use of iridium catalyst and mercury salts. The –OMp group was chosen as 
the anomeric protecting group of choice because of the ease of the protection and 
deprotection of this group. One of the other key factors in choosing this group was the 
ease of recrystallization of the product formed.  
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R 
 Condition Yield (%) Removal Condition 
-Allyl Allyl Alcohol, CF3COOH, 65 oC 91 
Ir[COD(PPhMe2)2]PF6, 
H2, THF, 16 h 
(ii) HgO, HgCl2 
Acetone/H2O 
-CH3 Amberhyst® Resin, CH3OH 86 Conc. H2SO4, Heat 
-OMp 
(i) Ac2O, Py 
(ii) p-Methoxyphenol, 
BF3OEt2, CH2Cl2 
(iii) Na, CH3OH 
83 (Over 3 
steps) 
Ceric ammonium nitrate 
CH3CN, H2O, 45 min 
 
Table 2-1. Choice of anomeric protecting group  
 
To synthesize the type A L-rhamnose building blocks, a 2, 3-O-benzylidene acetal of 1-
O-p-methoxyphenyl-2, 3, 4-hydroxy-α-L-rhamnopyranoside 1 was first prepared with 
benzaldehyde dimethyl acetal and pTSA as the acid catalyst. Next, the 4-O position was 
protected with the electron-withdrawing groups like acetate, benzoyl, p-nitrobenzoyl and 
benzylsulfonyl ether under basic conditions followed by the opening of the 2, 3-O-
benzylidene acetal with 80% acetic acid as shown in Scheme 2-1. The next step was to 
form the benzyl ether at the 2 and 3-O positions. The standard basic condition used for 
the formation of the benzyl ether, using sodium hydride and benzyl bromide was used for 
the synthesis of compound 19. With compounds containing base-labile acyl groups, the 
benzyl ether was formed under acidic condition of triflic acid with freshly prepared 
trichloroacetimidate of benzyl alcohol in high yields.   
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Conditions: a. (i) Ac2O, py (87%) (ii) p-methoxyphenol, BF3.OEt2, CH2Cl2 (82%) (iii) 
Na, CH3OH (92%) b. BnBr, NaH, DMF (63%) c. PhCH(OCH3)2, CH3CN, pTSA (85%) d. 
For 3: Ac2O, py (89%); for 4: BzCl, Et3N, CH2Cl2 (92%); for 5: p-NO2BzCl, Et3N, 
CH2Cl2 (71%); for 6: BnSO2Cl, 2,6-Lutidine, CH2Cl2 (89%); for 7: BnBr, NaH, DMF 
(87%) e. (i) 80% CH3COOH/H2O (ii) for 8, 9, 10: benzyltrichloroacetimidate, TfOH, 
CH2Cl2 (68%, 59%, 68% respectively); for 11: BnBr, NaH, DMF (56%)  
 
Scheme2-1. Synthesis of type A building blocks 
 
With these building blocks in hand, the next step was to form the trichloroacetimidate 
donors of these fully protected L-rhamnose. For this the p-methoxyphenyl (-OMp) 
protecting group was deprotected using ceric ammonium nitrate and then converted into 
the TCA donor under basic conditions with potassium carbonate. The donor containing p-
nitrobenzoyl at the 4-O position was highly crystalline in nature and did not dissolve in 
common solvents like dichloromethane and toluene under glycosylation conditions.   
 
The synthesis of type B building blocks was not as straightforward as that of the type A 
ones. The initial idea in this synthesis was to selectively open the 2, 3-O-benzylidene 
ester 7 to obtain 2-O benzyl ether and then protect 3-O with the electron-withdrawing 
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groups (Scheme 2-2). Reduction conditions with LiAlH4-AlCl3, DIBAL-H, Et3SiH-I2 and 
BH3THF-Bu2OTf were all used but all the reactions gave a mixture of the desired product 
13 along with the undesired product 14 in higher yields. It has been shown that only one 
of the isomers of the 2, 3-O-benzylidene acetal of L-rhamnose reacts to give the reductive 
cleavage of the acetal (Liptak, 1976). So, the selective opening of the bezylidine was not 
carried out, instead another approach to synthesize type B building block was 
investigated. Finally, compound 13 was synthesized by addition of 1.1 equivalent of 
benzyl bromide to a solution of the 1-O-p-methoxyphenyl-4-O-benzyl-rhamnopyranoside 
in 5% NaOH solution in CH2Cl2 (Scheme 2-3).    
 
 
Scheme 2-2. Selective opening of the 2, 3-O-benzylidene acetal 
 
 
Conditions. a. BnBr (1.1 eq), NaOH (5% aqCH2Cl2 (67%) b. For 15 Ac2O, py (85%); for 
16: BzCl, Et3N, CH2Cl2 (92%); for 17: p-NO2BzCl, Et3N, CH2Cl2 (76%)for 18: BnSO2Cl, 
2,6-Lutidine, CH2Cl2 (86%) 
 
Scheme 2-3. Synthesis of type B building blocks.  
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The 2, 4-dibenzyl-3-hydroxy-1-O-p-methoxyphenyl-α-L-rhamnopyranoside (13) was 
reacted with the various electron withdrawing groups to synthesize the fully protected 
type B building block of L-rhamnose (Scheme 2-3). This was converted into the 
trichloroacetimidate donor with trichloroacetonitrile and potassium carbonate as base. 
The products and yield of the reaction is shown in Scheme 2-4.  
 
 
Condition a. (i) CAN, CH3CN, H2O (ii) K2CO3, Cl3CCN, CH2Cl2 
Compound  R1 R2 Product Yield (%) 
 
8 Ac Bn 19 82 
9 Bz Bn 20 83 
10 p-NO2Bz Bn 21 65 
11 SO2Bn Bn 22 71 
12 Bn Bn 23 56 
15 Bn Ac 24 77 
16 Bn Bz 25 83 
17 Bn p-NO2Bz 26 72 
18 Bn SO2Bn 27 73 
 
Scheme 2-4. Synthesis of the L-rhamnose trihloroacetimidate donors.  
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Condition a. TMSOTf (0.15 eq), CH2Cl2, 0 oC 
 
Glycosyl 
Donor 
Glycosyl 
Acceptor 
 
Disaccharide Yield (%) α /β  ratio 
19 28 29 74 4:1 
20 28 30 61 3:1 
22 28 32 88 8:1 
23 28 33 75 Exclusively α 
24 28 34 68 10:1 
25 28 35 62 9:1 
27 28 37 71 2:1 
  
Scheme 2-5. Glycosylation reaction of the L-rhamnose donors with L-rhamnose acceptor 
28. 
 
Glycosylation of these donors was carried out with a L-rhamnose acceptor containing a 
fluorous-tag (28). The synthesis of this acceptor is discussed in chapter 4 under the 
synthesis of rhamnogalacturonan-I backbone. The glycosylation of the various L-
rhamnose donors with the acceptor along with the α/β ratio of the disaccharides formed 
is shown in Scheme 2-5. 
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Figure 2-12. Mannopyranosylation with electron withdrawing groups at O-3 (A) and O-4 
(B) positions of D-mannose donors (Baek et al, 2009). 
 
The results from these glycosylation reactions of rhamnose are tabulated in Table 2-2 and 
Table 2-3, along with the results from similar glycosylation reaction of mannose for 
comparison.  In the case of both mannose and rhamnose in the tabulated results, the 
glycosylation reaction was carried out with a secondary alcohol monosaccharide acceptor 
as shown in Scheme 2-5 and Fig 2-12, respectively. For D-mannose, the glycosyl 
acceptor was the secondary alcohol 1-O-methyl-3-O-benzyl-4, 6-O-benzylidene 
mannopyranoside, and for L-rhamnose in the study presented, the glycosyl acceptor was 
fluorous-tagged secondary alcohol of rhamnose (28). 
 
Electron withdrawing 
groups 
(At O-3 position) 
 
Rhamnopyranosylation 
α/β  
Mannopyranosylation 
α /β  
-SO2Bn 2:1 1:11.8 
-Ac 10:1 40.4:1 
-Bz 9:1 19.8:1 
-Bn* Exclusively α 2.7:1 
* No electron withdrawing group- a control. 
Table 2-2. Results of rhamnopyranosylation with L-rhamnose donor containing electron 
withdrawing group at O-3, compared with mannopyranosylation (Fig 2-12A). 
 
Electron withdrawing 
groups 
(At O-4 position) 
 
Rhamnopyranosylation 
α/β  
Mannopyranosylation 
α /β  
-SO2Bn 8:1 1:3.5 
-Ac 4:1 1:2.1 
-Bz 3:1 1:2.3 
 
Table 2-3. Results of glycosylation reaction of L-rhamnose donor containing electron 
withdrawing groups at O-4 position compared with mannosylation (Fig 2-12B) 
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Summarizing some of the key points from these results:  
1. The glycosylation with the 2, 3, 4-O-tribenzyl-rhamnose-trichloroacetimidate donor 
produced exclusive α - product.  
2. Non-participating electron withdrawing group (benzylsulfonyl) at O-3 was found to 
produce more α-glycosidic linkage compared to participating acyl type groups at O-3. 
3. Rhamnosylation with donors containing electron withdrawing groups at both 3-O and 
4-O are more α-directing. But in comparison to the 3-O position, this α- directing effect 
at 4-O is less.  
 
With participating electron withdrawing groups (Ac and Bz) at position O-3, of L-
rhamnose, more α -directing effect is observed. This is an evidence of remote 
participation by these groups. Plausible remote participation can take place with the 4C1 
conformer of L-rhamnose as shown in Fig 2-13. Once there is a conformational change 
from 1C4 to 4C1, a six membered acetal type ring can be formed with the acyl type 
protecting groups. The attack of the incoming nucleophile at this stage occurs from the 
less hindered face, now is the α -face of the donor. Such remote participation would be 
absent in case of non-participating group and the destabilization of the oxocarbenium ion 
will be the deciding factor in the α/β directing effect. 
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Figure 2-13. Proposed mechanism for the α-directing effect of participating groups at 
position O-3 of L-rhamnose 
 
 
At position 4, the remote participation by the acyl type protecting groups is absent as now 
the conformer change gives a highly unstable structure. The stability of the oxocarbenium 
ion formed during the reaction would be the main factor in the α/β directing effect of the 
electron withdrawing groups in this case.  
 
On comparing the results from the glycosylation reactions of mannose and rhamnose with 
similar secondary alcohols, we find that the preference of L-rhamnose toward α-
glycosidic linkage is very high. The results of L-rhamnose and D-mannose with electron 
withdrawing groups at O-3 are comparable and show the same trend, with both mannose 
and rhamnose producing excess α-glycosidic linkages. But in case of electron 
withdrawing groups at O-4, mannose shows a preference for β-glycosidic linkage, unlike 
L-rhamnose, where the α-linkage still predominates. The absence of the 6-hydroxyl 
function in L-rhamnose might be a factor in such difference of selectivities.  
Although, both these carbohydrates prefer the formation of α-linkage, the 
trichlororacetimidate driven glycosylation of L-rhamnose with both small and larger 
acceptors yield the α-linkage in excess.  
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Conclusion 
Various L-rhamnose trichloroacetimidate donors with electron-withdrawing groups at the 
O-3 and O-4 positions were synthesized. The introduction of the electron-withdrawing 
groups strategically at various positions in L-rhamnose could be effective in stereo-
directed synthesis of glycosidic linkage with L-rhamnose donors and various acceptors. 
Through this study, a plausible mechanism is proposed for the formation of more α-
glycosidc bond with the electron withdrawing group at O-3 with participating acyl type 
protecting groups compared to these groups at O-4 positions. Unlike β-mannosylations, 
the problem of formation of β-linkages in rhamnose with tricholoacetimidate assisted 
glycosylation still has challenges in terms of protecting groups and sterics, that can be an 
interesting challenge to further probe.  
Experimental section 	  
General methods 
	  
Reaction solvents were used directly from solvent tower (Swagelok). All other 
commercial reagents and solvents were used as received without further purification. The 
reactions were monitored and the Rf values determined using analytical thin layer 
chromatography (TLC) with Sorbent Technologies Silica gel HL TLC plates with UV 
254 (250 µm). The developed TLC plates were visualized by immersion in a solution of 
EtOH: conc. H2SO4: p-anisaldehyde (9:1:1) followed by heating on a hot plate. Silica gel 
flash chromatography was performed with ZeoPrep 60 Eco 40-63 µm. Fluorous phase 
chromatography using fluorous solid-phase extraction cartridges containing silica gel 
bonded with perfluorooctylethylsilyl chains (Fluorous Technologies, Inc.; Pittsburgh, 
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PA). All other fluorous reagents were also obtained from Fluorous Technologies, Inc. All 
moisture-sensitive reactions were performed in flame- or oven-dried glassware under a 
Ar(g) atmosphere. Bath temperatures were used to record the reaction temperature. All 
reactions were stirred magnetically at ambient temperature unless otherwise indicated. 1H 
NMR and 13C NMR spectra were obtained with a VarianVXR at 400 MHz and 100 MHz 
or BrukerDRX at 600 MHz or 100 MHz respectively. 1H NMR spectra were reported in 
parts per million relative to CDCl3 (7.26 ppm) and 13C NMR spectra were reported in 
parts per million relative to CDCl3 (77.23 ppm).  
 
Synthetic procedures 
 
1,	  2,	  3,	  4-­‐Tetra-­‐O-­‐acetyl-­‐α/β-­‐L-­‐rhamnopyranoside 
	  
	  
To a solution of pyridine (5.0 mL) and acetic anhydride (5.0 mL) α/β-L-rhamnose (5.0 g, 
0.027 mol) was added. The solution was stirred for 2h at ambient temperature and then 
quenched by pouring the mixture into water. The product was extracted with EtOAc (50 
mL). The organic layer was washed with sodium bicarbonate solution (3 X 50 mL), 2N 
hydrochloric acid solution (1 X 50 mL) and brine (2 X 50 mL), dried over MgSO4 and 
concentrated under reduced pressure to obtain 1 (8.25g, 87%, colorless oil). 
 
1H NMR (CDCl3, 400 MHz): δ (ppm) 5.94 (s, 1H), 5.24 (dd, J = 10.0 Hz, 1H), 5.18 (dd, 
J = 3.6 Hz, 1H), 5.05 (t, J = 10.0 Hz, 1H), 3.89 (m, 1H), 2.09 (s, 3H), 2.03 (s, 3H), 1.93 
(s, 3H), 1.21 (d, J = 6.0 Hz, 3H) 
O
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13C NMR (CDCl3, 100 MHz): δ (ppm) 170.2, 170.0, 169.9, 168.5, 90.7, 70.6, 68.9, 
68.7, 68.6, 21.1, 21.0, 20.9, 20.8, 17.6  
Rf (Hexane: EtOAc 2:1): 0.42 
 
1-­‐O-­‐p-­‐Methoxy-­‐2,	  3,	  4-­‐tri-­‐O-­‐acetyl-­‐α-­‐L-­‐rhamnopyranoside	  	  	  
 
	  
To a solution of peracetylated L-rhamnose (8.25g, 0.025 mol) in dichloromethane, 
BF3.OEt2 (3.3 mL, 0.025 mol) was slowly added at 0 oC followed by the addition of p-
methoxyphenol (3.75g, 0.031 mol). The reaction mixture was warmed to room 
temperature and stirred for 4h. The reaction was quenched by adding sodium bicarbonate 
solution (2 X 25 mL) and extracted with dichloromethane (50 mL). The organic layer 
was washed with brine (2 X 50 mL), dried with MgSO4 and the solvent removed under 
reduced pressure. The crude product was purified by flash chromatography (2:1 
hexane:ethyl acetate) to obtain 1-O-p-methoxy-2, 3, 4-tri-O-acetyl-α-L-
rhamnopyranoside.(8.5 g, 81%, white solid). 	  
1H NMR (CDCl3, 400 MHz): δ (ppm) 7.12-7.13 (d, J= 8.0 Hz, 2H), 6.98-6.96 (d, J= 8.0 
Hz, 2H 5.94 (s, 1H), 5.86 (s, 1H), 5.23 (dd, 1H), 5.12(t, 1H), 3.69 (m, 1H), 2.12 (s, 3H), 
2.09 (s, 3H), 2.03 (s, 3H), 1.32 (d, J = 6.0 Hz, 3H) 
13C NMR: CDCl3, 100 MHz): δ (ppm) 157.8, 151.1, 118.8, 118.5, 115.1, 115.2, 97.8, 
74.4, 72.0, 71.8, 68.9, 55.8, 17.7 
Rf (Hexane: EtOAc 3:2): 0.38 
O
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1-O-p-Methoxy-α-L-rhamnopyranoside (1) 
	  
To a solution of 1-O-p-methoxy-2, 3, 4-tri-O-acetyl-α-L-rhamnopyranoside (8.5 g, 0.021 
mol) in methanol (30 mL) sodium metal was added at ambient temperature and the 
solution was checked to have a pH of 9 -10 by pH paper. The reaction mixture was stirred 
for 1h. The reaction was quenched by adding Dowex® till the solution was neutral. The 
solution was filtered and the solvent removed under reduced pressure. The crude product 
was recrystallized by ethanol to obtain white needle like crystals of 1 (5.25 g, 92%, white 
crystal). 
 
1H NMR: (CDCl3, 400 MHz): 7.03-7.01 (d, J= 8.0 Hz, 2H), 6.92-6.90 (d, J= 8.0 Hz, 
2H), 5.03 (s, 1H), 4.12 (dd, 1H0, 3.81 (dd, 1H), 3.62 (dd, 1H), 3.33-3.31 (m, 1H), 1.39 
(d, 3H) 
13C NMR: (CD3OD, 100 MHz): δ (ppm) 154.1, 151.0, 118.1, 114.2, 99.3, 94.2, 74.2, 
73.1, 72.5, 69.4, 68.7, 54.8, 16.7 
Rf (CH2Cl2: CH3OH 4:1) 0.32 
 
1-O-p-Methoxy-2, 3-O-benzylidine-α-L-rhamnopyranoside (2) 
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To a solution of 1 (5.25 g, 0.02 mol) in acetonitrile (18 mL), benzaldehydedimethyl 
acetal (3.0 mL, 0.021 mol) was added, followed by the addition of p-toluenesulfonic acid 
(0.05 g, 0.37 mmol) at ambient temperature. The reaction was allowed to run for 1h and 
then quenched by the addition of triethylamine (0.15 mL) and the solvent removed under 
reduced pressure. The crude product was purified by flash chromatography (2:1 
hexane:ethyl acetate) to obtain 2 (R/S configuration) as a white solid (5.75 g, 85%, white 
solid). 
 
1H NMR: (CDCl3, 600 MHz): δ (ppm) 7.18-7.16 (m, 1H), 7.34-7.30 (m, 4H), 6.98-6.94 
(d, J = 6 Hz, 2H), 6.78-6.75 (d, J = 6 Hz, 2H), 5.87 (s, 1H), 5.65 (s, 1H), 4.75 (d, 1H), 
4.51-4.48 (m, 1H), 4.39-4.37 (m, 1H), 3.80-3.77 (m, 1H), 1.38- 1.36 (d, 3H) 
13C NMR: CDCl3, 100 MHz): δ (ppm) 134.8, 130.0, 129.2, 117.2, 114.6, 98.9, 72.4, 
72.1, 71.8, 68.2, 56.7, 17.8 
Rf (Hexane: EtOAc 3:2) 0.48 
 
1-O-p-Methoxy-2, 3-O-benzylidine-4-O-acetyl-α-L-rhamnopyranoside (3) 
	  
To a solution of 2 (0.385g, 1.01 mmol) in pyridine (10.0 mL), acetic anhydride (12.0 mL) 
was added at ambient temperature. The solution was stirred for 2h and then quenched by 
pouring the mixture into water. The product was extracted with EtOAc. The organic layer 
was washed with sodium bicarbonate solution, 2N hydrochloric acid solution and brine, 
O
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dried over MgSO4 and the solvent removed under reduced pressure. The crude product 
was purified by flash chromatography (2:1 hexane:ethyl acetate) to obtain 3 (R/S 
configuration) (0.371g, 89%, colorless oil). 
 
1H NMR: (CDCl3, 400 MHz): δ (ppm) 7.52-7.51 (m, J = 6Hz, 1H), 7.44 (s, 1H), 7.42-
7.42 (m, 2H), 7.04-7.03 (d, J= 6.0 Hz, 2H), 6.87-6.88 (d, J= 6.0 Hz, 2H), 6.29 (s, 1H), 
5.77 (s, 1H), 5.14-5.12 (dd, 1H), 4.72-4.71 (dd, 1H), 4.57-4.56 ( dd, 1H), 4.04-4.02 (m, 
1H), 3.81 (s, 3H), 2.15 (s, 3H), 1.29 (d, J=6.0 Hz, 3H) 
13C NMR: CDCl3, 100 MHz): δ (ppm) 155.1, 150.1, 138.2, 136.3, 129.7, 128.5, 127.0, 
126.3, 117.8, 114.7, 104.8, 96.2, 71.4, 64.8, 60.4, 55.6, 21.0, 17.1, 14.2 
Rf (Hexane: EtOAc 2:1): 0.51 
 
1-O-p-Methoxy-2, 3-O-di-benzyl-4-O-acetyl-α-L-rhamnopyranoside (8) 
	  
80% aqueous acetic acid was added to a solution of 3 (0.48g, 0.95 mmol). The reaction 
mixture was stirred at 65 oC for 2h and then the solvent removed under reduced pressure. 
The crude product was carried on to the next step without purification. 
Tricholoroacetimidate of benzyl aclcohol (0.24g, 1.04 mmol) was added to the reaction 
mixture in CH2Cl2 maintained at 0 oC followed by the addition of TfOH (142.5 µL, 9.5 
µmol). The reaction was stirred at 0 oC for 45 min, then quenched by addition of Et3N 
(1.32 mL) and concentrated under reduced pressure. The crude mixture was purified by 
O
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flash chromatography (3:2 Hexane: EtOAc) to obtain 8 (0.72 g, 68% over two steps, 
yellow oil).  
 
1H NMR: (CDCl3, 400 MHz): δ (ppm) 8.18-8.4 (m, 5H), 7.52-7.49 (m, 5H), 7.25-7.21 
(d, 2H), 6.96-6.14 (d, 2H), 5.51 (s, 1H), 5.41-4.39 (dd, 1H), 4.72-4.71 (dd, 1H), 4.57-4.56 
( dd, 1H), 4.22-4.19 (m, 1H), 3.91 (s, 3H), 3.86 (s, 2H), 2.10 (s, 3H), 1.29 (d, 3H) 
13C NMR: CDCl3, 100 MHz): δ (ppm) 169.2, 159.2, 152.3, 139.1, 138.9, 135.4, 131.2, 
131.7, 128.5, 127.0, 124.8, 116.4, 115.8, 95.7, 72.4, 66.8, 65.3, 54.8, 23.0, 18.1, 17.2 
Rf (Hexane: EtOAc 2:1): 0.42 
 
2, 3-O-Di-benzyl-4-O-acetyl-α/β-L-rhamnopyranoside trichloroacetimidate (19) 
	  
To a solution of 8 (0.031g, 6.4 mmol) in CH3CN:H2O (5:1) ceric ammonium nitrate 
(0.071g, 0.13 mmol) was added and the solution stirred for 1h. The reaction was 
quenched by the addition of sodium bicarbonate and extracted with dichloromethane. The 
organic layer was dried over MgSO4 and the solvent removed under reduced pressure. 
The crude product was dried under vacuum and carried out to the next step. The crude 
product obtained was dissolved in dichloromethane under Ar (g) atmosphere. K2CO3  
(0.044g, 0.32 mmol) was added followed by slow addition of trichloroacetonitrile 
(0.02mL, 0.20 mmol) and the reaction mixture was stirred for 45 min at 0 oC. The 
reaction mixture was quenched by the addition of triethylamine (0.25mL) and filtered 
O
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through celite®, washed with dichloromethane and solvent removed under reduced 
pressure. The crude product was purified by flash chromatography (3:2 hexane:ethyl 
acetate) to obtain 19 (0.027g, 82% over two steps, oil).  
 
1-O-p-Methoxy-2, 3-O-benzylidine-4-O-benzoyl-α-L-rhamnopyranoside (4) 
	  
To a solution of 2 (0.436g, 1.2 mmol) in pyridine (12.0 mL), benzoyl chloride (0.15 mL, 
1.3 mmol) was added at ambient temperature. The solution was stirred for 2h and then 
quenched by pouring the mixture into water. The product was extracted with EtOAc. The 
organic layer was washed with sodium bicarbonate solution, 2N hydrochloric acid 
solution and brine, dried over MgSO4 and the solvent removed under reduced pressure. 
The crude product was purified by flash chromatography (2:1 hexane:ethyl acetate) to 
obtain 4 (R/S configuration) (0.518g, 92%). 
 
1H NMR: (CDCl3, 600 MHz): δ (ppm) 8.23-8.21 (d, 2H), 8.18-8.17 (d, 2H), 7.69-7.64 
(m, 1H), 7.63-7.59 (m, 2H), 7.52-7.49 (m, 2H), 7.27-7.25 (d, J = 12 Hz, 2H), 6.81-6.79 
(d, J = 12 Hz, 2H), 5.55 (s, 1H), 5.17 (m, 1H), 4.27-4.25 (dd, 1H), 4.21 (m, 1H), 4.19-
4.15 (m, 1H), 3.15-3.18 (m, 1H), 1.36-1.34 (d, 3H) 
13C NMR: CDCl3, 100 MHz): δ (ppm) 134.9, 134.0, 131.2, 130.1, 129.1, 123.4, 118.3, 
115.0, 97.4, 71.8, 71.2, 66.3, 56.4, 46.1, 17.3 
Rf (Hexane: EtOAc 2:1) 0.32 
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1-O-p-Methoxy-2, 3-O-di-benzyl-4-O-benzoyl-α-L-rhamnopyranoside (9)	  
	  	  	   	  
80% aqueous acetic acid was added to a solution of 4 (0.43g, 1.15 mmol). The reaction 
mixture was stirred at 65 oC for 2h and then the solvent removed under reduced pressure. 
The crude product (0.31g) was dissolved in 12.0 mL dichloromethane. 
Benzyltrichloroacetimidate  (0.244g, 1.03 mmol) was added at 0 oC under Ar(g) 
atmosphere, followed by the addition of triflic acid (1.29 µL,8.6 µmol). The reaction 
mixture was stirred for 45 min. The mixture was quenched by adding Et3N (0.35mL) and 
concentrated under reduced pressure.  The product was purified by silica gel flash 
chromatography (40% EtOAc in Hexane) to obtain 9 (0.21g, 59% over two steps, yellow 
oil).  
 
1H NMR: (CDCl3, 600 MHz): δ (ppm) 8.71-8.69 (m, 5H), 7.99-7.94 (m, 5H), 7.65-7.63 
(d, 2H), 7.45-7.43 (d, 2H), 7.29-7.25 (m, 5H), 5.65 (s, 1H), 5.42 (m, 1H), 4.89 (s, 2H), 4. 
68 (s, 2H), 4.25 (dd, 1H), 3.81 (m, 1H), 1.28 (d, 3H) 
13C NMR: CDCl3, 100 MHz): δ (ppm) 164.9, 159.8, 138.4, 138.1, 137.3, 128.6, 128.3, 
127.9, 127.4, 127.0, 96.1, 91.2, 76.5, 76.1, 70.3, 69.1, 69.3, 65.6, 17.2 
Rf (Hexane: EtOAc 2:1) 0.35 
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2, 3-O-Di-benzyl-4-O-benzoyl-L-rhamnopyranoside trichloroacetimidate (20) 
 
To a solution of 9 (0.036g, 0.06 mmol) in CH3CN:H2O (5:1) ceric ammonium nitrate 
(0.076g, 0.13 mmol) was added and the solution stirred for 1h. The reaction was 
quenched by the addition of sodium bicarbonate and extracted with dichloromethane. The 
organic layer was dried with MgSO4 and the solvent removed under reduced pressure. 
The crude product (0.02g, 0.05 mmol) was dissolved in dichloromethane under Ar (g) 
atmosphere. K2CO3 (0.03g, 0.26 mmol) was added followed by slow addition of 
trichloroacetonitrile (0.15 mL, 1.59 mmol) and the reaction mixture was stirred for 45 
min at 0 oC. The reaction mixture was quenched by the addition of triethylamine (0.20 
mL) and filtered through celite®, washed with dichloromethane and solvent removed 
under reduced pressure. The crude product was purified by flash chromatography (3:2 
hexane:ethyl acetate) to obtain 20 (0.04 g, 83%, colorless oil). 
 
1-O-p-Methoxy-2, 3-O-benzylidine-4-O-p-nitrobenzoyl-α-L-rhamnopyranoside (5) 
 
To a solution of 2 (0.45g, 1.26 mmol) in dichloromethane (15.0 mL), p-nitrobenzoyl 
chloride (0.25g, 1.39 mmol) was added followed by the addition of Et3N (0.21 mL, 1.5 
mmol). The solution was stirred for 2h at room temperature and then quenched by 
O
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pouring the mixture into water. The product was extracted with EtOAc. The organic layer 
was washed with sodium bicarbonate solution, 2N hydrochloric acid solution and brine, 
dried over MgSO4 and the solvent removed under reduced pressure. The crude product 
was purified by flash chromatography (2:1 hexane:ethyl acetate) to obtain 5 (R/S 
configuration) (0.442g, 71%, yellow crystal). 
 
1H NMR: (CDCl3, 600 MHz): δ (ppm) 7.91-7.89 (d, 2H), 7.63-7.61 (d, 2H), 7.57-7.54 
(m, 5H), 7.15-7.13 (d, J = 12 Hz, 2H), 6.88-6.86 (d, J = 12 Hz, 2H), 6.21 (s, 1H), 5.25 (m, 
1H), 4.39-4.34 (dd, 1H), 4.30 (m, 1H), 4.28-4.25 (m, 1H), 3.05-3.02 (m, 1H), 1.38 (d, 
3H) 
13C NMR: CDCl3, 100 MHz): δ (ppm) ) 171.1, 136.8, 136.3, 135.1, 134.2, 133.6, 128.4, 
127.5.4, 117.6, 117.0, 96.2, 73.1, 72.2, 68.5, 66.4, 55.3, 18.1 
Rf (Hexane: EtOAc 2:1) 0.40 
 
1-O-p-Methoxy-2, 3-O-dibenzyl-4-O-p-nitrobenzoyl-α-L-rhamnopyranoside (10) 
 
80% aqueous acetic acid was added to a solution of 5 (0.71g, 0.89 mmol). The reaction 
mixture was stirred at 65 oC for 2h and then the solvent removed under reduced pressure 
to obtain crude 1-O-p-methoxy-4-O-p-nitrobenzoyl-α-L-rhamnopyranoside (0.28g). 
To a solution of crude product (0.28 g) in 15.0 mL dichloromethane, 
benzyltrichloroacetimidate  (0.20g, 0.82 mmol) was added at 0 oC under Ar(g) 
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atmosphere, followed by the addition of triflic acid (0.10 mL, 680 µmol). The reaction 
mixture was stirred for 45 min. The mixture was quenched by adding triethylamine and 
concentrated under reduced pressure.  The product was purified by silica gel flash 
chromatography (20% EtOAc in Hexane) to obtain 10 (0.63g, 68% over two steps, 
yellow oil). 
 
1H NMR (CDCl3, 600 MHz): δ (ppm) 8.32-8.30 (d, 2H), 8.29-8.27 (d, 2H), 7.38-7.29 
(m, 10H), 7.12-7.10 (d, 2H), 6.88-6.86 (d, 2H), 5.42 (m, 2H), 5.10-5.08 (m, 1H), 4.92 (s, 
2H), 4.89 (s, 2H), 4.23-4.20 (m, 1H), 3.81-3.79 (m, 1H), 3.71 (s, 3H), 3.52-3.49 (m, 1H), 
1.31 (d, 2H) 
13C NMR (CDCl3, 162 MHz): δ (ppm) 165.1, 158.2, 150.9, 138.3, 138.0, 137.6, 137.1, 
136.4, 130.9, 130.4, 129.1, 128.4, 113.6, 97.5, 79.2, 79.0, 77.2, 71.6, 65.5, 55.1, 54.2, 
16.1 
Rf (Hexane: EtOAc 2:1) 0.62 
 
2, 3-O-Dibenzyl-4-O-p-nitrobenzoyl-L-rhamnopyranoside trichloroacetimidate (21) 
 
 
 
To a solution of 10 (0.036g, 0.075 mmol) in CH3CN: H2O (5:1) ceric ammonium nitrate 
(0.12, 0.18 mmol) was added and the solution stirred for 1h. The reaction was quenched 
by the addition of sodium bicarbonate and extracted with dichloromethane. The organic 
O
OBnOBn
pNO2BzO
OC(NH)CCl3
	  	  	  
43	  
layer was dried over MgSO4 and the solvent removed under reduced pressure to obtain 
crude product (0.021g), which was dissolved in dichloromethane (10.0 mL) under Ar (g) 
atm followed by the addition of K2CO3 (0.030g, 0.2 mmol). Trichloroacetonitrile (0.013 
mL, 0.13 mmol) was added slowly and the reaction mixture was stirred for 45 min at 0 
oC. The reaction mixture was quenched by the addition of triethylamine (0.25 mL) and 
filtered through celite®, washed with dichloromethane and solvent removed under 
reduced pressure. The crude product was purified by flash chromatography (3:2 
hexane:ethyl acetate) to obtain 21 (0.026g, 65% over two steps, yellow crystals). 
 
 
1-O-p-Methoxy-2, 3-O-benzylidine-4-O-benzylsulfonyl-α-L-rhamnopyranoside (6) 
 
To a solution of 2 (0.365g, 1.05 mmol) in dichoromethane (12.0 mL), 
phenylmethylsulfonylchloride (0.22g, 1.16 mmol) was added followed by the addition of 
2,6 –lutidine (0.24 mL, 2.11 mmol). The solution was stirred for 2h at room temperature 
and then quenched by pouring the mixture into water. The product was extracted with 
dichloromethane. The organic layer was washed with sodium bicarbonate solution, 2N 
hydrochloric acid solution and brine, dried over MgSO4 and the solvent removed under 
reduced pressure. The crude product was purified by flash chromatography (2:1 
hexane:ethyl acetate) to obtain 6 (R/S configuration) (0.48g, 89%, white solid). 
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1H NMR: (CDCl3, 400 MHz): δ (ppm) 7.56-7.52 (m, 5H), 7.20-7.18 (d, 2H), 7.01-6.99 
(d, 2H), 5.99 (s, 1H), 5.71 (s, 1H), 4.89-4.86 (m, 1H), 4.26 (s, 2H), 4.02-3.99 (m, 2H), 
3.86-3.83 (m, 1h), 1.39 (d, 3H) 
13C NMR: CDCl3, 100 MHz): δ (ppm) 189.1, 131.5, 131.3, 129.4, 128.2, 127.2, 123.1, 
117.8, 117.0, 115.3, 114.9, 97.1, 83.4, 71.8, 70.0, 69.9, 66.3, 57.8, 57.1, 56.2, 17.8  
Rf (Hexane: EtOAc 2:1) 0.38 
 
 
1-O-p-Methoxy-2, 3-O-dibenzyl-4-O- benzylsulfonyl--α-L-rhamnopyranoside (11) 
 
80% aqueous acetic acid was added to a solution of 6 (0.49g, 0.98 mmol). The reaction 
mixture was stirred at 65 oC for 2h and then the solvent removed under reduced pressure 
to obtain crude product (0.23g), which was dissolved in DMF. NaH (0.10g, 3.9 mmol) 
was added under Ar (g) atmosphere at 0 oC followed by the addition of BnBr (0.46 mL, 
3.9 mmol). The reaction mixture was stirred at 0 oC for 1h and then warmed to room 
temperature and stirred for 3h. The reaction was quenched by the addition of water. 
Organic layer extracted with EtOAc and washed with brine. The organic layer was dried 
over MgSO4 and the solvent removed under reduced pressure. The crude product was 
purified by flash chromatography (2:1 hexane:ethyl acetate) to obtain 11 (0.32g, 56% 
over two steps, colorless oil). 
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1H NMR: (CDCl3, 600 MHz): δ (ppm) 7.63-7.61 (m, 5H), 7.55-7.51 (m, 5H), 7.29-7.25 
(m, 5H), 6.99-6.97 (d, 2H), 6.92-6.90 (d, 2H), 5.10 (s, 1H), 4.91-4.88 (m, 2H), 4.62 (s, 
2H), 4.51 (s, 2H), 4.22-4.19 (m, 1H), 3.98 (s, 2H), 3.51-3.47 (m, 1H), 1.29 (d, 3H) 
13C NMR: CDCl3, 100 MHz): δ (ppm) 138.1, 134.5, 131.9, 129.4, 129.1, 128.6, 128.7, 
127.7, 127.6, 115.2, 95.8, 79.8, 71.2, 70.3, 69.8, 59.1, 56.2, 18.1 
Rf (Hexane: EtOAc 3:2) 0.52  
 
2, 3-O-Di-benzyl-4-O- benzylsulfonyl-α-L-rhamnopyranoside tricholoracetimidate 
(22) 
 
To a solution of 11 (0.032g, 0.053 mmol) in CH3CN:H2O (5:1) ceric ammonium nitrate 
(0.06g, 0.10 mmol) was added and the solution stirred for 1h. The reaction was quenched 
by the addition of sodium bicarbonate and extracted with dichloromethane. The organic 
layer was dried over MgSO4 and the solvent removed under reduced pressure to obtain 
crude product (0.022g), which was dissolved in dichloromethane (10.0 mL) under Ar (g) 
atmosphere. K2CO3 (0.031g, 0.22 mmol) was added followed by slow addition of 
trichloroacetonitrile (0.13mL, 1.36mol) and the reaction mixture was stirred for 45 min at 
0 oC. The reaction mixture was quenched by the addition of triethylamine (0.15mL) and 
filtered through celite®, washed with dichloromethane and solvent removed under 
reduced pressure. The crude product was purified by flash chromatography (3:2 
hexane:ethyl acetate) to obtain 22 (0.024g, 71% over two steps, colorless oil). 
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1-O-p-Methoxy-2, 3, 4-tribenzyl-α-L-rhamnopyranoside (12) 
 
To a solution of 1 (0.82g, 2.1 mmol) in DMF, NaH (0.204g, 8.5 mmol) was added under 
Ar (g) atmosphere at 0 oC followed by the addition of BnBr (1.0 mL, 8.5 mmol) The 
reaction mixture was stirred at 0 oC for 1h and then warmed to room temperature and 
stirred for 3h. The reaction was quenched by the addition of water. The organic layer 
extracted with EtOAc and washed with brine. The organic layer was dried over MgSO4 
and the solvent removed under reduced pressure. The crude product was purified by flash 
chromatography (2:1 hexane:ethyl acetate) to obtain 12 (1.31 g, 63% yield). 
 
1H NMR (CDCl3, 600 MHz): δ (ppm) 7.49-7.46 (m, 5H), 7.38-7.32 (m, 10H), 6.95-6.93 
(d, 2H), 6.90-6.88 (d, 2H), 5.22 (s, 1H), 5.14-5.12 (m, 1H), 4.89 (s, 2H), 4.65 (s, 2H), 
4.41(s, 2H) 4.31-4.29 (m, 1H), 3.65-3.61 (m, 1H), 3.56 (s, 3H), 3.12-3.10 (m, 1H), 1.22 
(d, 2H) 
13C NMR (CDCl3, 162 MHz): δ (ppm) 154.2, 129.8, 129.5, 129.2, 128.3, 128.0, 117.6, 
115.3, 83.8, 78.2, 77.0, 76.8, 72.6, 63.6, 54.2, 53.8, 18.1 
Rf (Hexane: EtOAc 2:1) 0.35 
 
2,3,4-tribenzyl-α-L-rhamnopyranoside trichloroacetimidate (23) 
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To a solution of 12 (0.054g, 0.10 mmol) in CH3CN: H2O (5:1) ceric ammonium nitrate 
(0.1g, 0.12 mmol) was added and the solution stirred for 1h. The reaction was quenched 
by the addition of sodium bicarbonate and extracted with dichloromethane. The organic 
layer was dried over MgSO4 and the solvent removed under reduced pressure to obtain 
the crude product (0.033g), which was dissolved in dichloromethane under Ar (g) 
atmosphere. K2CO3 (0.052g, 0.37 mmol) was added followed by slow addition of 
trichloroacetonitrile (0.02mL, 0.2 mmol) and the reaction mixture was stirred for 45 min 
at 0 oC. The reaction mixture was quenched by the addition of triethylamine (0.15mL) 
and filtered through celite®, washed with dichloromethane and solvent removed under 
reduced pressure. The crude product was purified by flash chromatography (3:2 
hexane:ethyl acetate) to obtain 23 (0.035g, 56% over two steps, white solid). 
 
 
1-O-p-Methoxy-2, 3-O-benzylidine-4-O-benzyl-α-L-rhamnopyranoside (7) 
 
To a solution of 2 (2.4g, 6.6 mmol) in DMF, NaH (0.24g, 9.9mmol) was added under Ar 
(g) atmosphere at 0 oC followed by the addition of BnBr (1.17mL, 9.9mmol). The 
reaction mixture was stirred at 0 oC for 1h and then warmed to room temperature and 
stirred for 6h. The reaction was quenched by the addition of water. The organic layer was 
extracted with EtOAc and washed with brine. The organic layer was dried over MgSO4 
O
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and the solvent removed under reduced pressure. The crude product was purified by flash 
chromatography (2:1 hexane:ethyl acetate) to obtain 7 (2.56g, 87%, white solid). 
 
1H NMR: (CDCl3, 600 MHz): δ (ppm) 7.61-7.55 (m, 2H), 7.49-7.46 (m, 3H), 7.32-7.27 
(m, 3H), 7.17-7.15 (d, 2H), 6.88-6.86 (d, 2H), 6.05 (s, 1H), 5.78 (s, 1H), 5.12-5.10 (dd, 
1H), 4.95-4.94 (dd, 1H), 4.65 (m, 1H), 4.01-3.99 (m, 1H), 3.86 (s, 3H), 1.28-1.26 (d, 3H) 
13C NMR: (CDCl3, 100 MHz): δ (ppm) 129.9, 129.1, 128.6, 128.4, 127.2, 126.8, 117.6, 
115.5, 98.6, 79.9. 78.5, 74.5, 74.2, 55.8, 17.6 
Rf (Hexane: EtOAc 2:1) 0.77 
 
1-O-p-Methoxy-2, 4-O-di-benzyl-α-L-rhamnopyranoside (13) 
	  
80% aqueous acetic acid was added to a solution of 7 (2.56g, 5.71mmol). The reaction 
mixture was stirred at 65 oC for 2h and then the solvent removed under reduced pressure 
to obtain crude product (1.6g), which was dissolved in CH2Cl2. NaOH (5% aq) was added 
at room temperature followed by the addition of BnBr (0.58 mL, 4.8 mmol). The reaction 
mixture was stirred at 0 oC for 1h and then warmed to room temperature and stirred for 
4h. The reaction was quenched by the addition of water. The organic layer extracted with 
EtOAc and washed with brine. The organic layer was dried over MgSO4 and the solvent 
removed under reduced pressure. The crude product was purified by flash 
O
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chromatography (2:1 hexane:ethyl acetate) to obtain 13 (1.74g, 67% over two steps, 
colorless oil). 
 
1H NMR: (CDCl3, 600 MHz): δ (ppm) 7.40-7.36 (m, 10H), 6.98-6.96 (d, 2H), 6.94-6.92 
(d, 2H), 5.89 (s, 1H), 4.67 (s, 2H), 4.21(s, 2H), 4.01-3.99 (m, 1H), 3.66-3.63 (m, 1H), 
1.36 (d, 2H) 
13C NMR: (CDCl3, 162 MHz): δ (ppm) 138.5, 138.3, 128.9, 128.6, 128.4, 127.4, 127.0, 
117.9,115.6, 96.6, 94.8, 77.4, 74.3, 73.2, 71.9, 68.5,56.8 20.1 
Rf (Hexane: EtOAc 2:1) 0.50 
 
1-O-p-Methoxy-2, 4-O-di-benzyl-3-O-acetyl-α-L-rhamnopyranoside (15) 
	  
To a solution of 13 (0.43g, 0.61 mmol) in pyridine (10.0 mL), acetic anhydride (12.0 mL) 
was added at ambient temperature. The solution was stirred for 2h and then quenched by 
pouring the mixture into water. The product was extracted with EtOAc. The organic layer 
was washed with sodium bicarbonate solution, 2N hydrochloric acid solution and brine, 
dried over MgSO4 and the solvent removed under reduced pressure. The crude product 
was purified by flash chromatography (2:1 hexane:ethyl acetate) to obtain 15 (0.41g, 85% 
yield). 
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1H NMR: (CDCl3, 600 MHz): δ (ppm) 7.35-3.26 (m, 10H), 7.12-7.10 (d, 2H), 6.98-6.96 
(d, 2H), 4.85 (d, 1H), 4.74 (d, , 1H), 4.68 (d,1H), 4.12-4.07 (m, 2H), 3.93 (dd, J = 12.8 
Hz, 6.0 Hz, 1H), 3.75 (m, 1H), 3.36 (t, 1H), 2.56 (d, 1H), 2.0 (s, 3H), 1.32 (d, 3H). 
13C NMR: (CDCl3, 162 MHz): δ (ppm) 171.0, 112.5, 1128.0, 107.9, 107.6, 86.6, 81.7, 
75.3, 72.9, 70.2, 68.1, 67.5, 21.1, 18.0. 
Rf (Hexane: EtOAc 3:2) 0.55 
 
2, 4-O-Di-benzyl-3-O-acetyl-α/β-L-rhamnopyranoside trichloroacetimidate (24) 
 
To a solution of 15 (0.025g, 0.05 mmol) in CH3CN:H2O (5:1) ceric ammonium nitrate 
(0.057g, 0.12 mmol) was added and the solution stirred for 1h. The reaction was 
quenched by the addition of sodium bicarbonate and extracted with dichloromethane. The 
organic layer was dried over MgSO4 and the solvent removed under reduced pressure. 
The crude product (0.017g) was dried under vacuum and carried out to the next step. The 
crude product obtained was dissolved in dichloromethane under Ar (g) atmosphere, 
K2CO3  (0.031g, 0.22 mmol) was added followed by slow addition of trichloroacetonitrile 
(0.013mL, 0.13 mmol) and the reaction mixture was stirred for 45 min at 0 oC. The 
reaction mixture was quenched by the addition of triethylamine (0.25mL) and filtered 
through celite®, washed with dichloromethane and solvent removed under reduced 
pressure. The crude product was purified by flash chromatography (3:2 hexane:ethyl 
acetate) to obtain 24 (0.021g, 77% over two steps, oil). 
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1-O-p-Methoxy-2, 4-O-dibenzyl-α-L-rhamnopyranoside (16) 
	  
To a solution of 13 (0.436g, 1.2 mmol) in pyridine (12.0 mL), benzoyl chloride (0.15 mL, 
1.3 mmol) was added at ambient temperature. The solution was stirred for 2h and then 
quenched by pouring the mixture into water. The product was extracted with EtOAc. The 
organic layer was washed with sodium bicarbonate solution, 2N hydrochloric acid 
solution and brine, dried over MgSO4 and the solvent removed under reduced pressure. 
The crude product was purified by flash chromatography (2:1 hexane:ethyl acetate) to 
obtain 16 (0.518g, 92%). 
 
1H NMR (CDCl3, 600 MHz): δ (ppm) 7.67-7.64 (m, 5H), 7.39-7.33 (m, 5H), 6.98-6.96 
(d, 2H), 6.92-6.90 (d, 2H), 5.46 (s, 1H), 5.32-5.30 (m, 1H), 4.65 (s, 2H), 4.35 (s, 2H) 
4.31-4.29 (m, 1H), 3.44-3.42 (m, 1H), 3.38 (s, 3H), 3.22-3.20 (m, 1H), 1.33 (d, 2H) 
13C NMR (CDCl3, 162 MHz): δ (ppm) 201.2, 156.7, 139.2, 139.0, 138.9, 138.1, 137.2, 
135.9, 134.4, 128.3, 128.0, 117.6, 96. 95.2,8, 76.2, 76.0, 74.7, 74.2, 68.8, 55.2, 53.8, 19.3. 
Rf (Hexane: EtOAc 3:2) 0.33 
	  
2, 4-O-Di-benzyl-3-O-benzoyl-α-L-rhamnopyranoside trichloroacetimidate (25) 
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To a solution of 16 (0.036g, 0.64 mmol) in CH3CN:H2O (5:1) ceric ammonium nitrate 
(0.076g, 0.17 mmol) was added and the solution stirred for 1h. The reaction was 
quenched by the addition of sodium bicarbonate and extracted with dichloromethane. The 
organic layer was dried with MgSO4 and the solvent removed under reduced pressure. 
The crude product (0.024g, 0.053 mmol) was dissolved in dichloromethane under Ar (g) 
atmosphere, K2CO3 (0.03g, 0.26 mmol) was added followed by slow addition of 
trichloroacetonitrile (0.15 mL, 1.59 mmol) and the reaction mixture was stirred for 45 
min at 0 oC. The reaction mixture was quenched by the addition of triethylamine (0.20 
mL) and filtered through celite®, washed with dichloromethane and solvent removed 
under reduced pressure. The crude product was purified by flash chromatography (3:2 
hexane:ethyl acetate) to obtain 25 (0.040 g, 83%, colorless oil). 
 
1-O-p-Methoxy-2, 4-O-dibenzyl-3-O-p-nitrobenzoyl-α-L-rhamnopyranoside (17) 
	  
To a solution of 13 (0.051g, 0.13 mmol) in dichloromethane (15.0 mL), p-nitrobenzoyl 
chloride (0.023g, 0.12 mmol) was added followed by the addition of Et3N (0.12 mL, 1.35 
mmol). The solution was stirred for 2h at room temperature and then quenched by 
pouring the mixture into water. The product was extracted with EtOAc. The organic layer 
was washed with sodium bicarbonate solution, 2N hydrochloric acid solution and brine, 
dried over MgSO4 and the solvent removed under reduced pressure. The crude product 
was purified by flash chromatography (2:1 hexane:ethyl acetate) to obtain 17 (0.051g, 
76%, yellow solid).  
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2, 4-O-Dibenzyl-3-O-p-nitrobenzoyl-α-L-rhamnopyranoside trichloroacetimidate 
(26) 
	  
To a solution of 17 (0.051g, 0.086 mmol) in CH3CN: H2O (5:1) ceric ammonium nitrate 
(0.095g, 0.17 mmol) was added and the solution stirred for 1h. The reaction was 
quenched by the addition of sodium bicarbonate and extracted with dichloromethane. The 
organic layer was dried over MgSO4 and the solvent removed under reduced pressure to 
obtain the crude product (0.37g). Dichloromethane (10.0 mL) was added to the crude 
product under Ar (g) atm followed by the addition of, K2CO3 (0.053g, 0.38 mmol) was 
added followed by slow addition of trichloroacetonitrile (0.023 mL, 0.23 mmol) and the 
reaction mixture was stirred for 45 min at 0 oC. The reaction mixture was quenched by 
the addition of triethylamine (0.25 mL) and filtered through celite®, washed with 
dichloromethane and solvent removed under reduced pressure. The crude product was 
purified by flash chromatography (3:2 hexane:ethyl acetate) to obtain 26 (0.035g, 72% 
over two steps, colorless oil).  
 
1-O-p-Methoxy-2, 4-O-dibenzyl-3-O- benzylsulfonyl-α-L-rhamnopyranoside (18)	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To a solution of 13 (0.42g, 0.93 mmol) in dichoromethane (12.0 mL), 
phenylmethylsulfonylchloride (0.19g, 1.02 mmol) was added followed by the addition of 
2,6 –lutidine (0.21 mL, 1.86 mmol). The solution was stirred for 2h at room temperature 
and then quenched by pouring the mixture into water. The product was extracted with 
dichloromethane. The organic layer was washed with sodium bicarbonate solution, 2N 
hydrochloric acid solution and brine, dried over MgSO4 and the solvent removed under 
reduced pressure. The crude product was purified by flash chromatography (2:1 
hexane:ethyl acetate) to obtain 18 (0.47g, 86%, white solid). 
 
2, 4-O-Di-benzyl-3-O- benzylsulfonyl-α-L-rhamnopyranoside tricholoracetimidate 
(27)	  
	  
To a solution of 18 (0.047g, 0.079 mmol) in CH3CN:H2O (5:1) ceric ammonium nitrate 
(0.087g, 0.15 mmol) was added and the solution stirred for 1h. The reaction was 
quenched by the addition of sodium bicarbonate and extracted with dichloromethane. The 
organic layer was dried over MgSO4 and the solvent removed under reduced pressure to 
obtain crude product (0.31g), which was dissolved in dichloromethane (10.0 mL) under 
Ar (g) atmosphere. K2CO3 (0.044g, 0.03 mmol) was added followed by slow addition of 
trichloroacetonitrile (0.019mL, 0.19 mmol) and the reaction mixture was stirred for 45 
min at 0 oC. The reaction mixture was quenched by the addition of triethylamine 
(0.15mL) and filtered through celite®, washed with dichloromethane and solvent 
removed under reduced pressure. The crude product was purified by flash 
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chromatography (3:2 hexane:ethyl acetate) to obtain 27 (0.037g, 73% over two steps, 
colorless oil). 
 
cis-4-(1H, 1H, 2H, 2H, 3H, 3H-Perfluoroundecyloxy)-2-butenyl 2, 3, 4-tri-O-benzyl- 
α/β-L-rhamnopyranosyl-(12)-3,4-di-O-benzyl-α-L-rhamnopyranoside (33) 
	  
To a solution of 23 (0.035 mg, 0.59 mmol) and cis-4-(1H, 1H, 2H, 2H, 3H, 3H-
perfluoroundecyloxy)-2-butenyl-2-O-hydroxyl-3, 4-O-dibenzyl-α-L-rhamnopyranoside 
(0.020 g, 0.023 mmol ) in dichloromethane ( 4.0 mL), TMSOTf (650 µL, 35 µmol) was 
added at 0 oC. The reaction mixture was stirred at 0 oC for 2 h and then quenched with 
triethylamine (200 µL ) and concentrated under reduced pressure. The crude product was 
purified by fluorous solid-phase extraction (FSPE) using a fluorous solid-phase extraction 
cartridge. Non-fluorous compounds were eluted with 80% MeOH/water and the desired 
product was eluted by 100% MeOH. The solvent was removed under reduced pressure to 
provide compound 33 (0.023 g, 75%, oil). 
 
1H NMR: (CDCl3, 600 MHz): δ (ppm) 8.64-8.62 (m, 3H), 7.53-7.49 (m, 5H), 7.35-7.31 
(m, 5H), 7.22 (m, 2H), 5.68-5.66 (m, 2H), 5.12-5.94 (m, 1H), 4.94-4.88 (m, 1H), 4.84 -
4.70 (m, 1H), 4.67 (s, 2H), 4.63 (s, 2H), 4.16 (s, 2H), 3.94-3.91 (m, 1H),  3.63-3.61 
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(m,1H), 3.32-3.20 (m, 2H), 2.25-2.21, (m, 2H), 2.08-2.04 (m, 2H), 1.88 (d, 3H), 1.31 (d, 
3H) 
13C NMR: CDCl3, 100 MHz): δ (ppm) 130.4, 130.2, 128.7, 128.5, 128.3, 127.5, 127.4, 
127.2, 121.3, 120.9, 119.9, 119.2, 119.1, 117.4, 116.1, 93.9, 80.5, 80.2, 77.2, 75.4, 74.4, 
72.7, 69.9, 68.7, 68.0, 56.5, 46.9, 30.0, 20.2, 18.8, 17.2, 9.0, 8.7 
 
cis-4-(1H, 1H, 2H, 2H, 3H, 3H-Perfluoroundecyloxy)-2-butenyl 4-O-acetyl-2, 3-di-O-
benzyl- α/β-L-rhamnopyranosyl-(12)-3,4-di-O-benzyl-α-L-rhamnopyranoside 
(29) 
	  
To a solution of 19 (0.027 mg, 0.046 mmol) and cis-4-(1H, 1H, 2H, 2H, 3H, 3H-
perfluoroundecyloxy)-2-butenyl-2-O-hydroxyl-3, 4-O-dibenzyl-α-L-rhamnopyranoside 
(0.018 g, 0.020 mmol ) in dichloromethane ( 4.0 mL), TMSOTf (540 µL, 30 µmol) was 
added at 0 oC. The reaction mixture was stirred at 0 oC for 2 h and then quenched with 
triethylamine (198 µL ) and concentrated under reduced pressure. The crude product was 
purified by fluorous solid-phase extraction (FSPE) using a fluorous solid-phase extraction 
cartridge. Non-fluorous compounds were eluted with 80% MeOH/water and the desired 
product was eluted by 100% MeOH. The solvent was removed under reduced pressure to 
provide compound 29 (0.018 g, 74%, colorless oil). 
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1H NMR (CDCl3, 600 MHz): δ (ppm) 7.54-7.46 (m, 5H), 7.43-7.24 (m, 5H), 5.72-5.69 
(m, 2H), 5.42 (s, 1H), 4.94-4.93 (d, 1H), 4.81-4.79 (m, 1H), 4.69-4.63 (m, 2H), 4.37 (s, 
2H), 4.08 (s, 2H), 3.54-3.47 (m, 2H), 3.35-3.34 (m, 1H), 2.26 (s, 3H), 1.96 (d, 3H), 1.43-
1.21 (m,4H), 1.20 (d, 3H) 
13C NMR (CDCl3, 162 MHz): δ (ppm) 172.1, 160.0, 153.4, 138.4, 132.6, 132.1, 131.4, 
131.1, 129.9, 129.7, 128.7, 127.9, 108.1, 107.2, 96.9, 86.4, 77.0, 76.8, 68.9, 66.2, 65.9, 
58.7,47.5, 45.6, 31.2, 29.8, 24.3, 21.4, 20.7, 17.6 
HRMS: Calcd for C57H61O11F17K: 1242.59, found [M+K+2D]: 1290.44 
 
cis-4-(1H, 1H, 2H, 2H, 3H, 3H-Perfluoroundecyloxy)-2-butenyl 4-O-benzoyl-2, 3-di-
O-benzyl- α/β-L-rhamnopyranosyl-(12)-3,4-di-O-benzyl-α-L-rhamnopyranoside 
(30) 
 
To a solution of 20 (0.040 mg, 0.067 mmol) and cis-4-(1H, 1H, 2H, 2H, 3H, 3H- 
perfluoroundecyloxy)-2-butenyl-2-O-hydroxyl-3, 4-O-dibenzyl-α-L-rhamnopyranoside 
(0.023g, 0.026 mmol ) in dichloromethane ( 4.0 mL), TMSOTf (700µL, 39 µmol) was 
added at 0 oC. The reaction mixture was stirred at 0 oC for 2 h and then quenched with 
triethylamine (650 µL ) and concentrated under reduced pressure. The crude product was 
purified by fluorous solid-phase extraction (FSPE) using a fluorous solid-phase extraction 
cartridge. Non-fluorous compounds were eluted with 80% MeOH/water and the desired 
O
OBnOBn
BzO
O
O
BnO
BnO
OFtag
	  	  	  
58	  
product was eluted by 100% MeOH. The solvent was removed under reduced pressure to 
provide compound 30 (0.021g, 61%, yellow oil). 
 
1H NMR: (CDCl3, 600 MHz): δ (ppm) 8.27-8.20 (m, 5H), 8.19-8.08 (m, 5H), 7.92 (m, 
2H), 7.78 (m, 3H), 7.53- 7.20 (m, 5H), 7.41-7.37 (m,3H), 7.37-7.33 (m, 2H), 5.95 (m, 
2H), 5.58 (m, 2H), 4.94 (dd, 1H), 4.80 (dd, 1H), 4.74 (d, 1H), 4.64 (d, 1H), 6.61 (s, 2H), 
4.56 (d, 1H), 4.27-4.20 (m,1H), 4.11 (s, 2H), 4.06 (s, 2H), 3.57 (dd, 1H), 3.49 (s, 2H), 
2.26-2.22 (m, 2H), 1.91-1.90 (m, 2H), 1.36 (d, 3H), 1.24 (d, 3H) 
13C NMR: CDCl3, 100 MHz): δ (ppm) 162.3, 162.3, 162.3, 134.5, 134.5, 134.4, 134.2, 
130.6, 130.6, 130.5, 130.5, 128.9, 128.9, 128.8, 128.6, 128.5, 128.3, 128.1, 76.8, 72.9, 
71.5, 65.7, 63.5, 60.7, 51.5, 51.2, 29.5, 29.3, 22.7, 13.9, 13.4.  
HRMS: Calcd for C62H61O11F17: 1304.61, found [M+Na]: 1327.90 
 
cis-4-(1H, 1H, 2H, 2H, 3H, 3H-Perfluoroundecyloxy)-2-butenyl 4-O-benzylsulfonyl-2, 
3-di-O-benzyl- α/β-L-rhamnopyranosyl-(12)-3,4-di-O-benzyl-α-L-
rhamnopyranoside (32) 
 
 
 
 
To a solution of 22 (0.024mg, 0.038 mmol) and cis-4-(1H, 1H, 2H, 2H, 3H, 3H-
perfluoroundecyloxy)-2-butenyl-2-O-hydroxyl-3, 4-O-dibenzyl-α-L-rhamnopyranoside 
(0.013 g, 0.015 mmol ) in dichloromethane ( 4.0 mL), TMSOTf (400 µL, 22 µmol) was 
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added at 0 oC. The reaction mixture was stirred at 0 oC for 2 h and then quenched with 
triethylamine (220 µL ) and concentrated under reduced pressure. The crude product was 
purified by fluorous solid-phase extraction (FSPE) using a fluorous solid-phase extraction 
cartridge. Non-fluorous compounds were eluted with 80% MeOH/water and the desired 
product was eluted by 100% MeOH. The solvent was removed under reduced pressure to 
provide compound 32 (0.018 mg, 88%, white solid). 
 
1H NMR: (CDCl3, 600 MHz): δ (ppm) 7.56-7.51 (m, 5H), 7.41-7.35 (m, 5H), 7.32-7.27 
(m,5H), 7.12-7.06 (m, 5H), 6.98-6.94 (m, 5H), 5.72-5.69 (m. 2H), 5.61 (s, 1H), 4.83-4.81 
(m, 1H), 4.79-4.76 (m, 1H), 4.70 (s,2H), 4.62 (s, 2H), 4.62-4.57 (m, 2H), 4.16-4.06 (m, 
1H), 3.94-3.89 (m, 1H), 3.67 (m, 1H), 3.19-3.14 (m, 1H), 1.66 (d, 3H), 1.53-1.50 (m, 
2H), 1.42-1.39 (m, 2H) 
13C NMR: CDCl3, 100 MHz): δ (ppm) 140.1, 138.5, 137.9, 1, 129.4, 128.7, 128.2, 
128.1, 127.9, 127.6, 127.5, 127.2, 127.0, 96.1, 82.9, 75.6, 70.4, 69.4, 68.0, 66.2, 56.2, 
55.2, 54.5, 53. 2, 51.9, 45.2, 30.0, 29.7, 28.5, 25.2, 25.0, 23.7, 22.9, 13.9, 8.5 
HRMS: Calcd for C62H61O12 SF17: 1322.85, found [M+Na+3D]: 1348.61 
 
	  
cis-4-(1H, 1H, 2H, 2H, 3H, 3H-Perfluoroundecyloxy)-2-butenyl 3-O-acetyl-2, 4-di-O-
benzyl- α/β-L-rhamnopyranosyl-(12)-3,4-di-O-benzyl-α-L-rhamnopyranoside 
(34) 
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To a solution of 24 (0.021 mg, 0.040 mmol) and cis-4-(1H, 1H, 2H, 2H, 3H, 3H-
perfluoroundecyloxy)-2-butenyl-2-O-hydroxyl-3, 4-O-dibenzyl-α-L-rhamnopyranoside 
(0.014 g, 0.016 mmol ) in dichloromethane ( 4.0 mL), TMSOTf (240 µL, 24 µmol) was 
added at 0 oC. The reaction mixture was stirred at 0 oC for 2 h and then quenched with 
triethylamine (150 µL ) and concentrated under reduced pressure. The crude product was 
purified by fluorous solid-phase extraction (FSPE) using a fluorous solid-phase extraction 
cartridge. Non-fluorous compounds were eluted with 80% MeOH/water and the desired 
product was eluted by 100% MeOH. The solvent was removed under reduced pressure to 
provide compound 34 (0.013 g, 68%, colorless oil). 
 
1H NMR: (CDCl3, 400 MHz): δ (ppm) 7.37 -7.30 (m, 15H), 7.10-7.04 (m, 5H), 5.79-
5.77 (m, 2H), 5.76-5.74 (m, 2H), 5.12 (m, 2H), 4.61 (d, 1H), 4.49 (s, 2H), 4.47 (s, 2H), 
4.45-4.43 (m, 3H), 4.03-3.98 (m, 1H), 3.86 (s, 2H), 3.46-3.42 (m, 2H), 2.12 (s, 3H), 1.89 
(m, 2H), 1.28 (d, 3H), 1.26 (d, 2H) 
13C NMR: CDCl3, 100 MHz): δ (ppm) 170.6, 138.8, 138.5, 120.1, 128.9, 128.8, 128.7, 
128.4, 128.0, 99.6, 99.1, 82.0, 77.5, 77.6, 76.4, 75.8, 74.3, 74.2, 68.1, 58.3, 28.5, 25.1, 
24.3, 18.9, 18.8 
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cis-4-(1H, 1H, 2H, 2H, 3H, 3H-Perfluoroundecyloxy)-2-butenyl 3-O-benzoyl-2, 4-di-
O-benzyl- α/β-L-rhamnopyranosyl-(12)-3,4-di-O-benzyl-α-L-rhamnopyranoside 
(35) 
 
To a solution of 25 (0.025mg, 0.042 mmol) and cis-4-(1H, 1H, 2H, 2H, 3H, 3H-
perfluoroundecyloxy)-2-butenyl-2-O-hydroxyl-3, 4-O-dibenzyl-α-L-rhamnopyranoside 
(0.015 g, 0.016 mmol ) in dichloromethane ( 4.0 mL), TMSOTf (450 µL, 25 µmol) was 
added at 0 oC. The reaction mixture was stirred at 0 oC for 2 h and then quenched with 
triethylamine (150 µL ) and concentrated under reduced pressure. The crude product was 
purified by fluorous solid-phase extraction (FSPE) using a fluorous solid-phase extraction 
cartridge. Non-fluorous compounds were eluted with 80% MeOH/water and the desired 
product was eluted by 100% MeOH. The solvent was removed under reduced pressure to 
provide compound 35 (0.013g, 62%, oil). 
 
1H NMR: (CDCl3, 400 MHz): δ (ppm) 7.397.35 (m, 10H), 7.35-7.28 (m, 10H), 5.86-
5.84 (m, 2H), 5.63-5.61 (m, 2H), 4.99 (d, 1H), 4.97 (s, 2H), 4.86-4.84 (m, 2H), 4.82 (s, 
2H), 4.64 (s, 2H), 4.46-4.44 (m, 2H), 4.18-4.16 (m, 2H), 4.12 (s, 2H), 3.98 (s, 2H), 3.95 
(m, 2H), 3.89-3.87 (m, 2H), 2.12-2.10 (m, 2H), 1.86 (m, 2H), 1.24 (d, 3H), 1.22 (d, 2H) 
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cis-4-(1H, 1H, 2H, 2H, 3H, 3H-Perfluoroundecyloxy)-2-butenyl 3-O-benzylsulfonyl-2, 
4-di-O-benzyl- α/β-L-rhamnopyranosyl-(12)-3,4-di-O-benzyl-α-L-
rhamnopyranoside (37) 
 
To a solution of 27 (0.037 g, 0.060 mmol) and cis-4-(1H, 1H, 2H, 2H, 3H, 3H-
perfluoroundecyloxy)-2-butenyl-2-O-hydroxyl-3, 4-O-dibenzyl-α-L-rhamnopyranoside 
(0.021 g, 0.024 mmol) in dichloromethane ( 4.0 mL), TMSOTf (650 µL, 36 µmol) was 
added at 0 oC. The reaction mixture was stirred at 0 oC for 2 h and then quenched with 
triethylamine (210 µL ) and concentrated under reduced pressure. The crude product was 
purified by fluorous solid-phase extraction (FSPE) using a fluorous solid-phase extraction 
cartridge. Non-fluorous compounds were eluted with 80% MeOH/water and the desired 
product was eluted by 100% MeOH. The solvent was removed under reduced pressure to 
provide compound 37 (0.016 g, 71%, yellow oil). 
 
1H NMR: (CDCl3, 400 MHz): δ (ppm) 7.48-7.45 (m, 5H), 7.41-7.35 (m, 5H), 7.31-7.27 
(m,5H), 7.11-7.06 (m, 5H), 6.98-6.94 (m, 5H), 5.72-5.69 (m. 2H), 5.61 (s, 1H), 4.83-4.81 
(m, 1H), 4.79-4.76 (m, 1H), 4.70 (s,2H), 4.62 (s, 2H), 4.62-4.57 (m, 2H), 4.16-4.06 (m, 
1H), 3.94-3.89 (m, 1H), 3.67 (m, 1H), 3.19-3.14 (m, 1H), 1.66 (d, 3H), 1.53-1.50 (m, 
2H), 1.42-1.39 (m, 2H) 
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CHAPTER 3 
Automated Solution-Phase Synthesis of Plant Polysaccharide Homogalacturonan 
(HG) 
Sahana K. Nagappayya and Nicola L.B. Pohl* 
Portions of this chapter will be submitted to Organic and Biomolecular Chemistry 
Abstract 
A divergent synthesis of plant polysaccharide homogalacturonan (HG) backbone is 
developed. The α-linked galacturonic acid (galA) containing HG backbone is synthesized 
by glycosylation of galA trichloroacetimidate donors with galA fluorous-tagged 
acceptors on an automated solution phase platform. This is the first example of an 
automated solution phase synthesis of HG fragments.  
Introduction 
Plant cell wall consists of nearly 90% saccharides and 10% proteins, which are in the 
form of glycoproteins (McNeil et al, 1984). Cellulose, xyloglucan, xylans, 
xylogalacturonan, homogalacturonan, rhamnogalacturonans I and II are some of the 
polysaccharide components of plant cell wall. The various saccharides found on these 
polysaccharide components are D-glucose, D-galactose, D-galacturonic acid, L-rhamnose, 
D-xylose in varied linkages like β-1,4-linked-D-glucosyl residues in cellulose and 
xyloglucans, β-1,4-linked xylose in xylans and  β-1,2- linked in xyloglucans, α-1,4- 
linked D-galacturonic acid in homogalacturonan and rhamnogalacturon, α-L-rhamnosyl 
residues, on the backbone along with many other sugar residues like D-galactose, D-
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arabinose, L-fucose and unusual sugar like kdo (2-deoxy-D-manno-oct-2-ulosonic acid) 
on the side-chains of these polysaccharide backbones, shown in Fig 3-1.(Talmadge, et al, 
1973; Johansen et al, 2006). The heterogeneity of all the polysaccharides on the plant cell 
wall makes it one of the most complex natural structures.  
 
Majority of plant cell wall contain pectin polysaccharides (Ridley et al, 2001). Pectin is a 
class of polysaccharide that consists of 1,4- linked galacturonic acid residue on the 
backbone. The most abundant classes of pectin are homogalacturonan (HG) and 
rhamnogalacturonan (RG). Homogalacturonan (HG) is an important pectic 
polysaccharide containing linear chain consisting of repeating units of α-1, 4- linked 
galacturonic acid (Fig 3-2). Free acid and methyl esterified D-galacturonic acid residues 
are found on HG (O’Neil, et al, 1990, Caffall et al, 2009). This methyl esterification of 
the galacturonic acid seems to have a role in the various functions of the HG.  
 
 
Figure 3-1. Various pectic polysaccharides of the plant cell wall. A. Homogalacturonan 
(HG) B. Rhamnogalacturonan-I (RG-I) C. Rhamnogalacturonan-II. The side chains on 
the RG-II framework contains many sugar residues like α-L-fucose, β-D-glucuronic acid, 
methyl ester of β-D-glucuronic acid, α-L-arabinose, β-D-galactose etc (Mohanen, 2008) 
[−4)−α-GalA-(1,2)−α-L-Rha-(1,4)-α-GalA−4)−α-GalA-(1,2)−α-L-Rha-(1,]nB
[−4)−α-GalA-(1,4)-α-GalA-(1,4)-α-GalA-(1,4)-α-GalA-(1,4)-α-GalA-(1,4)-α-GalA-(1,4)-α-GalA-(1,-]nA
[−4)−α-GalA-(1,4)-α-GalA-(1,4)-α-GalA-(1,4)-α-GalA-(1,4)-α-GalA-(1,4)-α-GalA-(1,4)-α-GalA-(1,-]n
C
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Figure 3-2. Representation of the pectic polysaccharide homogalacturonan. A. 
Galactuonic acid residues are connected as 1, 4- α - linkages B. HG backbone with 1, 4-
α-galacturonic acid linkages shown.   
 
 
From the studies carried out by the enzymatic digestion of HG backbone, it was found 
that the highly methyl-esterified portion of the HG could not be cleaved by some 
enzymes, indicating that the esterification and the pattern of esterification of the 
galacturonic acid in HG is an important modification of the plant cell-wall (Knox et al, 
1990). Also, the highly methyl-esterified portion of the HG was found to be porous and 
provide permeability to the cell wall whereas the de-esterified portion of the HG was 
found to bind with Ca2+ and form gels, which is responsible for the mechanical strength 
of the cell wall (Willats et al, 2001). This rigid gel-like structure formation of de-
esterified galacturonic acid and the porous nature of the methyl-esterified portions of HG 
are important contributors to the structural properties of plant cell wall. This esterification 
and de-esterification of the galacturonic acid in HG take place at various developmental 
cycle of the plant growth (Knox, 1992).  
Along with the structural function of HG, owing to the presence of esters on the 
galacturonic acid residues, HG is also found to be involved in the defense mechanism of 
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the plant (McNeil et al, 1984). Not just the long chain polysaccharide of HG, but also 
smaller fragments of the plant polysaccharide are found to be very important in the 
defense mechanism of plants. It is well established that HG is involved in the synthesis of 
phytoalexins, antibiotic compounds produced by plants (McNeil et al, 1984). The 
production of phyloalexin is considered to be a defense mechanism in plants and the 
compounds that induce phyloalexin synthesis are termed elicitors (McNeil et al, 1984). It 
was found that the HG fragments containing α-linked galacturonic acid residues showed 
elicitor activity (Nothnagel, et al, 1983; Hahn et al, 1981). In this work, the HG fragments 
were isolated from the plant cell wall by enzymatic digestion. Upon incubation with 
endo-α-1, 4-polygalacturonase, an enzyme that breaks down the α -1, 4- linkage to give 
free galacturonic acid, the elicitor activity of HG fragment was lost (Nothnagel et al, 
1983). This study also implies that the galacturonic acid residues have to be contiguous 
for the elicitor activity of HG. In another study, the unesterified region of the HG 
fragment was found to be the elicitor-active portion of the plant polysaccharide (Davis et 
al, 1986). In this study, the enzyme α-1, 4-D-endopolygalacturonic acid lyase isolated 
from phytopathogenic bacterium Erwina carotovora was allowed to digest fragments of 
plant cell wall obtained from soybean and after extensive purification of the digested 
fragments, the authors concluded that the polysaccharide chain containing the α-1, 4-D-
galacturonic acid fragment had high elicitor activity.  
 
Another study on fragments of plant polysaccharide extracted from sycamore cell wall 
has shown that the HG portion of plant cell wall is also involved in hypersensitive cell 
death (Yamazaki et al, 1983). Hypersensitive cell death is a defense mechanism adopted 
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by plant cells where, upon invasion of cells by microbes, host cells start to die (Maclean 
at al, 1974). Strong evidence of the involvement of fragments of HG in inducing this 
hypersensitive cell death is found by assays of sublethal doses of toxic fragments of HG 
fragments digested by enzymes (Yamazaki, et al, 1983).  
 
Thus, the role of the HG fragments in the defense mechanism and structural rigidity of 
plant cell wall is extremely crucial. To study such activity of the HG in plant cell wall, a 
large polysaccharide of the α-1, 4-linked galacturonic acid HG is not required, a smaller 
oligosaccharide chain is also potent to study the activity. This makes the chemical 
synthesis of HG fragment an interesting target for carbohydrate chemists and then 
subsequently study for their activities. Although the fragments of the HG can be obtained 
by enzymatic action on the plant polysaccharide and then purification by a number of 
methods, this enzymatic extraction has many disadvantages. Firstly, not all the enzymes 
for synthesis of the various epitopes of the plant cell wall are known (Daas et al, 2001). 
Also, enzymatically cleaved HG fragments are not always homogeneous, random 
selection of fragments can be obtained and thus, the purification and further study on 
these fragments become challenging (McNeil et al, 1984). For systematic structure-
function relationship study of plant polysaccharides, clear and characterized structures 
are important. To obtain well-defined, homogeneous fragments of polysaccharides, 
chemical synthesis from readily available monosaccharides is a viable option. Previous 
efforts by many researchers to synthesize pure well-characterized fragments of plant 
polysaccharides have been carried out to obtain varying lengths of oligosaccharide chain 
from two to six units (Yamamoto et al, 2005; Clausen et al, 2003). In the studies 
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presented in this chapter, we have synthesized the D-galacturonic acid building blocks 
and then assembled these building blocks together on an automated solution phase 
platform developed in the Pohl Labs at Iowa State University.  
 
Automating the process of glycosylation reaction has been of considerable interest to 
groups across the world in the recent past (Zhang et al, 1999; Plante et al, 2001; Pohl, 
2008a). The first programmable synthesis of oligosaccharide was attempted by Wong and 
co-workers (Zhang et al, 1999). In this work, the researchers utilized a one-pot 
glycosylation strategy where all the glycosyl donors and acceptors required to build a 
polysaccharide were introduced into the reaction pot sequentially, eliminating 
purification at each step. The difference in reactivities of the various acceptors and 
donors was utilized and glycosyl donors were introduced into the reaction mixture based 
on their reactivity, with the most reactive donor added first and lesser reactive donors 
added later. This was a first step toward making oligosaccharide synthesis generally 
applicable and programmable. Although this is an elegant approach to the synthesis of 
oligosaccharides, the challenges in synthesizing sequentially less reactive building blocks 
to be introduced into the reaction pot at specific times, renders this method less 
applicable. 
 
The first robotically controlled synthesis platform to automate the oligosaccharide 
synthesis was developed by Seeberger and co-workers (Plante et al, 2001). In this 
process, a solid-phase peptide synthesizer was converted into a platform for carrying out 
glycosylation reactions. Once a computer program is set for the synthesizer, a robot 
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delivers the solution of the glycsoyl acceptors, donors and various reagents required for 
glycsosylation. During the whole synthesis cycle, the growing oligosaccharide chain is 
bound to a solid resin and is cleaved from it once the entire cycle of glycosylation 
reaction is complete. Although an attractive and innovative method for the synthesis of 
oligosaccharide chains, this method suffers form some fundamental setbacks. Firstly, the 
number of equivalents of the glycosyl donors for each coupling cycle varies from 10-15, 
which makes this synthesis extremely expensive. After all the protection-deprotection 
strategies applied to a monosaccharide to make it a glycosyl donor, the donor becomes 
expensive and using 10-15 equivalents of the expensive donor for one glycosylation 
makes this method extremely uneconomical. The other major drawback of this solid-
phase automated synthesis is the fact that each glycosylation reaction takes place on a 
starting material bound to the resin. If there is an error while building the sequence, it 
cannot be monitored and thus, cannot be rectified during the reaction sequence. Only 
after the reaction is complete and the final product is cleaved from the resin would the 
mistake be identified.  
 
Another approach to automate the synthesis of oligosaccharide chain is the use of a 
solution-phase synthesis platform (Pohl, 2008a). In this method, a robotic platform is 
used to carry out the entire sequence of glycosylation, deprotection and purification. 
Solutions of glycosyl donor and acceptors are transferred using a programmable needle to 
place in appropriate reaction vials to carry out glycosylation reactions. This solution-
phase automated synthesis of oligosaccharide requires only about 2-3 equivalents of the 
glycosyl donor. One of the most ingenious modifications in the solution-phase automated 
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synthesis is the ability to monitor the reaction sequence after each step. After each 
glycosylation and deprotection reaction, a small aliquot of the reaction mixture is 
transferred to the TLC block. A quick TLC of the reaction would give an indication of 
the progress of the reaction.  
 
 
Figure 3-3. Fluorous Solid Phase Extraction (FSPE) for fluorous tagged oligoasaccharide 
separation 
 
Another advantage of using the automated solution-phase synthesis platform is the use of 
Fluorous Solid Phase Extraction (FSPE). The FSPE is a separation method where a 
reverse phase silica gel bonded to fluorocarbon is used to separate out compounds based 
on their fluorous content  (Curran, 1998; Curran, 2001). In the automated solution-phase 
oligosaccharide synthesis, the growing saccharide chain is attached to a fluorous tag. A 
fluorous-tagged acceptor is synthesized and the first glycosylation takes place between 
the trichloroacetimidate donor and the fluorous-tagged acceptor. The purification of the 
disaccharide built at this stage is carried out by FSPE. A FSPE cartridge is introduced in 
the automated solution-phase synthesis platform, and after each deprotection cycle, the 
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reaction mixture is passed through this FSPE cartridge with appropriate fluorophobic and 
fluorophilic solvents to separate out fluorous-tagged oligosaccharide and the unreacted 
sugars, as shown in fig. 3-3. 
Results and discussions 
To synthesize the 1, 4- α linked D- galacturonic acid backbone on the automated solution 
phase synthesizer, a few factors had to be taken into account to design the right donor and 
acceptor molecules. The solution phase automated synthesizer is based on Schmidt’s 
tricholoroacetimidate chemistry (Schmidt et al, 1980). This is owing to the milder 
reaction conditions and reaction times on using the TCA donors compared with sulfur 
based donors. The activating conditions for using a sulfur based donors, previously used 
by Dautheau and co-workers to build α-linked galacturonic acid (Magaud et al, 1997), 
requires the activation condition of NIS and TfOH at -60 oC. This low temperature is not 
achieved on the available automated solution phase synthesizer. Although attempts are 
currently going on to use sulfur based donors on the automated platform, these studies are 
still in their infancy. On using TCA donors, the glycosylation reactions can be carried out 
0 oC, thus making the automation platform extremely suitable for tandem glycosylations.  
 
The α-selectivity of the glycosylation reaction is extremely important for building the 
HG backbone. On bechtop, since each step of glycosylation and deprotection can be 
worked up, the mixture of α/β products can be separated by tedious silica gel 
chromatography. But in case of glycosylations on the automated platform, the separation 
of any α/β mixture is avoided as much as possible since the entire reaction sequence is 
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carried out on the platform and then removed after the final deprotection step. FSPE 
separation is effective to separate mixtures on the basis of the fluorous content of the 
compounds; it is not used to separate mixtures of α/β products. This makes the design of 
the donor and acceptor building blocks extremely crucial.  
 
One of the most important factors in obtaining this selectivity is neighboring group 
participating groups at position 2-O. It is well known that by employing participating 
groups at 2-O positions, the β-product predominates due to anchimeric assistance. So, we 
had to design the D-galA building block with no neighboring group participating group at 
2-O position. Thus we used benzyl ether to protect the 2-hydroxyl.  Now, the group at 
position 4-O of the galA building block had to be such that it could be deprotected under 
mild conditions in the solution phase automated synthesizer and would also give good α-
selectivity of the glycosylation reaction.  
 
Previously, the 4-O hydroxyls of the D-galA donors have been protected as benzyl ether 
(Magaud et al, 1997), methoxyphenyl ether (Yamamoto et al, 2005) or allyl ether 
(Clausen et al, 2003). These protecting groups at 4-O- have provided excellent α- 
selectivity. But their deprotection conditions are harsh, and require long reaction times. 
On the automated solution phase synthesizer, shorter reaction times are preferred as the 
entire assembly of glycosyl donor and acceptors are kept in vials inside the synthesizer 
platform during the entire process of synthesis for the robotic needle to transfer. Although 
this assembly is under inert Ar(g) atmosphere, shorter reaction times to minimize any 
exposure to moisture and air are preferred. On the automated solution phase synthesizer, 
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the deprotection condition for protecting groups like acetate, levulinic ester, silyl 
protecting groups etc have been optimized.  
 
With all these factors in mind, we set out to design the D-galacturonic acid building block 
for our synthesis on the automated platform. Starting with D-galactose, 1-O-allyl-β-D-
galactopyranoside was synthesized in 3 steps in high yield. 2, 3-O-benzyl-1-O-allyl-β-D-
galactopyranoside was then synthesized by first protecting the 4 and 6- hydroxyls as the 
benzylidene acetal, and then installing non-participating benzyl ethers at the 2 and 3-O 
positions followed by opening the benzylidene acetal under standard aqueous acetic acid 
condition (Scheme 2-1).  
 
We first synthesized a 4-O acetate building block. To synthesize the galacturonic acid, 
the 6-O position was oxidized by BAIB/TEMPO at room temperature. After the mild 
oxidation, the resulting carboxylic acid was methyl esterified under microwave 
conditions. The allyl anomeric protecting group was removed by first isomerizing the 
allyl ether to a vinyl ether with Ir(I) catalyst followed by hydrolysis of the vinyl ether 
with Hg salts, The anomeric hydroxyl was converted to the tricholoroacetimidate donors 
under basic conditions (Scheme 2-2). Benchtop glycosylation with the 4-O acetate donor 
8 with the glycosyl fluorous tag acceptor 12 revealed that there was β-glycosyl linkage 
also being formed. The α/β selectivity with this building block could be improved. We 
speculate that this is perhaps due to the long-range participation by the acetate group. In 
order to avoid synthesizing mixtures of α and β compounds on the synthesizer, we set out 
to synthesize 4-O levulinic ester protected galA trichloroacetimidate donor 9 and 10 
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(Scheme 3-2). The α-selectivity with this building block was excellent. TLC showed that 
there was no β-glycosylated product formed. Benzyl ester of the 4-O levulinoyl 
carboxylic acid was also formed by treating the acid with benzyl bromide as shown in 
Scheme 3-2. We synthesized the benzyl ester of gala to install in the backbone of the HG 
molecule at specific location. After fully deprotecting all the benzyl groups on the HG 
fragment obtained from the synthesizer, there would be free acid left at the location of 
benzyl ester, which could be very useful for any assay with the backbone.  
 
 
Conditions: a. (i) NaOAc, Ac2O (86%) (ii) Allyl alcohol, BF3OEt2, CH2Cl2 (82%) (iii) Na, 
CH3OH (85%); b. (i) PhCH(OCH3)2, pTSA, CH3CN (89%) (ii) BnBr, NaH, DMF (81%) 
(iii) 80% CH3COOH/H2O (76%) 
 
Scheme 3-1. Synthesis of 3, 4-dibenzyl-1-O-allyl-β-D-galactopyranoside (2) 
 
 
Conditions: a. (i) BAIB, TEMPO, CH2Cl2, H2O (ii) For 3 CH3OH, cat. H2SO4, µwave 
(82% over two steps) For 4 BnBr, TBAI, Et3N, THF (81% over two steps) b.  For 5 
Ac2O, py (64%) For 6 & 7 LevOH, DCC, DMAP (6 85%; 7 92%) c. (i) 
Ir[COD(PPhMe2)2]PF6,H2, THF (ii) HgO, HgCl2 (ii) Acetone/H2O 8 (64%), 9 (78%), 10 
(85%) 
 
 
Scheme 3-2. Pre-glycosylation oxidation of D-galactose 
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Condition: a. 13, TMSOTf (0.10 equiv), CH2Cl2 (77%) b. Hydrazine acetate, CH2Cl2 
(94%)  
Scheme 3-3. Synthesis of the fluorous-tag acceptor of D-galacturonic acid.  
 
Fluorous alcohol 13 was reacted with the trichloroacetimidate donor D-galacturonic acid 
8 containing the methyl ester to give the fluorous-tagged acceptor 11 for the reaction on 
the solution-phase automated platform (Scheme 3-3). With these building blocks, 9, 10 
and 12 in hand, we set out to synthesize the HG backbone on the automated solution-
phase synthesizer. The scheme of the reaction on the automated platform is shown in 
Scheme 3-4.  
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Scheme 3-4: A schematic of the automated solution-phase workbench to build the HG 
hexasaccharide 14 (Note: The protocol for each step is explained in more detail in the 
experimental section) 
 
We introduced benzyl ester protected galA (10) as the second glycosyl donor, and all 
other positions of the glycosyl donor in the sequence were the methy ester of the galA 
(9). This produced the hexasaccharide 14, with one benzyl ester and the five methyl ester 
of the D-galacturonic acid. The benzyl ethers on the backbone were deprotected with 
H2/Pd, which also deprotected the benzyl ester of the galacturonic acid, giving the 
hexamer, 15 with one free acid residue at the backbone of the HG fragment. The 
hexasaccharide still contains the fluorous-tag at the reducing end of the oligosaccharide 
chain, so the chain is available for any further arrays based on the fluorous-tag.  
 
 
Figure 3-3. The hexasaccharide of homogalacturonan obtained from the automated 
solution-phase synthesizer (14). 
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Conclusion 
In conclusion, homogalacturonan fragment containing six α-D-galacturonic acid residues 
was successfully synthesized starting with D-galactose in 4% overall yield. This is the 
first example of an automated synthesis of HG. With the right building blocks in hand, 
their step-wise assembly on the automated solution phase platform is shown to be high 
yielding. This is an example of the application of the solution-phase automated synthesis 
to form linear oligosaccharide chain efficiently.  The deprotected hexasacharide 
synthesized contains one free carboxylic acid, which can be further used in enzymatic 
assays to study the impact of the methyl esterification of the HG backbone. Also, due to 
the presence of the fluorous-tag at the reducing end of the oligosaccharide chain, fluorous 
based arrays are also possible using these HG fragments. Thus, chemical synthesis of 
polysaccharides can be an important tool in further studies on the importance and 
applications of these polysaccharides, and automation provides a simpler way by which 
these oligosaccharides can be assembled.  
Experimental section 
General methods  
 
Reaction solvents were used directly from solvent tower (Swagelok). All other 
commercial reagents and solvents were used as received without further purification. The 
reactions were monitored and the Rf values determined using analytical thin layer 
chromatography (TLC) with Sorbent Technologies Silica gel HL TLC plates with UV 
254 (250 µm). The developed TLC plates were visualized by immersion in a solution of 
EtOH: conc. H2SO4: p-anisaldehyde (9:1:1) followed by heating on a hot plate. Silica gel 
flash chromatography was performed with ZeoPrep 60 Eco 40-63 µm. Fluorous phase 
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chromatography using fluorous solid-phase extraction cartridges containing silica gel 
bonded with perfluorooctylethylsilyl chains (Fluorous Technologies, Inc.; Pittsburgh, 
PA). All other fluorous reagents were also obtained from Fluorous Technologies, Inc. All 
moisture-sensitive reactions were performed in flame- or oven-dried glassware under a 
Ar(g) atmosphere. Bath temperatures were used to record the reaction temperature in all 
cases run without microwave irradiation. Microwave reaction was carried out in CEM 
Microwave. All reactions were stirred magnetically at ambient temperature unless 
otherwise indicated. 1H NMR and 13C NMR spectra were obtained with a VarianVXR at 
400 MHz and 100 MHz or BrukerDRX at 600 MHz. 1H NMR spectra were reported in 
parts per million relative to CDCl3 (7.26 ppm) and 13C NMR spectra were reported in 
parts per million relative to CDCl3 (77.23 ppm).  
Synthetic	  procedure 
	  
1, 2, 3, 4, 5, 6- Tetra-O-acetyl-β-D-galactopyranoside 
 
To a solution of sodium acetate (2.27 g; 0.027 mol) in 20 mL acetic anhydride at 80 oC, 
β-D-galactopyranoside (1.0 g; 5.5 mmol) was added in portions. After the addition, the 
reaction mixture was cooled and diluted with EtOAc, washed with sodium bicarbonate 
solution and brine, dried over anhydrous MgSO4 and concentrated under reduced 
pressure. The crude product was recrystallized with ethanol to obtain peracetylated β-
galactopyranoside (1.86g, 86%, white crystals). 
 
O
OAcAcO
AcO
AcO
OAc
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1H NMR (400 MHz, CDCl3): δ (ppm) 5.55-5.53 (d, J = 8 Hz, 1H), 5.42 (dd, 1H), 5.39-
5.37 (m, 1H), 5.28-5.25 (m, 1H), 4.32-4.29 (m, 2H), 4.27-4.24 (m, 1H), 2.24 (s, 3H), 2.20 
(s, 3H), 2.18 (s, 3H), 2.10 (s, 3H) 
13C NMR (100 MHz, CDCl3): δ (ppm) 170.2, 170.0, 169.8, 169.7, 169.5, 92.1, 70.2, 
70.0, 68.1, 68.0, 61.0, 20.1, 19.8, 19.7 
Rf (Hexane: EtOAc 2:1) 0.40 
 
1-O-allyl-2, 3, 4, 6-O-tetra-acetyl-β−D-galactopyranoside 
 
To a solution of peracetylated-β−galactopyranoside (1.86 g, 4.76 mmol) in 20 mL 
anhydrous dichloromethane at 0 oC, (5.97 mL, 0.047 mol) BF3.OEt2 was added dropwise 
under Ar(g) atmosphere. The reaction mixture was stirred at 0 oC for 30 minutes followed 
by the addition of allyl alcohol (1.6 mL, 0.023 mol). This mixture was allowed to warm 
to room temperature and stirred. After 4h, the mixture was extracted with EtOAc, washed 
with sodium bicarbonate solution, and brine. Dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. Silica gel flash chromatography with hexane: 
EtOAC (1:4) was performed to obtain 1-O-allyl-2, 3, 4, 6-O-tetra-acetyl-β−D-
galactopyranoside (1.53g, 82 %, oily syrup). 
 
1H NMR (400 MHz, CDCl3): δ (ppm) 5.90-5.83 (m, 1H), 5.39-5.38 9dd, 1H), 5.25-5.24 
(dd, 1H), 5.22-5.19 (m 1H), 5.25-5.24 (d, 1H), 4.53-4.51 (d, J=8Hz, 1H), 4.37-4.35 (m, 
O
OAcAcO
AcO
AcO
O
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1H), 4.32-4.31 (m, 1H), 4.21-4.20 (m, 1H), 2.09 (s, 3H), 2.08 (s, 3H), 2.06 (s, 3H), 
2.05(s, 3H) 
13C NMR (100 MHz, CDCl3): δ (ppm) 206.8, 170.9, 170.7, 169.2, 91.7, 74.1, 70.6, 
69.3, 68.0. 62.8, 30.8, 20.6, 20.8 
Rf (Hexane: EtOAc 2:1) 0.35 
 
1-O-Allyl-β-D-galactopyranoside (1)  
 
1-O-allyl-2, 3, 4, 6-O-tetra-acetyl-β−D-galactopyranoside (1.5g, 3.96 mmol) was 
dissolved in 18 mL methanol and 0.24 g of sodium metal was added. The solution was 
stirred for 1h and quenched by adding Dowex®, and filtered over a pad of Celite®, 
washed with methanol and concentrated. Flash chromatography with 2% methanol in 
dichloromethane was carried out to obtain 1 (0.74g, 85%, white solid) 
1H NMR (400 MHz, CD3OD): δ (ppm) 6.02-5.99 (m, 1H), 5.30-5.28 (d, 1H), 5.13-5.11 
(d, 1H), 4.15-1.13 (dd, 1H), 4.12-4.11 (dd, 1H), 4.03-4.01 (dd, 1H), 3.53 (s, 1H), 3.49 (m, 
2H), 3.45-3.44 (m, 1H)  
13C NMR (100 MHz, CDCl3): δ (ppm) 125.2, 135.1, 116.7, 98.5, 94.1, 71.2, 69.5, 69.6, 
68.3, 68.0, 65.4, 30.1 
Rf (CH2Cl2: CH3OH 4:1) 0.61 
 
 
 
O
OHHO
HO
HO
O
1
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1-O-Allyl-4, 6- O-benzylidine-β-D-galactoipyranoside  
 
15 mL anhydrous acetonitrile was added to (0.74g, 3.36 mmol) 1 followed by addition of 
(0.6 mL, 4.1 mmol) benzaldehyde dimethyl acetal. p-toluene sulfonic acid (0.025g, 
0.13mmol) was added and the mixture was stirred for 1h and then quenched by adding 
0.02 mL of triethylamine and concentrated. Flash chromatography with 2% methanol in 
dichloromethane was carried out to obtain β-1-O-allyl-4, 6- benzylidine-
galactopyranoside (0.93 g, 89%, white solid).  
 
1H NMR (400 MHz, CDCl3): δ (ppm) 7.53-7.51 (m, 2H), 7.37-7.32 (m, 3H), 5.97-5.91 
(m, 1H), 5.48 (s, 1H), 5.29-5.27 (d, 1H), 5. 22-5.20 (d, 1H), 4.86-4.83 (m, 2H), 4.22-4.19 
(m, 1H), 4.15-4.11 (m, 1H), 4.09-4.05 (m, 2H) 
13C NMR (100 MHz, CDCl3): δ (ppm) 138.4, 138.0, 133.8, 128.7, 128.6, 125.2, 120.1, 
117.6, 95.6, 89.9, 81.8, 76.2, 72.1, 69.2, 68.1, 62.3, 23.1, 21.2, 20.6 
Rf (CH2Cl2: CH3OH 4:1) 0.68 
 
1-O-Allyl-2, 3- dibenzyl-4, 6- O-benzylidine-β-D-galactopyranoside 
 
β-1-O-allyl-4, 6- benzylidine-galactopyranoside (0.93g, 3.0 mmol) was dissolved in 
15mL anhydrous N, N- dimethylformamide (DMF) followed by the addition of sodium 
OHO
HO
O
O
OPh
OBnO
BnO
O
O
OPh
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hydride (0.25 g, 0.01 mol) at 0 oC under Ar(g) atm and stirred for 30 min. Benzyl 
bromide (1.24 mL, 0.01 mol) was added to the reaction mixture and stirred for 8h at room 
temperature, and then quenched by the addition of water.  Reaction mixture was extracted 
with EtOAc. The organic layer was washed with sodium chloride solution, dried over 
anhydrous MgSO4, filtered and concentrated. Excess benzyl bromide was removed by 
flash chromatography with 2:1 hexane and EtOAc(20%) to obtain β-1-O-allyl-2, 3-
benzyl-4, 6-benzylidine galactopyranoside (1.16 g, 81%, white solid).  
 
1H NMR (400 MHz, CDCl3): δ (ppm) 7.56-7.52 (m, 5H), 5.99 – 5.93 (m, 1H), 5.50 (s, 
1H), 5.36 (d, 2H), 5.32 (d, 2H), 4.96 (d, 1H), 4.80 (s, 2H), 4.78 (s, 2H), 4.45 (dd, 1H), 
4.32 (dd, 1H), 4.00 (m, 1H), 3.55 (m, 1H) 
13C NMR (100 MHz, CDCl3): δ (ppm) 138.9, 138.2, 138.1, 133.8, 128.8, 128.7, 127.2, 
126.2, 117.2, 95.2, 83.9, 81.3, 80.5, 76.7, 72.1, 72.0, 69.2, 67.8 
Rf (Hexane:EtOAc 2:1) 0.40 
 
1-O-Allyl-2, 3- dibenzyl -β-D-galactopyranoside (2) 
 
β-1-O-allyl-2, 3-benzyl-4, 6-benzylidine galactopyranoside (1.16 g, 2.4 mmol) was 
dissolved in 20mL 80 % CH3COOH/ H2O and stirred at 65 oC for 3h. The solution was 
concentrated under reduced pressure and purified by a quick column with 25% EtOAc in 
hexane to give 2  (0.73g, 76%, colorless oil). 
OBnO
BnO
O
HO OH
2
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1H NMR (400 MHz, CDCl3): δ (ppm) 7.43-7.42 (m, 5H), 7.34-7.30 (m, 5H), 6.05-5.95 
(m, 1H), 5.26-5.36 (d, 1H), 5.18-5.14 (d, 1H), 4.78 (s, 2H), 4.74 (s, 2H), 4.70 (d, 1H), 
4.60 (d, 1H), 4.44-4.40 (dd, 1H), 4.05 (d, 1H), 3.77-3.73 (m, 2H), 3.29-3.26 (m, 1H) 
13C NMR (100 MHz, CDCl3): δ (ppm) 138.4, 138.0, 133.8, 128.2, 127.8, 127.5, 117.4, 
95.6, 80.5, 81.4, 72.1, 72.4, 73.0, 69.2, 68.7, 62.6 
Rf (Hexane:EtOAc 3:2) 0.28 
 
Methyl 1-O-allyl-2, 3- dibenzyl-β-D-galactopyranosyluronate (3)  
 
15mL anhydrous dichloromethane was added to (0.73 g, 1.8 mmol) of β-1-O-allyl-2, 3-
benzyl-galactopyranoside, followed by the addition of [bis(acetoxy)iodo] benzene 
(BAIB) (1.46g, 4.5 mmol) and of 2,2,6,6-tetramethyl-1-piperidinyloxyl (TEMPO) (0.05g 
0.36 mmol). The reaction mixture was stirred for 3h and quenched by slow addition of 
aqueous sodium thiosulfate solution. The product was extracted using dichloromethane. 
The organic layer was dried over anhydrous MgSO4 and concentrated under reduced 
pressure to obtain crude β-1-O-allyl-2, 3-benzyl-galacturonic acid (0.76g). This was 
carried out to the next step without further purification.  
The β-1-O-allyl-2, 3-benzyl-galacturonic acid was   dissolved in methanol (10 mL) 
followed by the addition of catalytic amount of sulfuric acid (0.5µL) This reaction was 
OBnO
BnO
O
COOCH3
HO
3
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allowed to stir at 60 oC in the microwave for 1h. The reaction mixture was allowed to 
come to room temperature and concentrated under reduced pressure.  
To the residue obtained aqueous sodium bicarbonate solution was added and the organic 
product was extracted with dichloromethane. The organic layer was dried over anhydrous 
MgSO4 and concentrated under reduced pressure. The crude product was purified by 
flash chromatography with Hexane: EtOAc (1:4) give 3 (0.64g, 82%, colorless oil). 
 
1H NMR (400 MHz, CDCl3): δ (ppm) 7.29-7.25 (m, 10H), 5.85-5.81 (m, 1H), 5.44 (dd, 
1H), 5.41 (s, 1H), 5.22 (d, 1H), 4.65 (d, 2H), 4.53 (s, 2H), 4.12 (dd, 1H), 4.34 (m, 1H), 
3.89 (s, 3H), 3.76 (dd, 1H) 
13C NMR (100 MHz, CDCl3): δ (ppm) 171.2, 18.4, 138.1, 138.9, 128.3, 127.8, 127.4, 
127.1, 115.2, 95.1, 90.2, 79.8, 78.2, 72.1, 71.2, 65.6, 20.2 
Rf (Hexane:EtOAc 2:1) 0.25 
 
Benzyl 1-O-allyl-2, 3- dibenzyl-β-D-galactopyranosyluronate (4) 
 
To a solution of 1-O-allyl-2, 3-dibenzyl- β-D-galactopyranoside (0.28g, 0.67 mmol) in 
THF (10 mL), Et3N (0.18 mL, 0.34 mmol) was added at room temperature. The solution 
was stirred under Ar (g) atmosphere and TBAI (0.12g, 0.33 mmol) was added followed 
by dropwise addition of BnBr (0.22 mL, 1.6 mmol). The solution was allowed to stir for 
12 h. The reaction mixture was concentrated and purified by silica gel flash 
chromatography with Hexane: EtOAc (3:2) to obtain pure 4 (0.29g, 81%, colorless oil). 
OBnO
BnO
O
COOBnHO
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1H NMR (400 MHz, CDCl3): δ (ppm) 7.38-7.35 (m, 10H), 7.35-7.31 (m, 5H), 6.02-5.89 
(m, 1H), 5.37 (dd, 1H), 5.31 (s, 2H), 5.22 (d, 2H), 4.95 (d, 2H), 4.71(s, 2H), 4.44 (dd, 
1H), 4.34 (m, 1H), 3.76 (dd, 1H), 3.58 (m, 1H) 
13C NMR (400 MHz, CDCl3): δ (ppm) 204.2, 161.2, 160.3. 155.1, 139.3, 139.0, 135.8, 
126.2, 126.5, 125.5, 122.3, 121.4, 118.6, 117.2, 96.3, 83.5, 72.1, 72.4, 71.2, 65.3, 65.1, 
55.4 
Rf (Hexane:EtOAc 2:1) 0.20 
 
Methyl 1-O-allyl-2, 3- dibenzyl- 4-acetyl-β-D-galactopyranosyluronate (5) 
 
To a solution of methyl 1-O-allyl-2, 3- dibenzyl-β-D-galactopyranosyluronate (0.64g, 
1.49 mmol) in dichloromethane (12mL), 4-dimethylaminopyridine (DMAP) (0.01g, 
0.03mmol) was added followed by the addition of acetic anhydride (1.6 mL) and for 2h 
and then diluted with dichloromethane and washed with aqueous sodium bicarbonate 
solution. The organic layer was dried with anhydrous MgSO4 solution, filtered and 
concentrated under reduced pressure. The product was purified by a short flash silica gel 
column with Hexane: EtOAc (1:4) to obtain 5 (0.69g, 88%, colorless syrup). 
 
1H NMR (400 MHz, CDCl3): δ (ppm) 7.39-7.34 (m, 5H), 7.31-7.28 (m, 5H), 6.01 (d, 
1H), 5.76-5.72 (m, 1H), 5.21-5.19 (d, 1H), 5.14-5.12 (d, 1H), 4.89 (s, 2H), 4.66 (s, 2H), 
4.31 (m, 2H), 3.65-3.62 (m, 1H), 2.01 (s, 1H) 
OBnO
BnO
O
COOCH3
AcO
5
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13C NMR (100 MHz, CDCl3): δ (ppm) 171.5, 168.2, 138.1, 137.6, 137.1, 132.3, 132.0, 
127.6, 127.4, 116.9, 95.3, 90.2, 80.1, 77.9, 72.0, 68.6, 68.1, 65.3, 21.9, 20.9 
Rf (Hexane:EtOAc 3:2) 0.45 
 
Methyl 1-O-trichloroacetimidate-2, 3- dibenzyl- 4-acetyl-β-D-
galactopyranosyluronate (8) 
 
Iridium (I) catalyst (0.011g; 0.013 mmol) was added to a solution of methyl 1-O-allyl-2, 
3- dibenzyl- 4-acetyl-β-D-galactopyranosyluronate (0.69 g, 1.46 mmol) in anhydrous 
THF. This solution was hydrogenated for 15 seconds (till the color of the solution 
changed from red to pale yellow) using a hydrogen gas balloon. After the hydrogenation, 
the reaction was allowed to run at room temperature under Ar(g) atm for 8h. The solvent 
was removed under reduced pressure and the residue was dissolved in 10 mL acetone and 
2mL H2O, followed by the addition HgO (0.16g, 0.65 mmol) and HgCl2 (0.35, 1.13 
mmol). This mixture was allowed to stir at room temperature for 5h and then filtered 
through a pad of Celite®. The residue was dissolved in dichloromethane, washed with 
aqueous KI solution, saturated sodium thiosulfate solution and sodium chloride solution. 
The organic layer was dried over anhydrous MgSO4 and concentrated under reduced 
pressure to obtain methyl-2, 3- dibenzyl- 4-acetyl-β-D-galactopyranosyluronate (0.34g, 
0.79 mmol). This was dissolved in anhydrous dichloromethane (10 mL) and of K2CO3 
(0.41g, 3.0 mmol) was added followed by the addition of trichloroacetonitrile (0.51 mL, 
5.1 mmol) under Ar(g) atm. The reaction was allowed to stir at room temperature for 1h 
OBnO
BnO
COOCH3
AcO
OC(NH)CCl3
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and filtered through a pad of Celite®. The filtrate obtained was concentrated under 
reduced pressure and purified by a quick flash column with Hexane: EtOAc (3:2) 
containing 0.1% Et3N to give 8 (0.33g, 64%, colorless oil).  
 
1H NMR (400 MHz, CDCl3): δ (ppm) ) 8.61 (s, 1H), 7.45-7.42 (m, 5H), 7.39-7.35 (m, 
5H), 6.13 (d, 1H), 5.14-5.12 (d, 1H), 4.68 (s, 2H), 4.45 (s, 2H), 4.22-4.20 (m, 1H), 3.32--
3.29 (m, 1H), 2.11 (s, 1H) 
13C NMR (100 MHz, CDCl3): δ (ppm) 200.1, 170.2, 165.1, 138.9, 138.6, 137.6, 130.1, 
129.8, 126.5, 125.1, 117.5, 91.3, 79.8, 76.9, 69.4, 68.1, 45.3, 22.1, 19.8 
Rf (Hexane:EtOAc 2:1) 0.78 
 
Methyl 1-O-allyl-2, 3- dibenzyl- 4-levulinyl-β-D-galactopyranosyluronate (6) 
 
To a solution of methyl 1-O-allyl-2, 3- dibenzyl-β-D-galactopyranosyluronate (0.37g, 
0.86 mmol) in dichloromethane, DMAP (0.005 g, 40 µmol) was added followed by the 
addition of levulinic acid (0.10g, 0.86 mmol) and DIC (0.13 mL, 0.86 mmol) and stirred 
at room temperature for 6 h. The reaction mixture was filtered through a pad of Celite® 
and washed with dichloromethane and then concentrated. The crude product was purified 
by a short silica gel flash chromatography to obtain 6 (0.38g, 85%, yellow oil). 
 
OBnO
BnO
O
COOCH3
LevO
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1H NMR (400 MHz, CDCl3): δ (ppm) 7.34-7.28 (m, 10H), 5.96-5.94 (m, 1H), 5.90 (dd, 
1H), 5.35 (d, 1H), 5.29 (d, 1H), 4.89 (d, 1H), 4.75 (s, 2H), 4.55 (s, 2H), 4.46 (dd, 1H), 
2.80-2.76 (m, 2H), 2.66-2.63 (m, 2H), 2.15 (s, 3H) 
13C NMR (100 MHz, CDCl3): δ (ppm) 206.3, 172.4, 170.1, 138.5, 137.2, 127.8, 127.7, 
127.5, 127.2, 117.4, 95.0, 85.3, 84.2, 78.6, 72.0, 69.8, 62.8, 29.5, 27.3, 21.2 
Rf (Hexane:EtOAc 3:2) 0.25 
 
Methyl 1-O-tricholoroacetimidate-2, 3- dibenzyl- 4-levulinyl-β-D-
galactopyranosyluronate (9) 
 
Iridium (I) catalyst (0.032g, 0.039 mmol) was added to a solution of methyl 1-O-allyl-2, 
3- dibenzyl- 4-levulinyl-β-D-galactopyranosyluronate (1.1 g, 2.26 mmol) in anhydrous 
THF. This solution was hydrogenated for 15 seconds (till the color of the solution 
changed from red to pale yellow) using a hydrogen gas balloon. After the hydrogenation, 
the reaction was allowed to run at room temperature under Ar(g) atm for 8h. The solvent 
was removed under reduced pressure and the residue was dissolved in 10 mL acetone and 
2mL H2O, followed by the addition HgO (0.16, 1.12 mmol) and HgCl2 (0.56g, 2.26 
mmol). This mixture was allowed to stir at room temperature for 5h and then filtered 
through a pad of Celite®. The residue was dissolved in dichloromethane, washed with 
aqueous KI solution, saturated sodium thiosulfate solution and sodium chloride solution. 
The organic layer was dried over anhydrous MgSO4 and concentrated under reduced 
pressure to obtain crude product of methyl 2, 3- dibenzyl- 4-levulinyl-β-D-
OBnO
BnO
COOCH3
LevO
OC(NH)CCl3
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galactopyranosyluronate (0.83g, 1.71 mmol) which was dissolved in anhydrous 
dichloromethane (10 mL) and K2CO3 (1.34g, 8.8 mmol) was added followed by the 
addition of trichloroacetonitrile (0.51 mL, 5.1mmol) under Ar(g) atm. The reaction was 
allowed to stir at room temperature for 1h and filtered through a pad of Celite®. The 
filtrate obtained was concentrated under reduced pressure and purified by a quick flash 
column with Hexane: EtOAc (3:2) containing 0.1% Et3N to give 9 (0.91g, 78%, yellow 
oil).  
 
1H NMR (400 MHz, CDCl3): δ (ppm) 8.64 (s, 1H), 7.36-7.27 (m, 10H), 6.66 (s, 1H), 
5.90 (s, 1H), 4.80 (dd, 1H), 4.74 (s, 2H), 4.71 (s, 2H), 4.64 -4.61 (m, 1H), 4.13-4.08 (m, 
2H), 3.97-3.90 (m, 2H), 3.79 (s, 1H), 2.73-2.72 (m, 2H), 2.62-2.64 (m, 2H), 2.14 (s, 3H),  
13C NMR (100 MHz, CDCl3): δ (ppm) 206.5, 171.3, 168.4, 160.3, 138.1, 137.9, 137.2, 
128.8, 128.2, 127.4, 91.3, 90.8, 77.5, 76.2, 72.0, 38.4, 28.7, 32.1, 21.0 
Rf (Hexane:EtOAc 3:2) 0.62 
 
Benzyl 1-O-allyl-2, 3- dibenzyl- 4-levulinyl-β-D-galactopyranosyluronate (7) 
 
To a solution of benzyl 1-O-allyl-2, 3- dibenzyl-β-D-galactopyranosyluronate (0.29g, 
0.57 mmol) in dichloromethane, DMAP (0.005 g, 40 µmol) was added followed by the 
addition of levulinic acid (0.06g, 0.57 mmol) and DIC (0.09 mL, 0.57 mmol) and stirred 
at room temperature for 6 h. The reaction mixture was filtered through a pad of Celite® 
OBnO
BnO
O
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and washed with dichloromethane and then concentrated. The crude product was purified 
by a short silica gel flash chromatography to obtain 7 (0.32g, 95%, yellow oil). 
 
1H NMR (600 MHz, CDCl3): δ (ppm) 7.36-7.31 (m, 5H), 7.24-7.20 (m, 5H), 6.21 (s, 
1H), 5.98-5.93 (m, 1H), 5.65-5.63 (d, 1H), 5.60-5.58 (d, 1H), 5.13-5.10 (m, 1H), 4.95 
(dd, 1H), 4.68 (s, 2H), 4.55 (s, 2H), 3.85-3.82 (m, 1H), 2.54-2.51 (t, 2H), 2.33-2.30 (t, 
2H) 
13C NMR (100 MHz, CDCl3): δ (ppm) 200.9, 172.8, 170.1, 138.9, 138.5, 134.5, 133.2, 
129.6, 128.6, 127.1, 116.9, 90.3, 77.3, 75.4, 70.9, 68.6, 66.5, 41.6, 39.5, 29.0, 25.7 
Rf (Hexane:EtOAc 3:2) 0.50 
 
Benzyl 1-O-tricholoroacetimidate-2, 3- dibenzyl- 4-levulinyl-β-D-
galactopyranosyluronate (10) 
 
Iridium (I) catalyst (0.09g, 0.001 mmol) was added to a solution of benzyl 1-O-allyl-2, 3- 
dibenzyl- 4-levulinyl-β-D-galactopyranosyluronate (0.32g, 0.54 mmol) in anhydrous 
THF. This solution was hydrogenated for 15 seconds (till the color of the solution 
changed from red to pale yellow) using a hydrogen gas balloon. After the hydrogenation, 
the reaction was allowed to run at room temperature under Ar(g) atm for 8h. The solvent 
was removed under reduced pressure and the residue was dissolved in 10 mL acetone and 
2mL H2O, followed by the addition HgO (0.05g, 0.27 mmol) and HgCl2 (0.14g, 0.54 
mmol). This mixture was allowed to stir at room temperature for 5h and then filtered 
OBnO
BnO
COOBnLevO
OC(NH)CCl3
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through a pad of Celite®. The residue was dissolved in dichloromethane, washed with 
aqueous KI solution, saturated sodium thiosulfate solution and sodium chloride solution. 
The organic layer was dried over anhydrous MgSO4 and concentrated under reduced 
pressure to obtain crude product of benzyl 2, 3- dibenzyl- 4-levulinyl-β-D-
galactopyranosyluronate (0.31g, 0.55 mmol) which was dissolved in anhydrous 
dichloromethane (10 mL) and K2CO3 (0.42g, 2.8mmol) was added followed by the 
addition of trichloroacetonitrile (0.16 mL, 1.6 mmol) under Ar(g) atm. The reaction was 
allowed to stir at room temperature for 1h and filtered through a pad of Celite®. The 
filtrate obtained was concentrated under reduced pressure and purified by a quick flash 
column with Hexane: EtOAc (3:2) containing 0.1% Et3N to give 10 (0.32g, 85%, yellow 
oil).  
 
1H NMR (400 MHz, CDCl3): δ (ppm) 8.64 (s, 1H), 7.36 (m, 10H), 6.66 (s, 1H), 5.90 (s, 
1H), 4.80 (dd, 1H), 4.74 (s, 1H), 4.71 (s, 2H), 4.64 (dd, 1H), 3.90 (s, 1H), 2.73 (m, 1H), 
2.62 (m, 2H), 2.14 (s, 3H) 
13C NMR (100 MHz, CDCl3): δ (ppm) 205.3, 172.8, 170.9, 160.1, 138.2, 138.0, 136.4, 
136.2, 135.7, 135.1, 134.3, 134.1, 129.7, 129.4, 127.3, 92.1, 90.8, 90.2, 77.3, 77.1, 72.0, 
68.2, 40.8, 38.9, 29.3, 28.2 
Rf (Hexane:EtOAc 3:2) 0.60 
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cis-4-(1H, 1H, 2H, 2H, 3H, 3H-Perfluoroundecyloxy)-2-butenyl methyl 2, 3-O-
dibenzyl-4-O-levulinyl- β-D-galactopyranosyluronate (11) 
  
To a solution of the methyl 1-O-tricholoroacetimidate-2, 3- dibenzyl- 4-levulinyl-β-D-
galactopyranosyluronate (0.47g, 0.82 mmol) in dichloromethane, a solution of fluorous 
alcohol (name) (0.18g, 0.32mmol) in 3.0 mL dichloromethane was added at 0 oC. TMOTf 
(46 µL, 5.6 µmol) was added and the reaction allowed to run for 1h at 0 oC. The reaction 
was quenched by adding Et3N (0.2mL) and concentrated under reduced pressure. FSPE 
was performed by dissolving the crude product in DMF (2.0 mL) and eluting out with 
80% methanol and methanol to obtain fluorous-tagged methyl 2, 3-O-dibenzyl-4-O-
levulinyl- β-D-galactopyranosyluronate (0.25g, 77%, colorless oil). 
 
1H NMR (400 MHz, CDCl3): δ (ppm) 7.45-7.41 (m, 5H), 7.36-7.31 (m, 5H), 6.01 (s, 
1H), 5.65 (m, 1H), 5.61 (m, 1H), 5.21 (dd, 1H), 4.65-4.63 (m, 1H), 4.78-4.75 (m, 1H), 
4.38 (s, 2H), 4.32-4.31 (m,1H), 4.29 (s, 2H), 4.22-4.19 (m, 2H), 3.68-3.66 (dd, 1H), 2.72-
2.71 (t, 2H), 2.22-2.20 (t, 2H), 2.01 (s, 3H), 1.99 (s, 3H) 
13C NMR (100 MHz, CDCl3): δ (ppm) 205.1, 172.3, 169.3, 138.9, 138.2, 137.3, 137.0, 
128.1, 127.8, 127.5, 119.2, 117.6, 113.0, 112.8, 111.6, 98.7, 96.0, 91.5, 72.0, 68.8, 68.3, 
65.4, 61.0, 38.2, 28.1, 20.5, 19.6 
Rf (Hexane:EtOAc 3:2) 0.66 
  
OBnO
BnO
COOCH3LevO
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cis-4-(1H, 1H, 2H, 2H, 3H, 3H-Perfluoroundecyloxy)-2-butenyl methyl 2, 3-O-
dibenzyl-β-D-galactopyranosyluronate (12) 
 
Hydrazine acetate (0.02g, 0.30 mmol) was added to a solution of 11 (0.25 g, 0.24 mmol) 
in CH2Cl2 (8mL)/methanol (8mL) mixture . The reaction mixture was stirred for 3 h at 
room temperature. The reaction solvent was evaporated and crude product was purified 
by flash column chromatography on silica gel using 20% EtOAc/hexane to obtain the 
product 12 (0.21g, 94%, colourless oil). 
 
1H NMR (400 MHz, CDCl3): δ (ppm) 7.39-7.33 (m, 5H), 7.28-7.25 (m, 5H), 6.10 (s, 
1H), 5.59 (m, 1H), 5.51 (m, 1H), 5.19-5.22, 1H), 4.68 (s, 2H), 4.65-4.63 (m, 1H), 4.78-
4.75 (m, 1H), 4.36 (s, 2H), 4.34-4.31 (m, 2H), 3.77-3.75 (dd, 1H), 2.21 (s, 3H) 
13C NMR (100 MHz, CDCl3): δ (ppm) 171.2, 138.9, 138.4, 137.3, 128.7, 127.8, 118.4, 
117.3, 117.0, 112.3, 90.5, 80.3, 29.6, 71.4, 67.2, 64.1, 33.2, 20.1 
Rf (Hexane:EtOAc 3:2) 0.21 
 
 
 
 
 
 
 
OBnO
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General methods for automated solution phase synthesizer cycles 
 
Scheme 3-5 Schematic of the solution phase automated synthesizer  
Number on the reagent 
rack 
 
Chemical 
1. DMF 
2.  Triethylamine 
3. Donor (10) 
4.  F-Tag Acceptor (12) 
5.  Hydrazine Hydrate/AcOH/Pyridine 
6.  Acetone 
Table 3-1. The arrangement of chemicals on the reagent rack 
Sample preparation 
 
A solution of the donor 9 (0.32 g, 0.53 mmol) was prepared in anhydrous 
dichloromethane in a 13 mL vial and placed at position 1 of the stock solution rack. 0.3 
M TMSOTf solution (1.05 mL) in dichloromethane was prepared in an 8 mL vial and 
placed at position 2 of the stock solution rack. 500 mL of anhydrous toluene was placed 
in the stock solution bottle and placed at the reservoir rack with tubing for rinsing the 
reactor vials. Methanol (100 mL) and 80% methanol (100 mL), triethylamine (8 mL) 
Reactor Vials Reagent Rack SPE Rack Stock Solution Rack
TLC Well Plate ReservoirTransfer Ports
Donor
TMSOTf
DCM
80% CH3OH
1 2
3 4
5
1
2
3
4
5
Methanol
6
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were prepared and placed at the indicated positions (Scheme 3-5), arrangements of the 
chemicals on the reagent rack of the automated synthesizer is shown in table 3-1. 
Fluorous-tagged acceptor 4 (0.086g, 0.14mmol) was dissolved in anhydrous 
dichloromethane in an 8 mL Wheaton E-Z extraction vial and placed at position 3 of the 
reagent rack. A solution of hydrazine acetate: AcOH: Pyridine (1:1:1, by volume) was 
prepared and placed on the reagent rack in an 8 mL vial vial capped with pre-punctured 
septa. DMF was placed at position 1 of the reagent rack in an 8 mL vial capped with pre-
punctured septa. Fluorous Solid Phase Extraction (FSPE) cartridge (2.0g, 10 mL) was 
activated by washing with 80% methanol in water and placed at SPE block. Underneath 
the FSPE cartridge, an empty Wheaton 8 mL E-Z extraction vial was placed.  
Cleaning cycle 
 
Before the start of the synthesis cycle on the automated solution phase synthesizer, all the 
reactor vials were washed by running a cleaning cycle, programed for the synthesizer. 
For the cleaning cycle, firstly, the synthesizer assembly was purged with Ar (g). Then the 
reactor vials were rinsed with 8 mL toluene (from the reservoir) and 8 mL methanol. The 
solvents were placed into the reactor vials by the robotic needle, and the reactor vials 
agitated for 10 minutes before removing the solvents. This was repeated three times. At 
the end of the third cycle, the reactor vials were dried under vacuum and then Ar (g) was 
purged for 30 min.  
 
Glycosylation 
 
For the glycosylation cylcle, the reactor vials were cooled to 0 oC. The solution of the 
acceptor (0.5 mL) was transferred from its position on the reagent rack to the reactor vial 
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by the robotic needle. The needle was rinsed with toluene and then the solution of the 
donor 9 (0.5 mL) was transferred from the stock solution rack into the reactor vial. After 
rinsing the needle again with toluene, TMSOTf solution (50 µL) was also transferred into 
the reactor vial. The reactor vial assembly was vortexed for 45 min maintaining the 
temperature at 0 oC under Ar (g) atm. At the end of 30 min, 30 µL of the reaction mixture 
was transferred to the TLC rack. The reaction was quenched by adding triethylamine 
solution (0.5 mL). This solution was concentrated under reduced pressure at elevated 
temperature (40 oC).  
 
Delevulination 
 
The dried residue of the evaporation cycle was diluted with dichloromethane (0.5 mL). A 
solution of hydrazine acetate/ pyridine and acetic acid (1:1:1) (0.5 mL) was added to the 
reactor vial and vortexed for 2 h. At the end of the deprotection, 30 µL of solution was 
transferred o the TLC well plate. Acetone (0.75 mL) was added to the reactor vial to 
quench the reaction followed by the addition of toluene (1.0 mL). This solution was 
concentrated under reduced pressure at elevated temperature (70 oC).  
 
FSPE 
 
For carrying out FSPE, DMF  (0.4 mL) was transferred from the reagent rack into the 
reactor vial and the reaction mixture was agitated for 5 min to dissolve the crude product. 
0.7 mL of the reaction mixture was transferred to the FSPE cartridge at the SPE rack. 
80% methanol (4.0 mL) was added to the reactor vial. This solution from the reactor vial 
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was transferred to the FSPE cartridge in three batches of 1.5 mL. 80% methanol solution 
(1 mL) was used to rinse the FSPE cartridge and the solution was disposed into the ‘SPE 
waste’. Methanol (1.5 mL) was added to the FSPE cartridge and the eluted solution was 
collected in the 8 mL vial placed underneath the cartridge as ‘SPE collect’. This washing 
with methanol was repeated three times. The collected solution was now transferred via 
the needle into the next reaction vial for glycosylation. Toluene (1 mL) was added to the 
reactor vial containing the pure fluorous-tagged glycosylated product and the solution 
concentrated under reduced pressure at elevated temperature (70 oC). 
 
HG backbone – from the synthesizer 
cis-4-(1H, 1H, 2H, 2H, 3H, 3H – Perfluoroundecyloxy) –2-butenyl methyl-2, 3-O- 
dibenzyl-α-D-galactopyranosyluronate-(1  4)-methyl-2, 3-O- dibenzyl-α-D-
galactopyranosyluronate-(1  4)-methyl-2, 3-O- dibenzyl-α-D-
galactopyranosyluronate- (1 4)- methyl-2, 3-O- dibenzyl-α-D-
galactopyranosyluronate-(1  4)-benzyl-2, 3-O- dibenzyl-α-D-
galactopyranosyluronate-(1  4)-methyl-2, 3-O- dibenzyl-α-D-
galactopyranosyluronate (13) 
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1H NMR (400 MHz, CDCl3): δ (ppm) 7.36-7.32 (m, 30H), 7.25-7.15 (m, 15H), 7.12-
7.10 (m, 20H), 5.79-5.76 (m, 2H), 5.73 -5.71 (m, 2H), 5.23 (d, 1H), 5.01 (d, 1H), 4.90-
4.88 (m, 6H), 4.80-4.76 (m, 6H), 4.68-4.58 (m, 8H), 4.03-3.91 (m, 6H), 3.90 (s, 3H), 3.62 
(s, 3H), 3.51 (s, 3H), 2,24-2.15 (m, 2H), 1.85-1.81 (m, 2H) 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
O
COOCH3
BnO
BnO
OFtag
O
COOBn
BnO
BnO
O
O
COOCH3
BnO
BnO
O
3
O
HOCOOCH3
BnO
BnO
O
13
	  	  	  
99	  
CHAPTER 4 
Synthesis of Plant Polysaccharide Rhamnogalacturonan-I on an 
Automated Solution-Phase Platform 
Sahana K. Nagappayya, Yonghai Chai and Nicola L.B. Pohl 
Abstract  
An automated solution phase synthesis of plant polysaccharide rhamnogalacturonan-I 
(RG-I) is reported using flourous-tagged α-L-rhamnopyranoside as the glycosyl acceptor 
and trichoroacetimidate of α-D-galacturonic acid, synthesized from α-D-galactose as the 
glycosyl donor. A hexasaccharide of the RG-I backbone is synthesized on this automated 
solution phase platform and is a first report of an automated synthesis of the RG-I 
backbone.  
Introduction  
Rhamnogalacturonan –I (RG-I) is a complex pectic polysaccharide that consists of a 
backbone of α-D-galacturonic acid and L-rhamnose [-2,)- α-L-Rha-(1, 4)- α-D-GalA-(1-] 
carrying side-chains of neutral carbohydrates (McNeil et al, 1980; Lau et al, 1985). The 
roles of such galacturonic acid containing polysaccharide, known as pectins, vary from 
plant growth and development (McNeil et al, 1984) to disease resistance (Ryan et al, 
1981) and they are now also used as gelling agents and stabilizers in food industry 
(Willats et al, 2006). Recent studies have suggested that changing the side chains on RG-I 
backbone may have significant roles in various stages of plant growth and development 
(Ooman, et al, 2002). The side chain of RG- I contains saccharides like single β-D-
galactose, and also polysaccharides like α-L-arabinan (Ridley, et al, 2001). The backbone 
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itself is known to contain both α-D-galacturonic acid and the methyl esterified α-D-
galacturonic acid residues (McNeil et al, 1984). But there is little information about the 
mechanism or specific molecular interaction of the various saccharides present on the 
RG-I backbone or its side-chains (Mohnen, 2008). 
 
Recently, Davis and co-workers demonstrated the involvement of RG-I backbone in 
forming Ca2+ bridges (Scanlan el al, 2010). In this elegant study, the researchers first 
chemically synthesized pentasaccharide backbone of RG-I and then set on to perform a 
solution-phase conformation study in the presence and absence of Ca2+ to validate the 
hypothesis that the methyl esters on the backbone of the pectin polysaccharide is indeed 
involved in Ca2+ binding bridges (Caffall et al, 2009). This is one of the first examples 
where the chemical synthesis of the plant polysaccharide helped in revealing a molecular 
basis of the dynamic process that takes place in solution. This study emphasizes the 
importance of chemical synthesis of pectin polysaccharide over study of inhomogeneous 
mixture of polysaccharides obtained after enzymatic digestion of pectins (Nakamura et al, 
2002). 
 
Fragments of RG have also shown to exhibit proteinase inhibitor inducing factor (PIIF) 
activity (Ryan et al, 1981). The phenomenon by which plants synthesize large amounts of 
proteins that inhibit insect and microbial proteinases upon mechanical injury is called the 
proteinase inhibitor-inducing factor (PIIF) (Green et al, 1972). Fragments of pectic 
polysaccharides, containing only few oligosaccharide residues, have shown to have PIIF 
activity, shown in injured cells from tomato leaves (Ryan et al, 1981). In this study, the 
authors extracted the PIIF from tomato leaves and subjected a batch of young tomato 
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plants with this solution of the extracted pure PIIF and another batch with a solution of 
RG-I fragments. Upon incubation and analysis, it was observed that both the batches 
induced proteinase inhibitors in the leaves of the tomato plant to the same extent. The 
involvement of RG-I as a PIIF was further confirmed by various analysis by this group.  
 
All the enzymes necessary for the biosynthesis of RG-I are not known yet and many 
enzymes that break the plant cell wall polysaccharides or synthesize them are still being 
studied (Nakamura et al, 2002; Sterling et al, 2006) and there is a lack of well-defined 
structures of RG-I due to the difficulty in isolating pure RG-I from its sources (Ridley et 
al, 2001). Chemical synthesis, therefore, provides a promising method to better 
understand the various roles of RG-I in plants and to also extend its utility. 
 
To make the glycosylation reactions consistent by minimizing human errors, an 
automated solution phase synthesis platform is used in this study.  In the automated 
solution-phase synthesis, the reaction is carried out on a programmable platform using a 
robotic system where the duration of each reaction and the amounts of reagents added are 
all controlled by the program thereby minimizing experimental errors. This automated 
solution phase platform is conveniently based on the Fluorous Solution Phase Extraction 
(FSPE) method for the purification of the growing oligosaccharide chain (Pohl, 2008a). 
For the solution-phase automated synthesis, a fluorous tag containing C8F17- handle is 
attached to the reducing end of the oligosaccharide chain. During FSPE, the impure 
mixture is passed through the fluorous silica cartridge, where using a combination of 
appropriate fluorophilic and fluorophobic solvents, fluorous-tagged compound can be 
easily separated from un-tagged compounds (Curran, 2001). This flourous-tag based 
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automated solution phase synthesis is becoming a very useful tool in oligosaccharide 
synthesis.  
Results and discussion 
In the synthesis of the rhamnogalacturonan-I backbone fragment, α-D-galacturonic acid 
tricholoroacetimidate was chosen as the donor and L-rhamnopyranoside with a C8F17- 
containing fluorous tag at the anomeric center was chosen as the glycosyl acceptor. The 
whole assembly of α-D-GalA-1, 2- α-L-Rha-1, 4- repeating unit was synthesized on the 
solution-phase automated synthesizer. Both post-glycosylation oxidation and pre-
glycosylation oxidation strategies have been applied for the synthesis of backbones 
containing galA (Yamanoto et al, 2005; Clausen et al 2003). In the previous attempts to 
synthesize RG-I backbone, the researchers started with α-D-galacturonic acid as the 
starting material and carried out functional group transformations to synthesize the galA 
donor (Nemati et al, 2008). In our strategy, we used the pre-glycosylation oxidation of D-
galactose to synthesize α-D-galacturonic acid tricholoroacetimidate donor 7.  The 
synthesis of this building block is discussed in detail in Chapter 3. The rhamnopyranosyl 
acceptor 3 was synthesized starting with L-rhamnose, by first making a 1, 2-orthoester 1 
and then benzylating the 3- and 4- O positions to give 2. Cleavage of this orthoester 2 
under acidic conditions give the 2-O acetate and free anomeric hydroxyl, which is 
coupled with fluorous tag 4 under standard glycosylating conditions (Scheme 4-1A). The 
fluorous tag 4 was developed by Pohl and co-worrkers (Mamidyala et al, 2008) and is a 
robust fluorous handle for the solution-phase automated synthesis. The synthesis of this 
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fluorous tag and is shown in Scheme 4-1B. The assembly of these building blocks on the 
solution-phase automated synthesizer is shown in Fig 4-1.  
 
 
Condition: A. a. (i) Ac2O, Py (89%) (ii) HBr/ CH3COOH, CH2Cl2 (81%) (iii) 
CH3CH(OCH3)2, TBAB, CH2Cl2, Et3N (85%) b. (i) Na, CH3OH (90%) (ii) BnBr, NaH, 
DMF (83%) c. (i) 2N HCl, CH2Cl2 (ii) Cl3CCN, K2CO3, CH2Cl2 (76% over two steps) B. 
(i) TMSOTf, CH2Cl2 (87%) (iv) Na, CH3OH (90%) C. d. (i) MsCl, ET3N, TBAB, CH2Cl2 
(98%) (ii) cis-1, 4 butenediol, KOH, CH2Cl2 (67%) 
 
Scheme 4-1. Synthesis of fluorous-tagged L-rhamnopyranoside building block 
 
 
Figure 4-1. Schematic of the automated solution phase synthesis of the RG-I fragment 
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Scheme 4-3. The hexasaccharide of RG-I 11- fully protected from the automated 
solution-phase synthesizer; 12- after deprotection of the benzyl groups.  
 
First the glycosylation between the fluorous-tagged L-rhamnose and fully protected α-D-
galacturonic acid tricholoroacetimidate was carried out by the robot, followed by the 
deprotection of the levulinate protecting group on the 4-O of the galacturonic acid 
building block. At this stage, FSPE was performed by dissolving the reaction mixture in 
DMF and running through the FSPE cartridge with 80% methanol/ water (fluorophobic), 
followed by 100% methanol (fluorophilic). The resulting disaccharide was glycosylated 
with L-rhamnopyranosyl tricholoacetimidate donor, and the cycle was continued till a 
hexasacchride was obtained. Each glycosylation and deprotection cycle was monitored 
by TLC. The complete successful synthesis of the hexasaccharide of the RG-I backbone 
was accomplished in 24 hours on the automated solution phase synthesizer. The details 
and specific requiremnets of the automation assembly are described in the experimental 
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section. This hexasaccharide was deprotected to remove all the benzyl ethers to obtain a 
fully deprotected, methyl ester and fluorous tag containing hexasaccharide of RG-I.  
Conclusion 
A successful synthesis of a hexasaccharide of RG-I was carried out on an automated 
solution-phase synthesis platform. Post-glycosylation oxidation strategy was used to 
synthesize D-galacturonic acid, which was glycosylated with L-rhamnosyl glycosyl 
acceptor on the automated solution phase synthesizer. This synthesis is a stepping-stone 
in the direction of carrying out RG-I backbone and side chain synthesis. Further studies 
on this fluorous-tagged RG-I backbone to gain knowledge of the enzymes involved in the 
synthesis and cleavage of the plant polysaccharide will be carried out along with 
designing and synthesizing some side-chain oligosaccharides of RG-I. 
Experimental Section 
General methods 
 
Reaction solvents were used directly from solvent tower (Swagelok). All other 
commercial reagents and solvents were used as received without further purification. The 
reactions were monitored and the Rf values determined using analytical thin layer 
chromatography (TLC) with Sorbent Technologies Silica gel HL TLC plates with UV 
254 (250 µm). The developed TLC plates were visualized by immersion in a solution of 
EtOH:conc. H2SO4: p-anisaldehyde (9:1:1) followed by heating on a hot plate. Silica gel 
flash chromatography was performed with ZeoPrep 60 Eco 40-63 µm. Fluorous phase 
chromatography using fluorous solid-phase extraction cartridges containing silica gel 
bonded with perfluorooctylethylsilyl chains (Fluorous Technologies, Inc.; Pittsburgh, 
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PA). All other fluorous reagents were also obtained from Fluorous Technologies, Inc. All 
moisture-sensitive reactions were performed in flame- or oven-dried glassware under a 
Ar(g) atmosphere. Bath temperatures were used to record the reaction temperature in all 
cases run without microwave irradiation. All reactions were stirred magnetically at 
ambient temperature unless otherwise indicated. 1H NMR and 13C NMR spectra were 
obtained with a VarianVXR at 400 MHz and 100 MHz or BrukerDRX at 600 MHz. 1H 
NMR spectra were reported in parts per million relative to CDCl3 (7.26 ppm) and 13C 
NMR spectra were reported in parts per million relative to CDCl3 (77.23 ppm).  
Synthetic procedures 
 
3, 4-O-Di-acetyl-1, 2-O-methoxyethylidene-β-L-rhamnopyranose. (1) 
 
Peracetylated L-rhamnose (5.1 g, 8.4 mmol) in dichloromethane (20 mL) at 0 oC, solution 
of 33% HBr/CH3COOH (14.0 mL, 0.23 mol) was added slowly using a dropping funnel. 
The reaction mixture was allowed to warm up to room temperature and stirred for 3h. 
The reaction was quenched by pouring in cold water. The organic layer was extracted 
with dichloromethane, washed with sodium bicarbonate solution, and brine. The 
dichloromethane layer was dried over anhydrous MgSO4 and concentrated under reduced 
pressure to obtain 1-bromo-2, 3, 4- tri-O-acetyl-α-L-rhamnopyranoside (4.4g, 81%, 
yellow oil). 
To the crude product obtained, dichloromethane (20.0 mL), TBAB (3.8g, 0.012 mol) and 
N,N-dimethylformamide dimethyl acetal (1.6 mL, 0.01 mol) at 45 oC and stirred. After 
8h, the reaction mixture was filtered and diluted with dichloromethane. The organic layer 
O
OAc
AcO
O
O
OCH3
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was washed with brine and dried over anhydrous MgSO4 and concentrated under reduced 
pressure. The crude product was purified by flash column chromatography (2:1 hexane 
and ethyl acetate with 1% triethylamine) to obtain 1 (3.2g. 85%, colorless oil). 
 
1H NMR (CD3OD, 400 MHz): δ (ppm) 5.67 (d, J = 2.0 Hz), 5.35 (dd, J = 10.0 Hz, 4.0 
Hz), 5.12 (t, J = 9.6 Hz), 4.78 (dd, J = 4.4 Hz, 2.4 Hz, 1H), 3.82 (m, 1H), 3.39 (s, 3H), 
2.23 (s, 3H), 2.21 (s, 3H), 1.80 (s, 3H), 1.34 (d, J = 6.4 Hz, 3H) 
13C NMR (CD3OD, 100 MHz): δ (ppm) 170.4, 170.4, 124.1, 97.4, 77.4, 70.8, 70.6, 68.4, 
50.0, 25.7, 20.9, 20.8, 17.0 
1, 2-O-Methoxyethylidene-β-L-rhamnopyranose 
      
The solution of 1 (3.2g, 0.01 mol) in methanol was stirred with sodium metal to make the 
solution basic (pH 9-10) for 2h. The solvent was removed under reduced pressure to 
obtain the crude product, which was dried under high vacuum for 6h and carried out for 
the next reaction without further purification. (2.1g, 90%, white solid) 
 
1H NMR (CD3OD, 400 MHz): δ (ppm) 5.48 (d, J = 2.4 Hz), 4.52 (dd, J = 4.0 Hz, 2.0 
Hz), 3.72 (dd, J = 8.8 Hz, 4.4 Hz), 3.34-3.29 (m), 1.67 (s, 3H), 1.34 (d, J = 6.0 Hz) 
13C NMR: (CD3OD, 100 MHz): δ (ppm) 125.0, 98.9, 81.6, 73.5, 73.1, 72.0, 49.8, 25.8, 
18.1 
 
 
O
OH
HO
O
O
OCH3
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3, 4-Di-O-benzyl-1, 2-O-methoxyethylidene-β-L-rhamnopyranose. (2) 
 
To a solution of 1, 2-O-methoxyethylidene-β-L-rhamnopyranose (2.1g, 9.5 mmol) in 
18mL DMF, NaH (1.0g, 0.03 mol) was added under Ar (g) atmosphere at 0 oC and stirred 
for 30 min, followed by the addition of BnBr (4.0 mL, 0.03 mol) and stirred for 8 h. The 
reaction mixture was quenched by addition of water. The product was extracted with 
ethyl acetate and washed with brine. The organic layer was dried over MgSO4 and 
solvent removed under reduced pressure. The crude product was purified by a flash silica 
gel column (2:1 hexane and ethyl acetate with 1% triethylamine) to obtain 2 as white 
solid. (3.1g, 83% yield, white solid) 
 
1H NMR (CD3OD, 400 MHz): δ (ppm) 7.53-7.27 (m, 10H), 5.37 (d, J = 2.0 Hz), 4.90 (d, 
J = 10.4 Hz), 4.79 (d, J = 11.6 Hz), 4.70 (d, J = 10.0 Hz), 4.68 (d, J = 9.2 Hz), 4.57 (dd, J 
= 4.0 Hz, 2.4 Hz), 3.85 (dd, J = 8.8 Hz, 4.0 Hz), 3.38 (m, 1H), 3.27 (s, 3H), 1.64 (s, 3H), 
1.29 (d, J = 6.0 Hz). 
13C NMR (CD3OD, 100 MHz): δ (ppm) 140.0, 139.7, 129.6, 129.5, 129.3, 129.3, 129.0, 
128.9, 125.2, 99.1, 81.0, 80.1, 78.9, 76.3, 73.0, 71.3, 50.0, 25.7, 18.4 
 
2-O-Acetyl-3, 4-di-O-benzyl-α/β-L-rhamnopyranose 
       
O
BnO
BnO
O
O
OCH3
O
BnO
BnO
OAc
OH
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To a solution of 32 in dicholoromethane, 2N hydrochloric acid solution was added in a 
separatory flask and shaken vigorously. This procedure was repeated twice with 20 mL 
2N hydrochloric acid solution. The organic layer was extracted with 20 mL 
dichloromethane and dried with anhydrous MgSO4 and solvent removed under reduced  
pressure. Flash silica gel chromatography was carried out with (3:3 hexane and ethyl 
acetate with 1% triethylamine) to obtain crude product.  
 
1H NMR (CD3OD, 400 MHz): δ (ppm) 7.34-7.22 (m, 10 H), 5.43 (dd, J = 3.2 Hz, 1.6 
Hz, 1H), 4.86 (d, J = 11.2 Hz, 1H), 4.68 (d, J = 11.2 Hz, 1H), 4.63 (d, J = 10.8 Hz, 1H), 
4.60 (d, J = 2.0 Hz, 1H), 4.50 (d, J = 11.2 Hz, 1H), 3.87 (dd, J = 9.2 Hz, 3.2 Hz, 1H), 3.66 
(m, 1H), 3.42 (t, J = 9.2 Hz, 1H), 3.34 (s, 3H), 2.09 (s, 3H), 1.20 (d, J = 6.0 Hz, 3H). 
13C NMR (CD3OD, 100 MHz): δ (ppm) 172.0, 140.0, 139.5, 129.5, 129.5, 129.4, 129.2, 
129.0, 128.9, 100.1, 81.3, 79.4, 72.9, 70.3, 68.9, 55.4, 21.0, 18.4 
 
2-O-Acetyl-3, 4-di-O-benzyl-α/β-L-rhamnopyranoside trichloroacetimidate (34) 
 
2-O-Acetyl-3, 4-di-O-benzyl-α/β-L-rhamnopyranose was dissolved in 15 mL 
dichloromethane followed by the addition of K2CO3 (3.2g, 0.02 mmol) and  
trichloroacetonitrile (3.8mL, 0.03 mol) under Ar (g) atmosphere. The reaction was 
allowed to stir for 1h at room temperature and filtered through a pad of Celite®. The 
O
BnO
BnO
OAc
OC(NH)CCl3
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filtrate obtained was concentrated under reduced pressure and purified by a quick flash 
column with 20% EtOAc in Hexane containing 0.1% Et3N to 3. (3.1g, 76%, colorless oil) 
 
1H NMR: (CDCl3, 400 MHz): δ (ppm) 8.68 (s, 1H), 7.39-7.20 (m, 10H), 6.21 (d, J = 2.0 
Hz, 1H), 5.58 (dd, J = 3.2 Hz, 2.4 Hz, 1H), 4.98 (d, J = 10.8 Hz, 1H), 4.78 (d, J = 11.2 
Hz, 1H), 4.68 (d, J = 10.8 Hz, 1H), 4.62 (d, J = 11.2 Hz, 1H), 4.04 (dd, J = 9.6 Hz, 3.6 
Hz, 1H), 3.98 (m, 1H), 3.58 (t, J = 9.6 Hz, 1H), 2.22 (s, 3H), 1.40 (d, J = 6.4 Hz, 3H) 
13C NMR (CDCl3, 100 MHz): δ (ppm) 170.2, 160.3, 138.3, 137.7, 129.2, 128.6, 128.6, 
128.5, 128.4, 128.3, 95.4, 91.0, 79.5, 77.3, 75.8, 72.2, 70.9, 67.7, 21.6, 21.2, 18.2 
 
cis-4-(1H, 1H, 2H, 2H,3H, 3H-Perfluoroundecyloxy)-2-butenyl-2-O-acetyl-3,4-O-
dibenzyl- α-L-rhamnopyranoside 
 
To a solution of 3 (1.5g, 0.02mol) in 18 mL dichloromethane, TMSOTf  (21µL, 2.0 
µmol) was added under Ar (g) atmosphere, followed by a solution of freshly prepared 
fluorous tag in toluene. The reaction mixture was stirred for 45 min under Ar (g) 
atmosphere and quenched by adding triethylamine and filtered through a pad of celite® 
and solvent removed under reduced pressure. A quick FSPE was carried out by 
dissolving the product in DMF and loading on the FSPE column and eluting out with 
100% CH3OH (10mL X 2) and 80% aqueous CH3OH (10mL X 2). The product obtained 
was concentrated under reduced pressure to obtain 3 (0.94g, 87% yield) 
O
BnO
BnO
OAc
O O C8F17
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1H NMR (CDCl3, 400 MHz): δ (ppm) 7.31-7.24 (m, 10H), 5.80-5.15 (m, 2H), 5.37 (dd, 
J = 3.2 Hz, 1.6 Hz, 1H), 4.93 (d, J = 8.1 Hz, 1H), 4.76 (s, 1H), 4.71 (d, J = 8.4 Hz, 1H), 
4.62 (d, J = 7.8 Hz, 1H), 4.5 (d, J = 8.4 Hz, 1H), 4.19-4.15 (dd, J = 9.3 Hz, 4.5 Hz, 1H), 
4.10-4.06 (dd, J = 9.6 Hz, 5.1 Hz, 1H), 4.04 (d, J = 3.9 Hz, 2H), 3.95-3.92 (dd, J = 6.9 
Hz, 2.4 Hz, 1H), 3,79-3,72 (m, 1H), 3.5 (t, J = 5.1 Hz, 2H), 3.44 (t, J = 9 Hz, 1H), 2.30-
2.14 (m, 5H), 1.95-1.80 (m, 2H), 1.45 (d, J = 6.0 Hz, 3H) 
13C NMR (CDCl3, 100 MHz): δ (ppm) 170.6, 139.1, 138.2, 131.0, 129.1, 128.9, 128.8, 
128.2, 98.2, 80.2, 78.34 , 75.5, 72.01, 69.3, 69.0 , 68.4 ,66.8, 62.98, 21.2, 20.8, 18.0 
 
cis-4-(1H, 1H, 2H, 2H, 3H, 3H-Perfluoroundecycloxy)-2-butenyl-2-O-hydroxyl-3,4-
O-dibenzyl-α-L-rhamnopyranoside  
 
To a solution of cis-4-(1H, 1H, 2H, 2H,3H, 3H-Perfluoroundecyloxy)-2-butenyl-2-O-
acetyl-3,4-O-dibenzyl- α-L-rhamnopyranoside (0.94g, 1.0 mmol) in methanol (12.0 mL) 
sodium metal was added at ambient temperature. The reaction mixture was stirred for 1h. 
The reaction was quenched by adding Dowex® till the solution is neutral, checked by pH 
paper. The solution was filtered and the solvent removed under reduced pressure. The 
crude product was purified by flash chromatography (4:1 dichloromethane:methanol) to 
obtain 4 (0.82g, 90% yield, colorless oil) 
 
O
BnO
BnO
OH
OFtag
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1H NMR (CDCl3, 400 MHz): δ (ppm) 7.31-7.24 (m, 10H), 5.73-5.66 (m, 2H), 4.92 (d, J 
= 11.2 Hz, 1H), 4.85 (s, 1H), 4.71 (s, 2H), 4.67-4.65 (d, J = 10.8 Hz, 1H), 4.22-4.17 (dd, J 
= 12.4 Hz, 5.2 Hz, 1H), 4.12-4.05 (m, 4H), 3.88-3.85 (dd, J = 9.2 Hz, 3.2 Hz, 1H), 3.79-
3.72 (m, 1H), 3.51-3.46 (m, 3H), 3.46 (s, 1H), 2.57-2.16 (m, 2H), 1.95- 1.80 (m, 2H), 
1.45 (d, J = 6 Hz, 3H) 
13C NMR (CDCl3, 100 MHz): δ (ppm) 138.5, 138.2, 130.1, 128.9, 128.7, 128.5, 128.3, 
128.3, 128.0, 127.9, 98.2, 80.2, 80.2, 75.5, 72.3, 68.9, 68.7, 67.5, 66.4, 62.6, 28.0, 20.8, 
18.0 
General methods for automated solution phase synthesizer cycles 
 
Scheme 4-2. Schematic of the automated solution phase synthesizer 
 
Reactor Vials Reagent Rack SPE Rack Stock Solution Rack
ReservoirTransfer Ports
Donor 1
TMSOTf
DCM
80% CH3OH
1 2
3 4
5 6
7 8
1
2
3
4
5
TLC Well Plate
Methanol
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Figure 4-2. Donor and acceptor for the automated solution phase synthesizer.  
 
Number on the reagent 
rack 
 
Chemical 
1. DMF 
2.  NaOCH3 
3.  F-Tag Acceptor (4) 
4.  Triethylamine 
5.  Donor (3) 
6.  AcOH 
7.  Acetone 
8.  Hydrazine Hydrate/AcOH/Pyridine (1:1:1) 
 
Table 4-1. The arrangement of all the chemicals on the automated solution phase 
synthesizer for the synthesis of RG-I backbone 
 
 
Sample preparation 
 
A solution of the donor 1 (0.215 g, 0.34 mmol)was prepared in anhydrous 
dichloromethane in a 13 mL vial and placed at position 1 of the stock solution rack. 0.3 
M TMSOTf solution (1.05 mL) in dichloromethane was prepared in an 8 mL vial and 
placed at position 2 of the stock solution rack. 500 mL of anhydrous toluene was placed 
in the stock solution bottle and placed at the reservoir rack with tubing for rinsing the 
reactor vials. Methanol (100 mL) and 80% methanol (100 mL), triethylamine (8 mL) 
were prepared and placed at the indicated positions (Scheme 4-2) of the automated 
synthesizer. Acceptor 4 (0.012 g, 0.21 mmol) was dissolved in anhydrous 
dichloromethane in an 8 mL Wheaton E-Z extraction vial and placed at position 3 of the 
reagent rack. Solution of donor 3 (0.18 mg, 0.35 mmol) was prepared by dissolving in 
O
LevOCOOCH3
BnO
BnO
OC(NH)CCl3
Glycosyl Donor 1 F-tag Acceptor 4
OBnO
BnO
OH
OFtag
OBnO
BnO
OAc
OC(NH)CCl3
Glycosyl Donor 3
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dichloromethane in an 8 mL Wheaton E-Z extraction vial and placed at the designated 
position on the reagent rack.  
Sodium methoxide (5.0 mL) solution (Na in methanol) was placed in an 8 mL vial 
capped with pre-punctured septa and placed at position 3 of the reagent rack. Acetic acid 
solution (0.45mL) in methanol (5.0 mL) was also placed in the 8 mL vial capped with 
pre-punctured septa and placed at the assigned position of the reagent rack. A solution of 
hydrazine acetate: AcOH: Pyridine (1:1:1, by volume) was prepared and placed on the 
reagent rack in an 8 mL vial vial capped with pre-punctured septa. DMF was placed at 
position 1 of the reagent rack in an 8 mL vial capped with pre-punctured septa.  
Fluorous Solid Phase Extraction (FSPE) cartridge (2.0g, 10 mL) was activated by 
washing with 80% methanol in water and placed at SPE block. Underneath the FSPE 
cartridge, an empty Wheaton 8 mL E-Z extraction vial was placed. The positions of the 
reagents on the reagent rack are shown in table 4-1. 
 
Cleaning cycle 
 
Before the start of the synthesis cycle on the automated solution phase synthesizer, all the 
reactor vials were washed by running a cleaning cycle, programed for the synthesizer. 
For the cleaning cycle, firstly, the synthesizer assembly was purged with Ar (g). Then the 
reactor vials were rinsed with 8 mL toluene (from the reservoir) and 8 mL methanol. The 
solvents were placed into the reactor vials by the robotic needle, and the reactor vials 
agitated for 10 minutes before removing the solvents. This was repeated three times. At 
the end of the third cycle, the reactor vials were dried under vacuum and then Ar (g) was 
purged for 30 min.  
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Glycosylation 
 
For the glycosylation cylcle, the reactor vials were cooled to 0 oC. The solution of the 
acceptor (0.5 mL) was transferred from its position on the reagent rack to the reactor vial 
by the robotic needle. The needle was rinsed with toluene and then the solution of the 
donor 1 or 3 (0.5 mL) was transferred from the stock solution rack into the reactor vial. 
After rinsing the needle again with toluene, TMSOTf solution (50 µL) was also 
transferred into the reactor vial. The reactor vial assembly was vortexed for 45 min 
maintaining the temperature at 0 oC under Ar (g) atm. At the end of 30 min, 30 µL of the 
reaction mixture was transferred to the TLC rack. The reaction was quenched by adding 
triethylamine solution (0.5 mL). This solution was concentrated under reduced pressure 
at elevated temperature (40 oC). The glycosylation reaction was performed in reactor 
vials 1, 2, 3, 4 and 5 (Scheme 4-2)  
Delevulination 
 
The dried residue of the evaporation cycle was diluted with dichloromethane (0.5 mL). A 
solution of hydrazine acetate/ pyridine and acetic acid (1:1:1) (0.5 mL) was added to the 
reactor vial and vortexed for 2 h. At the end of the deprotection, 30 µL of solution was 
transferred o the TLC well plate. Acetone (0.75 mL) was added to the reactor vial to 
quench the reaction followed by the addition of toluene (1.0 mL). This solution was 
concentrated under reduced pressure at elevated temperature (70 oC). Delevulination was 
performed in reactor vials 1, 3 and 5.  
 
Deacetylation 
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Methanol (0.5 mL) was added to the dried residue of the glycosylation reaction, followed 
by the addition of the sodium methoxide solution (0.4 mL). The reaction mixture was 
vortexed for 2h at room temperature. At the end of the reaction time, 30 µL of the 
reaction mixture was withdrawn and transferred to the TLC block. The deacetylation 
reaction was quenchd by adding acetic acid solution (0.75 mL). Toluene (1.5 mL) from 
the reservoir was added to the reactor vial and the solution concentrated under reducd 
pressure at elevated temperature (70 oC). Deacetylation was performed in reactor vials 2 
and 4.  
 
FSPE 
 
For carrying out FSPE, DMF  (0.4 mL) was transferred from the reagent rack into the 
reactor vial and the reaction mixture was agitated for 5 min to dissolve the crude product. 
0.7 mL of the reaction mixture was transferred to the FSPE cartridge at the SPE rack. 
80% methanol (4.0 mL) was added to the reactor vial. This solution from the reactor vial 
was transferred to the FSPE cartridge in three batches of 1.5 mL. 80% methanol solution 
(1 mL) was used to rinse the FSPE cartridge and the solution was disposed into the ‘SPE 
waste’. Methanol (1.5 mL) was added to the FSPE cartridge and the eluted solution was 
collected in the 8 mL vial placed underneath the cartridge as ‘SPE collect’. This washing 
with methanol was repeated three times. The collected solution was now transferred via 
the needle into the next reaction vial for glycosylation. Toluene (1 mL) was added to the 
reactor vial containing the pure fluorous-tagged glycosylated product and the solution 
concentrated under reduced pressure at elevated temperature (70 oC). 
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cis-4-(1H, 1H, 2H, 2H, 3H, 3H – Perfluoroundecyloxy) –2-butenyl methyl-2, 3-O- 
dibenzyl-α-D-galactopyranosyluronate-(1  2)-3, 4–O-dibenzyl–α-L-
rhamnopyranosyl- (1 4)-methyl-2, 3-O- dibenzyl-α-D-galactopyranosyluronate-
(1  2)-3, 4–O-dibenzyl–α-L-rhamnopyranosyl- (1 4)- methyl-2, 3-O- dibenzyl-α-D-
galactopyranosyluronate-(1  2)-3, 4–O-dibenzyl–α-L-rhamnopyranoside (11) 
  
 
 
1H NMR (400 MHz, CDCl3): δ (ppm) 7.39-7.35 (m, 15H), 7.30-7.24 (m, 18H), 7.23-
7.21 (m, 15H), 5.70-5.67 (m, 2H), 5.65-5.61 (m, 2H),  5.50-5.48 (m, 2H), 4.99-4.98 (d, 
2H), 4.90-4.88 (m, 2H), 4.82-4.78 (m, 4H), 4.78 (s, 4H), 4.63 -4.59 (m, 4H), 4.23-4.19 
(m, 3H), 4.03-4.01 (m, 2H), 3.48 (s, 6H), 2.35 -2.32 (m, 2H), 2.13-2.01 (m,4H),1.28 (d, 
3H), 1.25 (d, 3H), 1.13 (d, 3H) 
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4-(1H, 1H, 2H, 2H, 3H, 3H – Perfluoroundecyloxy)-2-butyl methyl-α-D-
galactopyranosyluronate-(1  2)-α-L-thamnopyranosyl-(14)-methyl-α-D-
galactopyranosyluronate-(1  2)-α-L-thamnopyranosyl-(14)-methyl-α-D-
galactopyranosyluronate-(1  2)-α-L-thamnopyranoside (12) 
 
 
 
1H NMR (400 MHz, CD3OD): δ (ppm) 5.21-5.19 (m, 8H), 4.39-4.36 (d, 2H), 4.11 (s, 
1H), 4.02-4.01 (m, 4H), 3.99 (s, 2H), 3.88 (m, 7H), 3.79-3.76 (m, 4H), 3.66-3.59 (m, 
12H), 3.54-3.51 (m, 9H), 3.49-3.44 (m, 6H), 2.34-2.30 (m, 4H), 1.90-1.88 (m, 2H), 1.31 
(d, 3H), 1.30 (d, 3H), 1.28 (d, 3H) 
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CHAPTER 5 
Probing the limitations of the fluorous content for tag-mediated 
microarray formation 
Heather D. Edwards, Sahana K. Nagappayya and Nicola L. B. Pohl* 
Portions of this chapter are published in Chem. Comm. 2012, 48, 510-5123 
Abstract 
The synthesis of a di-perfluorohexyl tag is reported for use in a fluorous-based 
carbohydrate microarray. A comparative microarray study with this di-perfluorohexyl tag 
and a mono-perfluorooctyl and mono-perfluorohexyl tag found the increased fluorous 
content conducive to better spot morphology and easier washing protocols without 
precluding reuse of the fluorous slide. 
Introduction 
Perfluorinated compounds (PFCs) have been extensively used in the past decade in 
commercial, industrial, and research studies, but now PFCs are becoming a major 
environmental concern (Cheng et al, 2008). The most environmentally persistent PFCs 
are perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA). Recent studies 
have found that the growing amounts of PFOS and PFOA found in water correlate with 
the bioaccumulation of PFCs in human and animals globally (Lopez-Espinosa et al, 2011, 
Penner et al, 2007). However, unlike the longer PFCs, C6 and shorter perfluorous chains 
are not environmentally persistent. (Loi et al, 2011)  Growing safety and health issues 
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  This work is reproduced from the original paper with permission of the Royal Society 
of Chemistry (RSC).	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with these 8-carbon-length fluorocarbons threaten their continued bulk manufacturing 
and therefore also the inexpensive use of this fluorous chain length in a variety of 
applications in which environmental escape of the PFCs is not a concern. However, such 
octylfluorous tags have already proven useful not only for efficient separations using 
fluorous solid phase extraction (FSPE but also as a convenient fluorous handle for 
microarray formation (Curran, 1998; Curran, 2008).  
Fluorous microarrays rely on non-covalent fluorous–fluorous interactions between the 
fluorous tail linked to the molecule used for screening and the fluorous coated glass slide. 
(Pohl, 2008b; Zhang et al, 2008) In addition to their use for carbohydrates, such 
octylfluorous- based microarrays have also been successful for screening other small 
molecule–protein interactions (Vegas et al, 2007; Liang et al, 2008) More recently, biotin 
was adhered to a fluorous-coated glass slide and it was demonstrated that C8F17-tagged 
molecules were better for fluorous biotin–avidin microarrays than the C6F1-tagged 
molecules in terms of spot intensity, size and spot morphology (Nicholson et al, 2007). 
Given that a shorter fluorous tag was likely not an option, we set out to discover a 
fluorous tag that could form strong enough non-covalent interactions for robust fluorous 
microarray studies without reliance on the C8F17 motif. 
Results and discussion  
First a route to the desired mono-C6F13-tag was designed based on the synthesis of the 
known mono-C8F17-allyl tag for direct comparison (Maidyala, et al, 2006). We started the 
synthetic route with perfluorohexyl iodide as an inexpensive precursor to obtain our 
desired product 3 (Scheme 5-1). Radical addition of per- fluorohexyl iodide to allyl 
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alcohol followed by reduction of the iodide provided perfluorohexyl alcohol 2. Alcohol 2 
was then mesylated for displacement by (Z)-1,4-but-2-endiol to provide the desired allyl 
tag 3 in 28% overall yield from allyl alcohol. 
 
Scheme 5-1. Synthetic route to the mono-C6F17-allyl flourous tag. 
As one hexylfluorous tag was insufficient for good spot formation on a fluorous slide, we 
next designed a new tag containing two C6F13-moieties for direct comparison with the 
related mono- C8F17and mono- C6F13-tagged carbohydrates described above. Such a di-
C6F13-tag would still need to allow the attached sugar to orient away from the slide 
surface in such a way that protein binding could take place. As many sugars come in the 
form of glycolipids, these structures were seen as inspiration for the design of compound 
7 with two fluorous tails attached to a group that served as a UV-active and removable 
linker (Scheme 5-2). Using ceric ammonium nitrate the fluorous linker could be readily 
removed from the di- C6F13-tagged peracetylated glucose (Tojino et al, 2008). The desired 
di- C6F13-tag synthesis then started with the known diester 4 made by addition of two 
allyl groups to diethylmalonate followed by radical addition of perfluorohexyl iodide to 
the resulting alkenes (Brace, 1999). The presence of the diesters precluded use of lithium 
aluminium hydride to remove the iodides; therefore, microwave-assisted conditions using 
OH
1
1) C6F13I, AIBN,
50 oC, 20 h, 75%
2) LAH, THF, 12h
0-21 oC, 64%
C6F13 OH
2
C6F13 O
HO
1) CH2Cl2, MsCl, DMAP
ET3N, 3 h, 98%
2) DMF, (Z)-1,4-but-2-endiol,
TBAB, KOH, 1 h, 70 oC, 60% 3
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zinc in acidic medium were developed for iodide removal to produce, after base-mediated 
saponification, diacid 5. The diacid was immediately subjected to heat-mediated 
decarboxylation to produce monoacid 6 (Loiseau et al, 2001; Kaplanek et al, 2006). This 
monoacid was reduced to the alcohol for a Mitsunobu reaction analogous to those 
previously carried out with other fluorous alcohols (Mizuno et al, 2008) to produce the 
desired di-fluorous tag 7 in a 14% overall yield from diester 4. The di-fluorous tag was 
found to be soluble to at least 1 M concentrations in the common solvents 
dichloromethane and toluene at room temperature. 
 
Scheme 5-2. Synthetic route to the di-C6F13 fluorous tag.  
With the necessary fluorous tags 3 and 7 in hand, the next step was their glycosylation 
with peracetylated trichloroacetimidate- activated (Schmidt et al, 1980) mannose, 
glucose, and rhamnose glycosyl donors. After Zemplen deacylation and reduction of the 
alkene, nine compounds were obtained to perform microarray experiments with 
O
O O
O
C6F13 C6F13
1) EtOH, HCl
Zn, µwave, 95%
2) EtOH, KOH,
94%
HO
O O
OH
C6F13 C6F13
II
4 5
180 oC, 55%
C6F13 C6F13
CO2H 1) LAH, Ether,
89%
2) PPh3, DIAD,
hydroquinone,
THF, 33% C6F13 C6F13
O
OH
6 7
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fluorescein isothiocyanate-labeled concanavalin A (FITC-ConA). ConA is known to bind 
to terminally α-linked D-mannose, whereas β-D-glucose and α-L-rhamnose are not 
ligands for this plant lectin (Ko et al, 2005) Previously reported FSPE protocols for the 
octylfluorous tagged monosaccharides were used for the purification of our new fluorous-
tagged mono- saccharides (Mizuno et al, 2008). Interestingly, the same solvents could be 
used for eluting the compounds with a single as for a double fluorous hexyl moiety. The 
aromatic ring also does not override the fluorous content in the FSPE protocol. 
 
Figure 5-1 Spotting arrangement of carbohydrates on the fluorous coated microarray 
slide. 
 
In order to compare the performance of the three fluorous-tags on the fluorous-coated 
glass slide, the carbohydrate microarray study was set up as shown in Figure 5-1. To 
make a 250 mM concentration of the carbohydrates, the fluorous-tagged 
monosaccharides were dissolved in methanol/DMSO/water (2 : 6 : 2) (Chen et al, 2008). 
These monosaccharides were then spotted multiply in groups of nine onto a commercially 
available fluoroalkylsilane- derivatized glass slide using a standard microarray spotting 
robot (Chen et al, 2008; Jaipuri et al, 2008). The slides were then incubated with a 200 
	  	  	  
124	  
mM solution of FITC-ConA in phosphate-buffered saline (PBS) for one hour. After 
incubation, the slide was washed with a 1X PBS containing 1% BSA solution twice and 
then washed once with distilled water (Liao et al, 2010). Next, the slide was scanned 
using a General Scanning ProScan Array HT at 488 nm to visualize the carbohydrate–
ConA binding (Figure 3). Finally, the data collected from the scan were processed 
through ImaGenes 8.0 software to obtain the intensities of each fluorous-tagged 
monosaccharide. 
Multiple spotting and scanning experiments revealed several key experimental details. 
We found that spotting on a new fluorous glass slide resulted in uneven spots; washing 
the slides with a 1 : 1 dichloromethane : methanol solution before printing solved this 
problem. The morphology of the spots is also affected by several physical factors like 
temperature, humidity and drying time. We printed the slides under three different 
humidity conditions (60%, 65% and 70% humidity) while maintaining the temperature at 
22 oC and observed that the slides printed at 70% humidity showed the best spots with no 
donut effect. (Note: Details are shown in the experimental section.) 
We speculate that the higher water content in air helps the hydrophilic carbohydrates to 
better orient on the glass slide to create the non-covalent fluorous–fluorous interactions 
with the fluorous molecules on the slide. Drying of the slide after printing also had an 
effect on the spot morphology. Less donut effect was observed when the slides were 
dried for a longer period of time. After testing for various drying times, we concluded 
that the slides should be kept in the humidity chamber for 18 hours and then outside of it 
for 2 hours before incubating. 
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After optimal spotting and drying conditions were found, comparisons among the three 
different fluorous tags were made. Fluorescence scans after various washing protocols 
show that the di- C6F13-tag-containing sugars were robust and could withstand more than 
two washings with 1X PBS containing 1% BSA. In many cases, the mono- C6F13-tag 
containing sugars were being washed away when washed more than once with the PBS 
solution containing BSA, whereas the intensity of the di- C6F13-tag containing sugars was 
the same even after washing multiple times. There was only a slight decrease in the 
intensity of the – C8F17 tag containing sugars with multiple washings with PBS as shown 
by the scans. Fig. 1 shows all nine of the fluorous-linked monosaccharides spotted on the 
same fluorous slide. As shown, only two of these fluorous- linked monosaccharides are 
seen bound to the ConA-FITC. The relatively weak non-covalent fluorous interaction of 
the mono- C6F13-tag with the slide due to less fluorous content precluded its visualization. 
Note also that the β-D-glucose and α-L-rhamnose compounds did not bind at all, as 
expected. From the slide we can see also that the di- C6F13-tag has a larger spot size and is 
brighter than the mono- C8F17-tag. Despite the apparent greater adhesion of the sugars 
attached to the di- C6F13-tag to the slides, the fluorous slides could still be washed and 
reused at least five times without significantly increasing background noise. 
Conclusion 
By software analysis of spot intensities, we can conclude that the spot intensity of the 
sugars attached to the di- C6F13-tag is two to four times more intense than that of the 
mono- C8F17-tag and its binding ability is superior to both the mono- C8F17- and - C6F13 
tag. The synthesis of the di- C6F13tag is relatively simple and has high yielding steps, 
which could be carried out on a larger scale. Clearly, the standard mono-C8F17 tag can be 
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effectively and efficiently replaced by the di- C6F13-tag. Given its comparable behaviour 
on fluorous silica gel, this new tag could also possibly replace the octylfluorous tag in the 
purification of compounds using FSPE in both manual and automated syntheses.  
Experimental section  
General methods  
 
Reaction solvents were used directly from solvent tower (Swagelok). All other 
commercial reagents and solvents were used as received without further purification. The 
reactions were monitored and the Rf values determined using analytical thin layer 
chromatography (TLC) with Sorbent Technologies Silica gel HL TLC plates with UV 
254 (250 µm). The developed TLC plates were visualized by immersion in a solution of 
EtOH: conc. H2SO4: p-anisaldehyde (9:1:1) followed by heating on a hot plate. Silica gel 
flash chromatography was performed with ZeoPrep 60 Eco 40-63 µm. Fluorous phase 
chromatography using fluorous solid-phase extraction cartridges containing silica gel 
bonded with perfluorooctylethylsilyl chains (Fluorous Technologies, Inc.; Pittsburgh, 
PA). All other fluorous reagents were also obtained from Fluorous Technologies, Inc. All 
moisture-sensitive reactions were performed in flame- or oven-dried glassware under a 
Ar(g) atmosphere. Bath temperatures were used to record the reaction temperature in all 
cases run without microwave irradiation. Microwave reaction was carried out in CEM 
Microwave. All reactions were stirred magnetically at ambient temperature unless 
otherwise indicated. 1H NMR and 13C NMR spectra were obtained with a VarianVXR at 
400 MHz and 100 MHz or BrukerDRX at 600 MHz. 1H NMR spectra were reported in 
parts per million relative to CDCl3 (7.26 ppm) and 13C NMR spectra were reported in 
parts per million relative to CDCl3 (77.23 ppm).  
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Synthetic procedure 
 
4,4,5,5,6,6,7,7,8,8,9,9,9-tridecafluoro-2-iodononan-1-ol (1) 
 
To a mixture of allyl alcohol (1.0 g, 17 mmol) and perfluorohexyl iodide (7.7 g, 17 
mmol) was added AIBN (0.30 g, 1.7 mmol) at 20 ºC. The mixture was cooled to -78 ºC 
to freeze the contents and then degassed, warmed to 20 ºC, and then blanketed with 
argon. The reaction mixture was heated to 70 ºC and stirred for 20 h. The reaction was 
then dissolved in hexane and poured through a fritted glass funnel and immediately 
purified by flash column chromatography with hexane to obtain 1 (82%, 7.1 g, white 
solid).  
1H NMR (CDCl3, 400 MHz): δ (ppm) 3.21-3.19 (m, 2H), 2.98-2.95 (m, 2H), 1.65-1.61 
(m, 2H) 
13C NMR (CDCl3, 100 MHz): δ (ppm) 116.3, 112.1, 90.2, 56.8, 32.1, 31.9, 30.3, 28.5, 
28.1, 28.0, 24.2 
 
4,4,5,5,6,6,7,7,8,8,9,9,9-tridecafluorononan-1-ol (2) 
 
Compound 1 (6.5 g, 13 mmol) was dissolved in tetrahydrofuran (150 mL) and cooled to 0 
ºC under argon. Once cooled, lithium aluminum hydride (0.98 g, 26 mmol) was slowly 
added to the mixture. The reaction vessel was warmed to 22 ºC and stirred for 12 h. The 
HO C6F13
I
HO C6F13
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reaction was quenched very slowly with water (30 mL) by adding it dropwise. The 
solution was then filtered and washed with NaHCO3 (50 mL) and extracted with ethyl 
acetate (2 x 80 mL). The organic layer was dried over MgSO4. The solvent was removed 
under reduced pressure. The crude product was purified by flash column chromatography 
to obtain 2 (2:1 hexane: ethyl acetate) (83%, 4.1 g, clear oil).  
1H NMR (CDCl3, 400 MHz): δ (ppm) 3.13-3.10 (t, 2H), 2.64-2.61 (m, 2H), 1.87-1.82 
(m, 2H) 
13C NMR (CDCl3, 100 MHz): δ (ppm) 115.6, 110.2, 69.1, 35.5, 26.4, 26.2, 25.4, 22.6, 
21.0, 21.0 
 
4,4,5,5,6,6,7,7,8,8,9,9,9-tridecafluorononyl methanesulfonate (4) 
 
To a solution of 3-(perfluorohexyl)propanol 3 (1.7 g, 4.6 mmol) in dichloromethane (20 
mL) was added triethylamine (1.3 mL, 9.1 mmol) and the mixture was cooled to 0 °C. 
Mesyl chloride (0.7 mL, 9.1 mmol) was added dropwise over 10 min and the reaction 
mixture was allowed to warm to ambient temperature over 3 h. The reaction mixture was 
diluted with dichloromethane (20 mL) and the organic layer was washed with water (20 
mL) and brine (20 mL), and dried over MgSO4. The solvent was removed under reduced 
pressure. The crude product was purified by flash column chromatography (2:1 hexane: 
ethyl acetate) to provide 4 (2.0 g, 98%, pale yellow oil). 
 
OMsC6F13
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1H NMR (CDCl3, 400 MHz): δ (ppm) 4.34-4.30 (t, J =12, 2H), 3.05 (s, 3H), 2.32-2.19 
(m, 2H), 2.13-2.06 (m, 2H) 
13C NMR (CDCl3, 100 MHz): δ (ppm) 117.6, 68.1, 37.7, 27.9, 27.6, 27.4, 23.6, 21.0, 
20.9 
 
(Z)-4-((4,4,5,5,6,6,7,7,8,8,9,9,9-tridecafluorononyl)oxy)but-2-en-1-ol  
 
A solution was made of cis-1,4-butenediol (3.6 mL, 44 mmol) and 3-
(perfluorohexyl)propyl	  methyl sulfonate (2.0 g, 4.4 mmol) in DMF (20 mL). A second 
solution was made of tetrabutylammonium bromide (0.16 g, 0.5 mmol) in DMF (20 mL), 
to which powdered KOH (0.25 g, 4.4 mmol) was added.  The first solution was added 
dropwise over 5 min to the second solution and the reaction mixture was stirred for 12 h 
at ambient temperature then poured into water (20 mL). The aqueous layer was extracted 
with ethyl acetate (40 mL) and the organic layer was washed with water (30 mL) and 
brine (30 mL), and dried over MgSO4. The solvent was removed under reduced pressure. 
The crude product was purified by flash column chromatography (2:1 hexane: ethyl 
acetate) to provide 3 (1.2 g, 60%, pale yellow oil).  
 
1H NMR (CDCl3, 400 MHz): δ (ppm) 5.85-5.79 (m, 1H), 5.72-5.66 (m, 1H),  4.07-4.06 
(d, J = 6 Hz, 2H), 3.53-3.50 (t, J = 11.6 Hz, 2H), 2.25-2.12 (m, 2H), 1.92-1.85 (m, 2H), 
1.67-1.66 (m, 2H) 
13C NMR (CDCl3, 100MHz): δ (ppm) 132.4, 128.5, 123.9, 117.6, 69.1, 66.72, 59.0, 
28.2, 23.6, 21.0 
HO O C6F13
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4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-octadecafluorononyl methanesulfonate  
 
To a solution of 3-(perfluorooctyl) propanol 3 (0.81 g, 1.8 mmol) in dichloromethane (20 
mL) was added triethylamine (0.15 mL, 3.6 mmol) and the mixture was cooled to 0 °C. 
Mesyl chloride (0.28 mL, 3.6 mmol) was added dropwise over 10 min and the reaction 
mixture was allowed to warm to ambient temperature over 3 h. The reaction mixture was 
diluted with dichloromethane (20 mL) and the organic layer was washed with water (20 
mL) and brine (20 mL), and dried over MgSO4. The solvent was removed under reduced 
pressure. The crude product was purified by flash column chromatography (2:1 hexane: 
ethyl acetate) to provide 4 (0.998 g, 97%, pale yellow oil). 
 
1H NMR (CDCl3, 400 MHz): δ (ppm) 4.45-4.40 (t, J =12, 2H), 3.01 (s, 3H), 2.34-2.20 
(m, 2H), 2.18-2.15 (m, 2H) 
13C NMR (CDCl3, 100M Hz): δ (ppm) 67.8, 37.4, 25.4, 26.5, 26.2, 21.4, 21.0, 19.2 
 
(Z)-4-((4,4,5,5,6,6,7,7,8,8,9,9,10,10, 11, 11,11-heptadecafluorononyl)oxy)but-2-en-1-ol  
 
A solution was made of cis-1, 4-butenediol (0.998 mL, 0.021 mol) and 3-
(perfluorooctyl)propyl	  methyl sulfonate (1.07 g, 2.42 mmol) in DMF (20 mL). A second 
solution was made of tetrabutylammonium bromide (0.15 g, 0.48 mmol) in DMF (15 
OMsC8F17
HO O C8F17
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mL), to which powdered KOH (0.27 g, 0.048 mol) was added.  The first solution was 
added dropwise over 5 min to the second solution and the reaction mixture was stirred for 
12 h at ambient temperature then poured into water (20 mL). The aqueous layer was 
extracted with ethyl acetate (40 mL) and the organic layer was washed with water (30 
mL) and brine (30 mL), and dried over MgSO4. The solvent was removed under reduced 
pressure. The crude product was purified by flash column chromatography (2:1 hexane: 
ethyl acetate) to provide 5 (0.91 g, 67% , pale yellow oil).  
 
1H NMR (CDCl3, 400 MHz): δ (ppm) 6.75-6.72 (m, 1H), 6.58-6.54 (m, 1H), 4.42 (d, 
2H), 4.18-4.15 (d, 2H), 3.42-3.40 (t, J = 11Hz, 2H), 2.58-2.55 (m, 2H), 1.54-1.52 (m, 1H)  
13C NMR (CDCl3, 100 MHz): δ (ppm) 131.2, 128.7, 128.5, 69.8, 65.4, 58.7, 29.7, 29.5, 
29.0, 24.1, 23.8, 22.2 
 
2, 3, 4-Tri-O-acetyl-rhamnopyranoside  
 
To a solution of the peracetylated L-rhamnose (1.5g, 4.51mmol) in DMF (15.0 mL), 
freshly prepared hydrazine acetate (0.49g, 5.41 mmol) was added at 50 oC. The reaction 
mixture was stirred at 50 oC for 45 min. The reaction mixture was allowed to come to 
room temperature and diluted with EtOAc (30 mL); the organic layer was washed with 
water (30 mL) and brine (30 mL), and dried over MgSO4. The solvent was removed 
O
OAcOAc
AcO
OH
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under reduced pressure to obtain 2, 3, 4-tri-O-acetyl-rhamnopyranoside (1.18g, 90%, 
white solid). 
1H NMR (400MHz, CDCl3): 5.77-5.75 (m. 1H), 5.63 (dd, 1H), 5.32 (dd, 1H), 5.21(dd, 
1H), 4.22-4.25 (m, 1H), 2.31 (s, 3H), 2.19 (s, 3H), 2.01 (s, 3H), 1.42 (d, 3H)  
13C NMR (100 MHz, CDCl3): δ (ppm) 171.2, 170.9, 168.8, 90.6, 74.2, 73.1, 68.9, 68.3, 
20.1 
 
2, 3, 4-Tri-O-acetyl-rhamnopyranoside trichloroacetimidate (14) 
 
To a solution of 2, 3, 4-tri-O-acetyl-rhamnopyranoside (1.2g, 4.1 mmol) in CH2Cl2 (20 
mL), trichloroacetonitrile was added (2.2 mL, 0.022 mol) followed by the addition of 
TMSOTf (74 µL, 0.40 mol) at 0 oC. The reaction mixture was stirred at O oC for 1h and 
then quenched with triethylamine and concentrated under reduced pressure. The crude 
product was purified by flash column chromatography (4:1 hexane: ethyl acetate) to 
provide 14 (1.5 g, 85%, pale yellow solid).  
1H NMR (CDCl3, 400MHz): δ (ppm) 5.72-5.69 (m, 2H), 5.26 (dd, 1H), 5.10 (dd, 1H), 
4.68 (dd, 1H), 4.19-4.17 (m, 1H), 4.13-4.10 (m, 1H), 4.06-4.05 (dd, 1H), 3.89-3.87 (m, 
1H), 2.19-2.16 (m, 2H), 2.10 (s, 3H), 2.05 (s, 3H), 2.01 (s, 3H),1.87-1.85 (m, 2H), 1.21 
(d, 3H) 
O
OAcOAc
AcO
OC(NH)CCl3
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13C NMR (100 MHz, CDCl3): δ (ppm) 202.6, 188. 6, 165.2, 166.1, 138.2, 138.2, 115.6, 
114.9, 101.8, 101.4, 72.5, 71.8, 68.5, 66.6, 66.1, 46.2, 25.1, 24.8, 20.4, 18.1 
 
4-((6,6,7,7,8,8,9,9,10,10,11,11,11-tridecafluoro-2-(4,4,5,5,6,6,7,7,8,8,9,9,9 
tridecafluorononyl)undecyl)oxy)phenyl-2,3,4-tri-O-acetyl-α-L-rhamnopyranoside  
 
To a solution of 2,3,4-tri-O-acetyl-α-L-rhamnopyranosyl trichloroacetimidate 14 (84 mg, 
0.19 mmol) and compound 7 4  (4-((6,6,7,7,8,8,9,9,10,10,11,11,11-tridecafluoro-2-
(4,4,5,5,6,6,7,7,8,8,9,9,9- tridecafluorononyl)undecyl)oxy)phenol (81 mg, 0.98 mmol ) in 
toluene ( 4.0 mL), TMSOTf (0.35 mL, 1.9 µmol) was added at 0 oC. The reaction mixture 
was stirred at 0 oC for 20 min and then quenched with triethylamine (190 µL ) and 
concentrated under reduced pressure. The crude product was purified by fluorous solid-
phase extraction (FSPE) using a fluorous solid-phase extraction cartridge. Non-fluorous 
compounds were eluted with 80% MeOH/water and the desired product was eluted by 
100% MeOH. The solvent was removed under reduced pressure to provide compound 19 
(56 mg, 51%, oil) 
 
1H NMR (CDCl3, 400MHz): δ (ppm) 7.65-7.63 (dd, J = 12Hz, 2H), 7.26-7.23 (dd, J = 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4 HDE provided compound 7 
O
OAcOAc
AcO
O O
C6F13
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12 Hz, 2H), 5.37-5.35 (m, 1H), 5.26 (dd, 1H), 5.15 (dd, 1H), 5.09-5.07 (m, 1H), 4.12-
4.10 (m, 2H), 3.16- 3.14 (d, J = 8Hz, 2H), 2.34 (dd, 1H), 2.05 (s, 3H), 2.04 (s, 3H), 2.02 
(s, 3H), 1.27-1.24 (m, 4H), 2.07-2.06 (m, 4H), 1.24-1.21 (m, 4H), 1.21-1.20 (d, 3H) 
13C NMR (CDCl3, 100 MHz): δ (ppm): 170.4, 157.3, 154.1, 132.9, 132.3, 128.8, 128.6, 
116.1, 115.8, 69.1, 68.0, 67.7, 51.0, 35.6, 33.4, 32.1, 29.9, 24.0, 16.6, 14.7, 14.0, 10.2 
 
4-((6,6,7,7,8,8,9,9,10,10,11,11,11-tridecafluoro-2-(4,4,5,5,6,6,7,7,8,8,9,9,9- 
tridecafluorononyl)undecyl)oxy)phenyl-α-L-rhamnopyranoside  
 
To a solution of compound 19 (42 mg, 37 µmol) in methanol (2.0 mL) K2CO3 (30 mg, 22 
mmol) was added. The reaction mixture was stirred at ambient temperature for 2 h and 
then filtered over Celite®. The solvent was removed under reduced pressure to provide 
compound 19 (28 mg, 71%, oil). 
1H NMR (CD3OD, 400MHz): δ (ppm) 7.67-7.64 (dd, 12Hz, 2H), 7.49-7.46 (dd, 12Hz, 
2H), 4.61-4.58 (m, 1H), 4.35-4.28 (m,1H), 4.12-4.10 (m, 1H), 3.75-3.73 (m, 1H), 3.52-
3.54 (m, 1H), 3.47 (d, 2H), 2.21-2.10 (m, 4H), 1.72-1.70 (m, 4H), 1.23-1.21 (m, 4H), 
1.21- 1.20 (d, 3H) 
13C NMR (CD3OD, 100 MHz): δ (ppm) 127.7, 123.9, 117.6, 114.8, 90.8, 69.9, 69.3, 
O
OHOH
HO
O O
C6F13
C6F13
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69.1, 67.7, 65.0, 45.3, 28.4, 23.5, 19.5, 16.23 
HRMS calcd. for C32H30F26O6Na: 1027.15, found [M+Na]+2D: 1031.98  
 
cis-4-(1H, 1H, 2H, 2H,3H, 3H-Perfluorononyloxy)-2-butenyl-2,3,4-O-tri-O-acetyl-
α−L-rhamnopyranoside  
 
To a solution of 2,3,4-tri-O-acetyl-α-L-rhamnopyranosyl trichloroacetimidate (21 mg, 49 
μmol) and compound 5 (11 mg, 24 μmol) in toluene (3.0 mL), TMSOTf (9.0 μL, 0.49 
μmol) was added at 0 oC. The reaction mixture was stirred at 0 oC for 20 min and then 
quenched with triethylamine (0.68 μL) and concentrated under reduced pressure. The 
crude product was purified by fluorous solid-phase extraction (FSPE) using a fluorous 
solid-phase extraction cartridge. Non-fluorous compounds were eluted with 80% 
MeOH/water and the desired product was eluted by 100%MeOH. The solvent was 
removed under reduced pressure to provide compound 20 (15 mg, 85%). 
1HNMR (CDCl3, 400MHz): δ (ppm) 5.74-5.71 (m, 2H), 5.29 (dd, 1H), 5.07 (dd, 1H), 
4.75 (dd, 1H), 4.19-4.17 (m, 1H), 4.13-4.10 (m, 1H), 4.06-4.05 (dd, 1H), 3.89-3.87 (m, 
1H), 2.19-2.16 (m, 2H), 2.15 (s, 3H), 2.04 (s, 3H), 2.03 (s, 3H), 1.90-1.88 (m, 2H), 1.23-
1.21 (d, 3H) 
13C NMR (CDCl3, 100 MHz): δ (ppm) 205.6, 184. 6, 167.3, 166.1, 137.1, 136.6, 116.5, 
O
OAcOAc
AcO
O O
C6F13
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115.9, 103.2, 102.6, 71.5, 70.8, 70.3, 68.5, 66.6, 66.1, 46.2, 26.1, 25.6, 20.4, 17.2 
Microarray preparation, screening and notes5 
Microarrays were printed by the MicroarrayerXactII™ (LabNEXT Inc. 733 Beaver Road, 
Glenview, IL 60025) robotic pin  (Xtend MP Microarray Pins 0.35 mm) deposition of the 
three different fluorous-tagged sugars in methanol/DMSO/water (v:v:v = 2:6:2) (250 µM 
solution) from a 384-well  plate  onto  commercially  available  fluorinated  glass  slides  
(Fluorous Technologies, Inc.; Pittsburgh, PA) at 70% humidity and a temperature of 22 
ºC. (Note that the slide will work better if it is washed once with a 1:1 solution of 
dichloromethane:methanol.) The glass slide was allowed to dry for 15 h to 24 h inside a 
humidity chamber and for another 2 h outside of it. This drying procedure helped in 
avoiding the donut effect and allowed the molecules to orient themselves on the slides to 
obtain good spots. The ConA-FITC 200 µM solution was composed of the FITC-labeled 
ConA (Sigma, 1 mg/1 mL, 200 µL) in a 1X PBS (780 µL) 1 mM CaCl2 (10 µL) and 1 
mM MnCl2 (10 µL) were used for the detecting protein-carbohydrate interactions. The 
arrays were incubated with the protein solution (150 µL) by using a PC500 CoverWell 
incubation chamber (Grace Biolabs, Bend, OR) for 1 h, and then washed twice with 1X 
PBS containing 1% BSA followed by washing once with distilled water. They were then 
dried and scanned at Iowa State University DNA facility. The slides were scanned using 
a General Scanning ProScanArray 5000 set at 488 nm. The fluorescent intensities were 
determined using the ImaGene 8.0 software. 
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  The microarray spotting, incubation and screening was carried out with HDE.  
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During the microarray study we found that the spots had many inconsistencies depending 
on the environmental conditions. One of the major factors affecting the spot morphology 
was humidity. So, we did a comparative study by changing humidity and keeping the 
temperature constant at 22 ºC by using the already known mannose-C8F17 tags. We 
started with 60% humidity as most microarray studies were previously performed at 60% 
humidity condition. Then we tested 65% and 70% humidity conditions. From the slides 
shown below, we can conclude that the slide at 60% humidity has donut effect whereas 
the slide at 65% humidity has a slightly less donut effect, and the slide at 70% humidity 
has no donut effect at all. Also, consistently good spots were observed with the slides 
printed at 70% humidity (Figure 5-2). Based on these results, for all the studies in this 
paper, we performed the microarray at 70% humidity.  
 
Humidity 60%                                  Humidity 65%                                Humidity 70% 
 
                                                   
Figure 5-2. Effect of humidity changes on the fluorous coated glass slide.     
 
Also, we found that the use of new slides caused inconsistencies in the spots in terms of 
binding ability of the carbohydrate to the slide. The new slide always showed prominent 
donut effect and most of time the spot would be completely washed away. So, we washed 
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the slides by adopting the method used by Spring and co-workers using 1:1 
dichloromethane:methanol (Vegas et al, 2008). We decided to wash the new slide once 
with the 1:1 solution first before printing. Also, we were able to wash and reuse the slides 
at least five times.  
 
While printing we observed contamination of the spots from the pins. The washing 
protocol of the array was not very well set up for carbohydrate microarray studies. So, we 
had to wash the pins out by hand after each spot with acetone. We used the same pin for 
each spot to get reliable results.  
 
To develop a good washing protocol for the fluorous tagged carbohydrates, we scanned 
the slide after each washing with 1XPBS containing 1% BSA. We found that the first 
wash with 1XPBS containing 1% BSA was most effective in clearing the protein from 
the slide whereas the second wash had little effect. Also, we found that washing with 
distilled water had no effect on the slide. Each slide was washed twice with 1XPBS  
containing 1% BSA and once with distilled water to remove any remaining salts that may 
have deposited on the slide.  
 
The slides below are the results that we obtained from the microarray studies. The β-D-
glucose and the α-L-rhamnose slide showed nothing, as expected. The α-D-mannose slide 
showed that the mono-C6F13-tag was washed away, while the di-C6F13-tag and mono-
C8F17-tag were clearly noticeable. The last slide has all nine fluorous-tagged 
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monosaccharides placed in one well. From this slide there are only two spots in each well 
indicating what the first three slides data shows.  
 
Mannose Slide:  
Mono-C8F17-Man     Di-C6F13-Man     Mono-C6F13-Man 	  	  	  	  	  	  	  	  	  	  
	  
	  
	  
	  
 
Rhamnose Slide: 
  Mono-C8F17-Rha       Di-C6F13-Rha       Mono-C6F13-Rha 
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CHAPTER 6 
Conclusions and Future Directions 
	  
In this dissertation methods development for glycosylation reactions of L-rhamnose using 
trichloroacetimidate donors, for automated solution-phase synthesis with application 
toward the synthesis of plant polysaccharides - homogalacturonan and 
rhamnogalacturonan-I and for a new fluorous tag for microarray studies are reported.  
For the development of a method for achieving β-glycosidic linkages of L-rhamnose, the 
effect of electron-withdrawing protecting groups was analyzed. By employing both 
participating and non-participating electron-withdrawing groups strategically placed on 
the glycosyl donor, it was shown that such protecting group manipulations can control the 
stereochemistry at the anomeric center and the synthesis of difficult anomeric linkages, 
like β-L-rhamnose, could be achieved. Although the α-glycosylated product 
predominated in most cases, it was shown that by varying the protecting groups, the 
amount of β-product could be increased. From the results of glycosylation, a role for 
remote protecting groups in controlling anomeric selectivities was also proposed. These 
results are an important step in the study of glycosylation reactions as obtaining the 
absolute stereochemistry at the anomeric center is a tricky problem and synthesizing β-
rhamnopyranosides is particularly challenging. This study with the electron-withdrawing 
groups paves the way for such protecting group manipulation studies for obtaining better 
stereoselectivity of glycosylation reactions in other cases, too. The promising results 
highlighted in chapter 2 of the dissertation can be combined with steric effects of the 
protecting group and the combined effects of electron withdrawing ability and sterics can 
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afford methods for better design of building blocks to obtain difficult anomeric linkages.  
To automate the glycosylation reactions needed to build carbohydrate chains, the utility 
of an automated solution phase synthesizer in building the backbone of plant 
polysaccharides homogalacturonan and rhamnogalacturonan-I was also discussed. 
Methods for the synthesis of hexasaccharides of HG and RG-I were developed on the 
automated solution phase synthesis platform. These studies are the first examples of 
automated syntheses of plant polysaccharides. The well-defined and characterized 
structures of these plant polysaccharides can be extremely useful in studying the activity 
of enzymes that synthesize or degrade these polysaccharides in plants. With these 
convenient new methods for making these backbone chains, and the study of protecting 
groups in the design and synthesis of building blocks to control anomeric selectivities, the 
construction of oligosaccharide fragments can be simplified. With such tool sets now 
available, future studies into the enzymatic synthesis and degradation and possible 
binding partners of these oligosaccharides can be tackled. 
The advantage of the fluorous-based automated solution phase synthesis was discussed in 
the application of the fluorous-tagged carbohydrates for microarray studies. The fluorous 
tag containing two C6F13 chains is shown to be a superior tag for fluorous-based 
microarray formation compared to the previous single C8F17-containing tag. This di-tag 
can also be incorporated in the future into the building blocks for the synthesis of longer 
oligosaccharide chains in the automated solution phase platform to effect their easy 
separation on the basis of their fluorous tag content. If longer oligoaccharides are targeted 
for synthesis and the traditional mono-tag is not potent enough for good separation, the 
di-tag developed can be a very useful handle in such cases. With the flourous di-tag there 
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are also new possibilities for applications in the selective retention of fluorous content on 
the fluorous cartridge to separate differentially fluorous-tagged molecules.  
The concept of selecting the best method for building block synthesis in terms of the use 
of protecting groups, combined with automating the process of glycosylation to 
synthesize longer oligosaccharide chains and the use of fluorous di-tagging strategies 
discussed in this dissertation all open the possibilities for better understanding of 
oligosaccharide synthesis and the application of such oligosaccharides to probe the 
biological roles of these complex rhamnose-containing and other plant oligosaccharides. 
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APPENDIX A CHAPTER 2 1H AND 13C NMR SPECTRA 
1, 2, 3, 4-Tetra-O-acetyl-α/β-L-rhamnopyranoside 	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1-O-p-Methoxy-2, 3-O-benzylidine-α-L-rhamnopyranoside 
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1-O-p-Methoxy-2, 3-O-benzylidine-4-O-acetyl-α-L-rhamnopyranoside 
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1-O-p-Methoxy-2, 3-O-benzylidine-4-O-benzoyl-α-L-rhamnopyranoside	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1-O-p-Methoxy-2, 3-O-di-benzyl-4-O-benzoyl-α-L-rhamnopyranoside 
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1-O-p-Methoxy-2, 3-O-benzylidine-4-O-p-nitrobenzoyl-α-L-rhamnopyranoside 
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1-O-p-Methoxy-2, 3-O-benzylidine-4-O-benzylsulfonyl-α-L-rhamnopyranoside 
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1-O-p-Methoxy-2, 3-O-dibenzyl-4-O- benzylsulfonyl--α-L-rhamnopyranoside 
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1-O-p-Methoxy-2, 3, 4-tribenzyl-α-L-rhamnopyranoside 
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1-O-p-Methoxy-2, 3-O-benzylidine-4-O-benzyl-α-L-rhamnopyranoside  
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1-O-p-Methoxy-2, 4-O-di-benzyl-α-L-rhamnopyranoside 
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1-O-p-Methoxy-2, 4-O-di-benzyl-3-O-acetyl-α-L-rhamnopyranoside 
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1-O-p-Methoxy-2, 4-O-dibenzyl-α-L-rhamnopyranoside 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
O
OBnBzO
BnO
OMp
	  	  	  
173	  
cis-4-(1H, 1H, 2H, 2H, 3H, 3H-Perfluoroundecyloxy)-2-butenyl 2, 3, 4-tri-O-benzyl- 
α/β-L-rhamnopyranosyl-(12)-3,4-di-O-benzyl-α-L-rhamnopyranoside 
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cis-4-(1H, 1H, 2H, 2H, 3H, 3H-Perfluoroundecyloxy)-2-butenyl 4-O-acetyl-2, 3-di-O-
benzyl- α/β-L-rhamnopyranosyl-(12)-3,4-di-O-benzyl-α-L-rhamnopyranoside 
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cis-4-(1H, 1H, 2H, 2H, 3H, 3H-Perfluoroundecyloxy)-2-butenyl 4-O-benzoyl-2, 3-di-
O-benzyl- α/β-L-rhamnopyranosyl-(12)-3,4-di-O-benzyl-α-L-rhamnopyranoside  
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cis-4-(1H, 1H, 2H, 2H, 3H, 3H-Perfluoroundecyloxy)-2-butenyl 4-O-benzoyl-2, 3-di-
O-benzyl- α/β-L-rhamnopyranosyl-(12)-3,4-di-O-benzyl-α-L-rhamnopyranoside  
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cis-4-(1H, 1H, 2H, 2H, 3H, 3H-Perfluoroundecyloxy)-2-butenyl 4-O-benzylsulfonyl-2, 
3-di-O-benzyl- α/β-L-rhamnopyranosyl-(12)-3,4-di-O-benzyl-α-L-
rhamnopyranoside 
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cis-4-(1H, 1H, 2H, 2H, 3H, 3H-Perfluoroundecyloxy)-2-butenyl 3-O-acetyl-2, 4-di-O-
benzyl- α/β-L-rhamnopyranosyl-(12)-3,4-di-O-benzyl-α-L-rhamnopyranoside 
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cis-4-(1H, 1H, 2H, 2H, 3H, 3H-Perfluoroundecyloxy)-2-butenyl 3-O-acetyl-2, 4-di-O-
benzyl- α/β-L-rhamnopyranosyl-(12)-3,4-di-O-benzyl-α-L-rhamnopyranoside 
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cis-4-(1H, 1H, 2H, 2H, 3H, 3H-Perfluoroundecyloxy)-2-butenyl 3-O-benzoyl-2, 4-di-
O-benzyl- α/β-L-rhamnopyranosyl-(12)-3,4-di-O-benzyl-α-L-rhamnopyranoside 
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cis-4-(1H, 1H, 2H, 2H, 3H, 3H-Perfluoroundecyloxy)-2-butenyl 3-O-benzylsulfonyl-2, 
4-di-O-benzyl- α/β-L-rhamnopyranosyl-(12)-3,4-di-O-benzyl-α-L-
rhamnopyranoside 
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APPENDIX B.  CHAPTER 3 1H AND 13C NMR SPECTRA 
	  
1, 2, 3, 4, 5, 6- Tetra-O-acetyl-β-D-galactopyranoside 
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1-O-allyl-2, 3, 4, 6-O-tetra-acetyl-β−D-galactopyranoside	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1-O-Allyl-β-D-galactopyranoside (1)  
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1-O-Allyl-4, 6- O-benzylidine-β-D-galactoipyranoside  
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1-O-Allyl-2, 3- dibenzyl-4, 6- O-benzylidine-β-D-galactopyranoside 
	  	  	  
	  	  	  
	  	  	  	  	  
OBnO
BnO
O
O
OPh
	  	  	  
187	  
	  
1-O-Allyl-2, 3- dibenzyl -β-D-galactopyranoside (2) 
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Benzyl 1-O-allyl-2, 3- dibenzyl-β-D-galactopyranosyluronate (4) 
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Methyl 1-O-allyl-2, 3- dibenzyl- 4-acetyl-β-D-galactopyranosyluronate (5) 
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Methyl 1-O-trichloroacetimidate-2, 3- dibenzyl- 4-acetyl-β-D-
galactopyranosyluronate (8) 
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Methyl 1-O-allyl-2, 3- dibenzyl- 4-levulinyl-β-D-galactopyranosyluronate (6) 
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Methyl 1-O-tricholoroacetimidate-2, 3- dibenzyl- 4-levulinyl-β-D-
galactopyranosyluronate (9) 	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193	  
cis-­‐4-­‐(1H,	  1H,	  2H,	  2H,	  3H,	  3H-­‐Perfluoroundecyloxy)-­‐2-­‐butenyl	  methyl	  2,	  3-­‐O-­‐
dibenzyl-­‐4-­‐O-­‐levulinyl-­‐	  β-D-galactopyranosyluronate (11) 	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cis-­‐4-­‐(1H,	  1H,	  2H,	  2H,	  3H,	  3H-­‐Perfluoroundecyloxy)-­‐2-­‐butenyl	  methyl	  2,	  3-­‐O-­‐
dibenzyl-­‐β-D-galactopyranosyluronate (12) 
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cis-4-(1H, 1H, 2H, 2H, 3H, 3H – Perfluoroundecyloxy) –2-butenyl methyl-2, 3-O- 
dibenzyl-α-D-galactopyranosyluronate-(1  4)-methyl-2, 3-O- dibenzyl-α-D-
galactopyranosyluronate-(1  4)-methyl-2, 3-O- dibenzyl-α-D-
galactopyranosyluronate- (1 4)- methyl-2, 3-O- dibenzyl-α-D-
galactopyranosyluronate-(1  4)-benzyl-2, 3-O- dibenzyl-α-D-
galactopyranosyluronate-(1  4)-methyl-2, 3-O- dibenzyl-α-D-
galactopyranosyluronate (13) 
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APPENDIX C.  CHAPTER 4 1H AND 13C NMR SPECTRA 
3, 4-O-Di-acetyl-1, 2-O-methoxyethylidene-β-L-rhamnopyranose 
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3, 4-Di-O-benzyl-1, 2-O-methoxyethylidene-β-L-rhamnopyranose. 	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2-O-Acetyl-3, 4-di-O-benzyl-α/β-L-rhamnopyranoside trichloroacetimidate 
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cis-4-(1H, 1H, 2H, 2H,3H, 3H-Perfluoroundecyloxy)-2-butenyl-2-O-acetyl-3,4-O-
dibenzyl- α-L-rhamnopyranoside 	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200	  
cis-4-(1H, 1H, 2H, 2H, 3H, 3H-Perfluoroundecycloxy)-2-butenyl-2-O-hydroxyl-3,4-
O-dibenzyl-α-L-rhamnopyranoside  	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201	  
cis-4-(1H, 1H, 2H, 2H, 3H, 3H – Perfluoroundecyloxy) –2-butenyl methyl-2, 3-O- 
dibenzyl-α-D-galactopyranosyluronate-(1  2)-3, 4–O-dibenzyl–α-L-
rhamnopyranosyl- (1 4)-methyl-2, 3-O- dibenzyl-α-D-galactopyranosyluronate-
(1  2)-3, 4–O-dibenzyl–α-L-rhamnopyranosyl- (1 4)- methyl-2, 3-O- dibenzyl-α-D-
galactopyranosyluronate-(1  2)-3, 4–O-dibenzyl–α-L-rhamnopyranoside 
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202	  
4-(1H, 1H, 2H, 2H, 3H, 3H – Perfluoroundecyloxy)-2-butyl methyl-α-D-
galactopyranosyluronate-(1  2)-α-L-thamnopyranosyl-(14)-methyl-α-D-
galactopyranosyluronate-(1  2)-α-L-thamnopyranosyl-(14)-methyl-α-D-
galactopyranosyluronate-(1  2)-α-L-thamnopyranoside (12). 
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         APPENDIX D.  CHAPTER 5 1H AND 13C NMR SPECTRA   
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   
4,4,5,5,6,6,7,7,8,8,9,9,9-tridecafluorononan-1-ol (2) 
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(Z)-4-((4,4,5,5,6,6,7,7,8,8,9,9,9-tridecafluorononyl)oxy)but-2-en-1-ol  	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(Z)-4-((4,4,5,5,6,6,7,7,8,8,9,9,10,10, 11, 11,11-heptadecafluorononyl)oxy)but-2-en-1-ol  	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2, 3, 4-Tri-O-acetyl-rhamnopyranoside  
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4-((6,6,7,7,8,8,9,9,10,10,11,11,11-tridecafluoro-2-(4,4,5,5,6,6,7,7,8,8,9,9,9 
tridecafluorononyl)undecyl)oxy)phenyl-2,3,4-tri-O-acetyl-α-L-rhamnopyranoside  
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4-((6,6,7,7,8,8,9,9,10,10,11,11,11-tridecafluoro-2-(4,4,5,5,6,6,7,7,8,8,9,9,9- 
tridecafluorononyl)undecyl)oxy)phenyl-α-L-rhamnopyranoside  
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4-((6,6,7,7,8,8,9,9,10,10,11,11,11-tridecafluoro-2-(4,4,5,5,6,6,7,7,8,8,9,9,9- 
tridecafluorononyl)undecyl)oxy)phenyl-α-L-rhamnopyranoside  
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